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ABSTRACT

Importance: Diabetes is a common world-wide disease characterized by insulin resistance and as
result there is an increased risk of cardiovascular disease and other metabolic abnormalities, that
contribute to irreversible end-organ damage. The cause of diabetes is multifactorial and includes
genetic, inflammatory and environmental factors plus lifestyle issues. Because in diabetes there
are high levels of glucose and glycated hemoglobin, these molecules are used in clinical settings
for the acute and chronic management of diabetic patients.
Objectives: a. To design and build an electrochemical biological sensor using the enzyme Glucose
Oxidase (GOX) to detect glucose in biological fluids.
b. To design and build an electrochemical biological sensor using amino-phenyl-boronic acid
(APBA) to detect glycated hemoglobin (HbA1c) in blood.
Methodology: The two types of electrodes were built using a similar carbon-coated cellulose
matrix followed by a surface pretreatment (Pre-Anodization), and by the addition of cross-linking
molecules in order to generate specific covalent bonds. Theses cross-linkers attach to anodized
cellulose fibers by specific functional groups as carboxyl’s, generating avid binding sites for either
GOX or APBA. The GOX transfers electrons to the matrix through its flavin adenine nucleotide
(FAD) subunits as its oxidase’s glucose; the number of electrons transferred is proportional to the
glucose concentration in the test solution. Due to the presence of catalase activity in the APBAHbA1c complexes, and in the presence of H2O2, a proportional number of electrons to the number
of bound glycated hemoglobin is transferred to the matrix.
Results: The specific covalent immobilization of GOX and cofactor APBA, was successfully
achieved on carbon precoated cellulose matrix. The proposed use of zero-length cross-linkers
create the indispensable molecular bindings sites for the functionality of theses disposable papercarbon electrodes. The GOX-based sensor showed a high sensitivity (60.8723 A. mM-1cm-2) and
specificity for the detection of glucose. This APBA-based sensor also showed in laboratory
settings high specificity and sensitivity (208.9461 A mM-1cm-2).
Conclusions and Relevance: These new laboratories tested electrodes to detect glucose and
HbA1c met FDA requirements and have a great potential to be used as new biosensors for the
management of diabetes in clinical settings. Furthermore, these electrodes have the potential for
clinical acceptance due to their manufacturing friendliness of portability, high sensitivity, high
specificity and low costs.
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CHAPTER 1. INTRODUCTION AND BACKGROUND

Diabetes is quickly growing to be an epidemic disease, due to the fact that in the last three decades
(CDC, 2011). About 30.3 million children and adults in the U.S. have diabetes, (9.4% of the
population), according to the CDC (ADA, 2015; CDC, 2017). Of those, 23.1 million people were
diagnosed with diabetes and 7.2 million were undiagnosed (CDC, 2015; CDC, 2017). In addition,
84.1 million people are classified as a pre-diabetes (CDC, 2014; CDC, 2017). Diabetes is more
prevalent in the elderly population, where it affects 1 in 4 people over the age of 65 or 23.1 million
adults (CDC Newsroom, 2019). However, it also affects the younger population, with one in five
adolescents and one in four young adults having pre-diabetes with an adverse cardiometabolic risk
(Andes et al, 2019).
An estimated of 1.3 million new cases of diabetes were diagnosed among US adults aged 18 years
or older in 2017 (CDC Newsroom, 2019).
The organization for economic cooperation and development (OECD) countries, (comprising 34
countries; including United States, Canada, Australia, Japan, Korea, Mexico, Chile and several
European countries), reports 85 million people have diabetes representing around 7% of the
population aged 20-79 years. By 2030, this number will be projected to reach 108 million people
in OECD countries (Wise, J, 2015), and 439 million of the world’s adult population (7.7%). In
developed and developing countries, the projected increase in the numbers of adult with diabetes
is 20% and 69% respectively (Shaw et al, 2014). According the World health organization (WHO)
in 2014, 422 million adults had diabetes (Shaw et al, 2010), (WHO Web-assessed in May 2019).
In the U.S., based on race and ethnicity, diabetes affects 15.1% of American Indians/Alaskan
Natives, 12.7% Non-Hispanic black, 12.1% of Hispanics, 8.0% of Asian Americans and 7.4%
1

Non-Hispanic whites (CDC, 2017). Diabetes was the seventh leading cause of death in the United
States in 2015 (CDC, 2017).

Diabetes can be classified as:
1. Type 1 diabetes, (T1D): In T1D the body produces no insulin, due to the failure of the beta cells
of the islets of Langerhans in the pancreas, which can affect adults and children, and represents
5% of people with diabetes (WHO/IDF, 2006; ADA, 2008).
2. Type 2 diabetes, (T2D): T2D is characterized by an insufficient production of insulin by the
pancreas by beta cells, from insulin resistance by the cells specifically in the liver, muscles and fat
tissue, even when there is a normal level of insulin, and represents approximately 95% people with
diabetes (WHO/IDF, 2006; ADA, 2008; Vijan, S., 2010).
3. Gestational diabetes (GDM): GDM is a condition when expecting women exhibit high blood
glucose levels, especially during the second and third trimester of pregnancy (Moore & Griffing,
2014).
4. Specific types of diabetes: Examples of this class are diseases of exocrine pancreatic function,
such as monogenic diabetes (MODY) and chemical/drug induced diabetes (ADA, 2019, WHO,
2019).

The screening for diabetes and pre-diabetes is the primary objective for determining the diabetes
care (US. PSTF, 2008). Hypertension and dyslipidemia are clear risk factors for cardiovascular
disease (CVD) and diabetes (Lopez-Jaramillo et al, 2014) with CVD is being a major cause of
morbidity and mortality for individuals with diabetes.
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Glucose is the parameter key for diabetes control. Diabetes can be diagnosed by the measurement
of insulin secretion and response to glucose levels. The two most frequently used tests are:
1. Fasting plasma glucose (FPG) level at or above ≥126 mg/dL (7.0 mmol/L), OR
2. Glycate hemoglobin (HbA1c) at or above 6.5 % (48 mmol/mol), OR
3. 2-h plasma glucose (PG) ≥200 mg/dL (11.1 mmol/L during an oral glucose tolerance test
(OGTT). (ADA, 2008; WHO/IDF, 2006, ADA, 2019).

Pre-diabetes is defined as a condition in which individuals have fasting plasma glucose (FPG) of
100 mg/dL to 125 mg/dL (5.6 mmol/L – 6.9 mmol/L) or HbA1c > 5.7 % to <6.5% (39 – 47
mmol/mol) or 2-h plasma glucose (PG) during 75 g oral glucose tolerance test (OGTT) of 140
mg/dL to 199 mg/dL (7.8 mmol/mol – 11.0 mmol/mol) levels higher than normal, but no higher,
to be classified as diabetes (Vijan, S. 2010; CDC, 2012; ADA, 2019). This metabolic state is
generally not characterized by a decreased blood insulin level. (See Appendix 1.1, 1.2 & 1.3 for
more details to diagnostic diabetes and Pre-diabetes).

Glycated Hemoglobin (HbA1c), may be considered as the most important biomarker for assessing
long-term glycemic status due the presence and severity of hyperglycemia, implying diabetes
(≥6.5%) or pre-diabetes state (≥5.7% - <6.5%), and can be considered as risk factor (Lyons &
Basu, 2012). Individuals with HbA1c values between 6.0% - 6.5%, have a 25% to 50% risk of
developing diabetes over the next 5 years, that is 20 times higher compared to individuals having
HbA1c concentrations of 5.0% (Zhang, et al 2010). (See Appendix 2. 1. HgbA1c discovery and
medical clinic utility).
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There is a direct correlation between insulin resistance and HbA1c, showing a strong relationship
with the sensitivity of insulin in healthy subjects with normal glucose tolerance (NGT), low levels
of insulin sensitivity correspond a high levels of insulin resistance (Lin, et al, 2014). HbA1c is a
reliable biomarker and an excellent indicator of insulin resistance for testing individuals for
diabetes, prediabetes and poor glycemic control in children having higher levels of cholesterol,
and triglycerides (Borai, et al, 2011; Onal et al, 2014). Patients with obesity and any other
component of metabolic syndrome [glucose metabolism disorders or glucose intolerance, high
blood pressure (HTN), dyslipidemia] and are related to insulin resistance as a common pathway
for them, and HbA1c can identify persons at increased risk for cardiovascular disease (CVD),
Stroke, and death (Selvin et al, 2010).
HbA1c is a more predictable measurement of chronic glucose levels, expressing the degree of
glucose exposure over a long period of time. HgbA1c, due to this factor, has a more intimate
relationship with the of complications, more a than a single measurements or continuous episodic
measurements in glucose values. HbA1c value shows the effectiveness of the therapy by monitoring
long-term serum glucose regulation (ADA, 2010), the implementation of HbA1c control method,
soon after the diagnosis of diabetes, is also associated with long-term reduction in micro-vascular
disease (nephropathy, neuropathy and retinopathy) (UKPDS, 1998; Carnethon et al, 2010; WHO,
2011; Stokes & Metha, 2013). Measuring HbA1c levels is not recommended as frequently as
measuring glucose levels, but has advantages, because it can be done even in the non-fasting state,
has a higher repeatability, and lower costs. HbA1c testing has an important role in the diagnosis of
diabetes or pre-diabetes; it assess the effectiveness and safety for a management plan to control
the hyperglycemic or hypoglycemic levels, in patients with type 2 diabetes and type 1 diabetes;
and as preventive assessment identifying patients with high risk, who can developed major
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complications. “American diabetes association (ADA) proposed optimal targets, but each target
must be individualized to the needs of each patient and his or her disease factors” (ADA, 2018). In
pregnant women HgA1c levels exhibited high sensitivity and low specificity for diagnosing
gestational diabetes, and values of HbA1c levels between 5.7 – 6.4% are an appropriate and
effective indicator for identifying patients at highest risk of developing gestational diabetes (GDM)
and a predictor of potential postpartum death (Fong et al, 2014; Kwon et al, 2015).

The formation of HbA1c is mainly dependent on the interaction between blood glucose
concentration and the life span of red blood cells (RBC). The amount of HbA1c is directly
proportional to a time-averaged concentration of glucose within the red blood cell, and the fact
that HbA1c accumulates through the red cell’s life-span explains why young red cells have lower
amounts of HbA1c than old red cells (Bunn et al, 1976). Thus, the amount of HbA1c reflects the
average of blood glucose levels for the last 2-3 months, the average lifespan of red blood cells; the
daily fluctuations of the glucose level cannot affect the HbA1c levels and are therefore used as a
more accurate index for diagnosis and long-term monitoring and control for the Diabetes (Pundir
& Chawla, 2014). According the international HbA1c derived average glucose (ADAG) study,
HbA1c has a strong and significant correlation between the HbA1c levels and the estimated average
glucose (eAG) or mean blood glucose (MBG), suggesting that both result (HbA1c levels and eAG
result) must be reporting to clinicians to have a better evaluation profiles of the patients (ADA,
2018), (See Appendix 2. 2).

Glucose is a primary source of energy for cells, essential for metabolism and homeostasis. Glucose
transporters allow the movement of glucose through the plasma membrane of the cells. The
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facilitated diffusion glucose transports (GLUT) type, a facilitated diffusion mechanisms, from the
extracellular space to the intracellular space but driven through a chemical gradient either into the
cells or out the cells; and the sodium-glucose linked transporters (SGLT) type, which must work
with the sodium concentration gradient; are the main glucose transports. Basically, this kind of
family’s transporters are known to facilitate the entry of glucose into the cells and each one has
many different members, which are directly related to the distribution, substrate specificity, the
organ involved, and regulatory mechanism, due to specialized expression. Glucose transporters
the sodium (Na+) coupled glucose transporters (SGLT) with 14 members, is an active glucose
process transport which needs to work against a glucose concentration gradient from the lumen of
intestine or the nephron against glucose concentration gradient by coupling glucose uptake with
the Na+ gradient, which is being transported down its concentration gradient, maintained by the
active transport of Na+ across the basolateral surface cells by membrane-bound sodium-potassium
ATPase (Na+-K+-ATPase), as a source of chemical potential. The SGLT1 is primarily expressed
in intestine; SGLT2 is highly expressed in the cortex of the kidney; SGLT3 functions as glucose
sensor in the cholinergic neurons, skeletal muscle, kidney, intestine, brain and the liver, controlling
glucose levels. The second family is known as the glucose facilitative transporters (GLUT), protein
involved in glucose translocation across the cell membrane, with 14 members, working basically
for a diffusion process, due to the gradient of concentration. One of the most important transporters
is known as GLUT1 found in the erythrocyte membrane, known as Erythrocyte-type transporter
GLUT1, and in the blood-brain barrier. GLUT3 confined only to tissues with a high glucose
demand, brain and nerve. GLUT4, high-affinity insulin responsive GLUT4, occurs basically only
in skeletal muscles and adipose tissues. Understanding the working mechanisms of glucose
transport; its expression in different and specific tissues, its acute and chronic regulation through
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circulating hormones, and their defects or damages to this transportation system, all together or
independent can be the basis for diseases such as diabetes, obesity, nonalcoholic fatty liver,
hypertension. Allowing physicians and researchs to have a better approaches for prevention and
management of diabetes, with new antidiabetic drugs, new methods for non-invasive diagnosis
and close monitoring blood sugar levels (Gould & Holman, 1993; Cholkar, et al, 2013; Ward, C.,
2015; Navale & Paranjape, 2016; Deng & Yan, 2016; Litwack, Gerald, 2018).

1.1. Introduction of the Glucose Biosensor (PA-PPE-GOX-Glucose).
All glucose measurements are based on interactions with one of the three enzymes: hexokinase
(HK), beta D-glucose: oxygen-1-oxidoreductase (GOX), and glucose-1-dehydrogenase (GDH)
(Yoo & Lee, 2010; Price, C, 2003; D’Costa et al, 1986).
GOX is a glycoprotein, with a molecular weight of about 150-180kDa (Gao et al, 2014). It is the
enzyme most widely used in glucose sensors, consisting of two identical 80-kDa subunits with two
flavin adenine dinucleotide (FAD) coenzymes, bounded as a redox cofactor. The active site is a
flavin adenine nucleotide (FAD) which exist in two forms: oxidized (FAD) or reduced (FADH2)
(Bolt, A, 1998). (See figure 1.1)

Figure 1.1. Crystal (X-ray) structure of glucose oxidase. Viswanathan, Sowmya; Li, Pingzuo; Choi, Wonbong et al.
Protein–carbon nanotube sensors: Single platform integrated micro clinical lab for monitoring blood analytes.
Methods in Enzymology. 2012. Vol. 509. Chapter 9: 165-194. Permission received to publish figure.
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Immobilized GOX-FAD, oxidizes -D-glucose to −D-gluconolactone and gluconic acid as final
product, and the FADH2 generated by this reaction can be oxidized to FAD by oxygen with
hydrogen peroxide the byproduct of this reaction, and using as a glucose as an electron donor,
according the follow equation: (Wilson & Turner, 1992) (See figure 1.2).
Equation 1:
GOX(FAD) + -D-Glucose➔ GOX(FAD) Glucose➔ GOX(FADH2) glucono-d-lactone
GOX(FADH2) +O2 ➔ GOX(FAD) + H2O2 ➔ 2H+ + O2 + 2e-

Figure 1.2 Glucose oxidase catalyzes glucose oxidation releasing electrons. Viswanathan, Sowmya; Li, Pingzuo;
Choi, Wonbong et al. Protein–carbon nanotube sensors: Single platform integrated micro clinical lab for monitoring
blood analytes. Methods in Enzymology. 2012. Vol. 509. Chapter 9: 165-194. Permission received to publish figure.

The GOX is immobilized on the surface of an electrode, is covered by a membrane, which provides
more stability to the enzyme and prevents interference from other substances that can react with
the enzyme (Gao et al, 2014; Harper & Anderson, 2010). Glucose oxidase activity must be
converted into an analytical signal (Bolt, 1998), and the formation of hydrogen peroxides can be
used as a signal, too (Yoo & Lee, 2010). The decrease in the oxygen concentration due to the
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reactant consumption or the increase in the hydrogen peroxide reaction product, can both be
determined electrochemically (Yoo & Lee, 2010). Oxidation of hydrogen peroxide at a platinum
electrode generates a number of electron transfers, and this electron flow is directly proportional
to the number of glucose molecules present in the blood (Guilbaut & Lubrano, 1973), thus this
method is an example of indirect glucose detection.

The newest generation of glucose biosensors are reagent less, such as amperometric glucose
biosensor, based on direct electron transfer (DET) between the cofactor FAD of GOX and the
electrode surface without mediators (Wang, J. 2008). GOX immobilized onto the heterogeneous
surface has an electrochemical response due to a redox reaction of FAD/FADH2, and FAD
undergoes a redox reaction where two-electron are coupled with two-protons according to the
following equation:
Equation 2: GOX/FAD + 2e- + 2H+ = GOX/FADH2.

Two electrons act in the electrochemical process of FAD/FADH2, with two-proton redox reactions.
GOX has an isoelectric point of -0.40V to -0.48V and can carry charges showing a pair of weak
redox peaks in the cyclic voltammetry diagram, with an anodic peak at Epa = -0.445 V, a cathodic
peak at Epc = -0.483 V, a differential electric point of Ep = 0.038 V and a midpoint potential of
E1/2 = 0.464 V. Together, this proves that the redox center of GOX, FAD, is reduced to FADH2
and reversibly, is re-oxidized to FAD in the redox process (Cai & Chen, 2004).
GOX based, glucose biosensors, have attracted much attention due to their simplicity in
fabrication, reagent-less nature, portability, low operational costs, the fact that they do not require
an electron transport mediator between the enzyme substrate complex and the electrode, and there
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has high sensitivity and specificity. (Wang et al, 2009, 97.18 A mM-1cm-2; Salimi et al, 2009,
826.3 nA M-1cm-2; Zhang et al, 2011; 16.6 A mM-1cm-2; Sehat et al, 2014; 278.4 A mM-1cm-2).

The main limitation is that the commercially available GOX, GDH, FAD and GDHpyrroloquinoline quinone (GDH-PQQ) based glucometers have a narrow range of operation (20
mg/dL- 600 mg/dL) and only two met the ISO-2013 criteria for the international standards for
blood glucose monitoring systems, which requires that 95% of measured glucose values to fall
within ± 15 mg/dL (at <100 mg/dL) or ± 15 % (at ≥ 100 mg/dL) (Freckmann et al, 2012 and
Ekhlaspour et al, 2016). Such bottlenecks arise in part due to limitations in DET, and the
inaccessibility of actives sites of GOX. In fact, for most glucose biosensors, the active redox center
of GOX: FAD/ FADH2 is deeply embedded within a protein shell at approximately a 13 Ǻ depth
which limits electron-transfer rate between the active site of GOX and the electron surface (Wilson
& Turner, 1992; Ivnitski et al, 2008; Guo & Li, 2010).
Attempts at increasing the DET of GOX using functionalized carbon nanotubes-composites of
carbon nanotubes and graphene have been reported, however due to structural deformability and
non-ohmic contacts this approach suffers from low electrical conductivity (Chen et al, 2012; Mani
et al, 2013; Palanisamy et al, 2014; Terse-Thakoor et al, 2015). Yang et al, 2008, reported
improved DET from GOX using pre-anodized screen-printed carbon electrodes, treated with a
sulfonated perfluorocarbon polymer dispersion (Nafion®).

To achieve the covalent immobilization of GOX, on a pre-anodized paper-carbon electrode (PAPPE), we propose here to use a zero-length cross linking agent. Cross linkers are molecules with
more than one reactive end, that can attach to specific functional groups, like carboxyl, amines,
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sulfhydryl and others generating covalent bonds with proteins like enzymes. The crosslinker 1ethyl-3-3-dimethylaminopropyl carbodiimide hydrochloride (EDC) is a carbodiimide joining
carboxylates with primary amines at zero-length. By adding a N-hydrosuccinimide (NHS), an ester
group is formed as a reactive group when EDC is activated. NHS ester-activated crosslinkers,
known as 1-Hydroxy-2,5-pyrrolidinedione or N-hydroxysuccinimide, which react with primary
amines in slightly alkaline conditions of pH 7.2 – 8.5, to yield stable amide bonds (Prasad et al,
2007).

Pre-anodization
A pre-anodization (PA) procedure of the printed paper carbon electrode is the first step of
generating a more sensitive electrode. This step is followed by EDC/NHS modification and the
covalent immobilization of GOX. PA occurs without mediator; it causes the carbon atoms at the
surface of the electrode to reorient, by increasing roughness porosity, and generating new edgeplane sites, as well as, generating new functional carbonyl groups at the surface of the edge-planes
and this modification is thought to increase the amount of enzyme at the surface improving DET.
It has been shown that the oxidation on pre-anodized substrates occurs at a much higher potential
with significant shifts in peak potentials reflecting a faster electron transfer reaction. The increased
electrocatalytic activity has been related a reorientation of the surface bound carbon-oxygen
functional groups, and a generation of the new edge planes sites, through atomic reorientation. In
addition, this techniques introduces surface carbonyl groups which appear at the more reactive
edge-plane sites, which in turn paves the way for much improved crosslinking as well as
electrochemical conductivity (Prasad et al, 2007; Prasad et al, 2008; Yang et al, 2014;
Thiyagarajan et al, 2014).
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By utilizing EDC and NHS (Janegitz, et al 2011; Prasad et al, 2015), we proposed to bind GOX
to PA-PPE, and to study this modified electrode for its ability to detect glucose. As one will see at
the conclusion of this dissertation, these modifications improved the electrodes, to the point of
reliable glucose concentrations detection in the range from 18 mg/dL and 900 mg/dL, covering the
entire range of hypoglycemic and hyperglycemic states, while maintaining low cost and portability
required for a point-care testing device.

1.2. Introduction to glycated hemoglobin biosensor (PA-PPE-APBA-HbA1c).
The formation of HbA1c is mainly dependent on the interaction between blood glucose and red
blood cells (RBC). HbA1c should be directly proportional to a time-averaged concentration of
glucose within the red blood cell, and the fact that HbA1c accumulates through the red cell’s lifespan, which explains why young red cells have lower amounts of HbA1c than old red cells (Bunn
et al, 1976). According to Bunn et al, 1976, the time-averaged rate calculated for synthesis of
HbA1c was 7.1 nM/mL per day. The extremely slow conversion of HbA0 to HbA1c suggests a nonenzymatic process (Bunn et al, 1978). As a consequence, turnover of red blood cells and the
concentration of glucose: 50% of HbA1c value is the result of the glucose exposure during the
previous 30 days period, 40% of HbA1c value is the result of the glucose exposure during the 3090 days period and 10% value formed by glucose exposure during the previous 91-120 days period
(Henrichs, H., 2009). Thus, the amount of HbA1c is proportional to the average of blood glucose
level over 2-3 months and is largely independent of hourly and daily glucose levels fluctuations.
Therefore, its value is generally seen as a more accurate index for diagnosis and an important
indicator during long-term monitoring and control of diabetes (Pundir & Chawla, 2014).
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The hematocrit (HCT), plasma viscosity (1.34 mPa-s) and the aggregation and deformability of
RBC regulate the blood viscosity (3 x 10-3 to 4 x 10-3 Pa-s). An increased blood viscosity decreases
the diffusion of blood components, and therefore decreases the current in amperometric sensors.
The intravascular viscosity of the diabetic erythrocyte has been shown to be increased due to
increased HbA1c levels in patients with poor diabetic control. The glycosylation process may alter
the interaction between the hemoglobin and the RBC membrane, modify the flexibility and
deformability of the RBCs (viscoelastic properties of the erythrocyte membrane), altering their
internal viscosity, with consequently impairment of blood rheology. These alterations in the
hemoglobin molecule, RBC membrane, advanced glycation end products, associated with a
hyperglycemic state, oxidative stress by reactive oxygen species (ROS), increased levels of
markers of inflammation [C-reactive protein (CRP), interleukin (IL)-6, plasminogen activator
inhibitor-1(PAI-1), tumor necrosis factor-alpha (TNF)], increase the trend towards aggregation,
deformability of RBC, hypoxia with subsequent vascular vasodilatory adaptations, and contribute
to the development of diabetic micro and macrovascular diseases and diabetic microangiopathy
(Watala et al, 1992; Paneni et al, 2013; Martin-Timon et al, 2014; Chawla et al, 2016; Sherwani
et al, 2016). Hyperglycemia in both T1D and T2D, represents the main risk key factor for
microvascular complications, has the same risk for cardiovascular diseases (CVD) and mortality,
with a higher risk ratio over CVD mortality per unit change of HbA1c 1% increase in T1D (50%)
than in T2D (7%) (Juutilainen et al, 2008; Tandon et al, 2012).
HbA1c is formed by condensation of glucose molecule with the N-terminal amino group of valine
of the −chains of HbA0 (22) undergoing an Amadori rearrangement, to form a more stable
ketoamine linkage, a post-translational modification of HbA0. as shown in Figure1. 3.. In order of
prevalence, the main sites of hemoglobin glycosylation, are -Val-1, -Lys-66 and -Lys-61.

13

Fig.1.3 The condensation of HgA0-(2-2) -(-Val-NH2) with -D-Glucose.

The HbA1c level can be defined as the ratio between the HbA1c concentration and total hemoglobin
concentration Hb T (Pundir & Chawla, 2014).
In healthy people, hemoglobin (Hb) consists of approximately 97% adult hemoglobin (HbA), 2.5%
HbA2 and 0.5% fetal hemoglobin (HbF). Approximately 94% of HbA is non-glycated, and 6% is
glycated hemoglobin (Lenters-Westra et al, 2013). Glycated hemoglobin consists of HbA1a and
HbA1b called minor components which make up ~1% and HbA1c also called main component, the
remaining ~5% of the total 6% glycated hemoglobin (Fitzgibbons et al, 1976; Bunn et al, 1978;
Bunn et al, 1976). The HbA1c levels found in clinical investigations range from 5% to 20% with
values from 4% to ≤5.5% considered normal. A 1% change in the HbA1c level reflects a fluctuation
of mean blood glucose (MBG) concentration in plasma of approximately ~2.0 mM/L or 35.64
mg/dL, based on the following equation:
Equation 3: [MBG (mmol/L) = (1.98 x HbA1c) - 4.29], ~35.64 mg/dL (Pundir & Chawla, 2014).

The national glycohemoglobin standardization program (NGSP) expresses the values of HbA1c as
a proportion of the total hemoglobin (HbA1c%), and the international federation of clinical
chemistry and laboratory medicine (IFCC) expresses the value of HgbA1c as millimoles of HbA1c
per mole of total hemoglobin (mmol/mol) (Ang et al, 2014; Jia, W., 2016). Since 2007 the globally
accepted consensus HbA1c should be presented in both NGSP and IFCC units.
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The A1c-derived average glucose (ADAG) study supports the notion of a close relationship
between A1c levels and average glucose (AG), for both type of diabetes, and express HbA1c as:
Equation 4: eAG (mg/dL) = (28.7 x HbA1c %) – 46.7,
and the relationship between the NGSP network (%HbA1c) and the IFCC network (mmol/mol)
could be express as:
Equation 5: NGSP = [0.09148 * IFCC] + 2.152)
(Nathan et al, 2008; Hanas & John, 2010; Hanas & John, 2013).
In the U.S. physicians use the NGSP units. (See Appendix 2.2 for more details of the relationships).
Amperometric methods to detect HbA1c, are based on the recognition of amino-phenyl-boronic
acid (APBA), which interact with the sugars and has the ability to bind glucose and glycated
proteins through a boronic acid-diol bond. Boronic acid could covalently bind to either 1, 2 or 1,
3-diol group and the cis-diol group, of the surface sugar from glycated proteins, under weak
alkaline conditions, to form reversible cyclic boronic esters (Figure 1. 4). With the bound sugar,
boronic acid-modified electrode surface have been shown to be more negatively charged (Song &
Yoon, 2009). The catalytic reduction of H2O2 by HbA1c can be monitored as an analytical signal in
sensor, due to Hgb having four iron heme groups that catalyze the reduction reaction of H2O2 (Kim
& Shim, 2013, Sheikholeslam et al, 2011). Reduction of hydrogen peroxide at a platinum electrode
generates a number of electrons transfers, and this electron flow is directly proportional to the
numbers of HbA1c molecules present in blood (Kim & Shim, 2013). Since the reduction of H2O2 is
specifically catalyzed by HbA1c (Bunn et al, 1978). Amperometric assays based on HbA1c do not
require any enzymes. These types of HbA1c biosensors are reagent less, based on DET between
the cofactor APBA and HbA1c and the electrode surface without mediators (Song & Yoon, 2009).
The APBA serves 2 functions:
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a. selective binding to HbA1c over the other immobilized hemoglobins (using boronic acid part),
b. Participation in the electrochemical reaction for HbA1c measurement through its ferrocene part
(Park et al,2008; Chuang et al, 2012).

Figure 1.4. The conjugation of HbA1c and 3-aminophenyl-boronic acid (3-APBA)

Since only APBA and the immobilized HbA1c are needed for continuous and efficient electron
transfer (Park et al, 2008; Chuang, et al, 2012), the use the pre-anodization procedure, to increase
surface carboxylic and carbonyls groups functionalities on the edge planes, may also enhance the
signals of APBA-HbA1c anode and shifts the redox potential to a more positive potential range
than the redox potential of conventional APBA systems (Sheikloleslam et al, 2011; Prasad et al,
2012).

1.3. Environmental concerns.
Before developing a universal biosensor device for glucose and HbA1c, as a word of caution,
researchers need to consider different variables and limitations.
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The limitations are related to the environmental conditions of blood, human physiological and
pathological conditions such as, hematocrit (HCT), blood osmolarity, partial pressure of oxygen
(PaO2), pH, Temperature (T), altitude, and Humidity (Yoo et al, 2010; Erbach et al, 2016). High
HCT and high osmolarity slows the diffusion, and reduces the current, as well as reducing the
glucose readings. A high PaO2 can decrease glucose readings (Tang et al, 2001), and oxygen as
competes with the mediator for the electrons from the enzyme. Extreme conditions such as high
and low temperature, humidity, altitude, and pH, can influence the kinetics of the biochemical
reaction, altering the stability of the enzyme and the reliability of glucometers (Lam et al, 2014;
Tang et al, 2000).
The interferents substances or electrochemical interferents substances as: uric acid, creatinine,
acetaminophen, cholesterol, triglycerides, salicylic acid, ascorbic acid, oxygen, dopamine,
mannitol, methyldopa, are all known as electroactive species of molecules that can interfere within
the operative potential of amperometric sensors, causing false high blood glucose readings, due to
more free electrons from non-glucose molecules (Yoo et al, 2010; Erbach et al, 2016; FDA, 2016).

The performance accuracy of blood glucometers (GM) needs to be “matched appropriately to the
clinical requirements for the setting in which they are used” (Walsh, 2012). These clinical accuracy
requirements would be equivalent to analytic standards that would permit appropriate treatment
decisions to be made directly from GM results as accuracy and precision. “Patients in these
professional healthcare settings may be seriously ill, and clinically fragile, and are more likely than
lay users, to present physiological and pathological factors that could interfere with glucose
measurements” (FDA, 2018), therefore, GMs to be used at these POC of prescription drugs in
professional healthcare settings must have a highly accuracy.
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In October, 2016 The Food and Drug Administration (FDA), issued the guidance for blood glucose
monitoring systems (BGMS) intended to use in diverse professional healthcare, such as general
hospital wards, intensive care units, acute and chronic care facilities, assisted living facilities,
nursing homes and physicians ’offices, on subjects in different states of health. “BGMSs intended
for prescription-use in the hospital setting should be able to measure blood glucose accurately
down to 10 mg/dL and up to 500 mg/dL, or a clinical justification should be provided for alternate
measuring ranges and BGMSs intended for use outside a hospital setting and which will not
reasonably be used to test neonatal samples should be able to measure blood glucose accurately
down to 20 mg/dL”. “The term lay-user encompasses a group of individuals with wide ranges in
age, dexterity, vision, training received on performing testing, and other factors that can be critical
to the patient’s ability to accurately use the device and interpret test results”.
In 2018, FDA released a draft guidance document for the industry on self-monitoring blood
glucose (SMBG) test system for over-the-counter use, intended for self-monitoring blood glucose
by lay-users at home. “To meet the clinical needs of the user population, SMBGs should minimally
be able to measure blood glucose accurately between 50 mg/dL and 400 mg/dL, or a clinical
justification should be provided for alternate measuring ranges”. Generating a distinction between
two basic glucometers according to the intention of use:
a. BGMSs intended for use in point-of-care professional healthcare settings and
b. SMBGs intended for home use for self-monitoring by lay-users,
“the FDA believes that by making this distinction, SMBGs can be better designed to meet the
needs of their intended use populations, thereby providing greater safety and efficacy” (FDA, 2016
& 2018). (See Appendix 1.4 for more details).
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SMBG has been established as a valuable tool for the management of diabetes (Poolsup et al,
2009; ADA, 2013; Czupryniak et al, 2014). The goal of SMBG is to help the patient to achieve
and maintain normal glucose concentration in order to delay or prevent the progression of microvascular (retinopathy, nephropathy, & neuropathy) and macro-vascular (stroke, coronary artery
disease) complications (Adler et al, 2000; Ali et al, 2013). The American diabetes association
(ADA), recommends that SMBG be an integral part of treatment for patients with type 1 and type
2 diabetes. When SMBG was incorporated in the management for diabetes, due to the fact that the
diabetic population was correctly identified, and that the population that where on the edge,
(prediabetic state patients), could be recognized, and grouped with this classification and separated
from diabetics, with greater acuity.

SMBG had a maximum market share in 2016, but due to implementation of SMBG as a therapy
and the rise in the prevalence of diabetes worldwide has a major influence in this market segment
to grow rapidly in the forthcoming years. “One of the major growth drivers of the market segment
is the preference for early diagnosis, which helps in enabling appropriate and prompt intervention
and reducing overall disease burden and promoting health”. The global market for blood glucose
monitoring devices (BGMs) is expected to grow at a moderate rate and record a compound annual
growth rate (CAGR) of close to 12% during the forecast period. Educators of the American
diabetes association have a released procedure for primary care practice, which states that the costs
of medical services incurred by diabetic patients can be reimbursed through medicare. Due to the
availability of theses reimbursement options, this can be considered as one of the growth drivers
for the global BMG devices market, because it positively influences the increases in sales.
“Vendors are increased their online marketing and promotional activities, that means the demand
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for online purchase of glucose meters, blood glucose strips and lancets are growing, and all these
factors intensify the level of market competition in the forthcoming years”. There exists a
competitive scenario (approx. 200 companies) between the company manufacture’s, to have a
good product due to sensitivity, technology, differentiation and operative service (see de Global
BGM devices market by Technavio, 2017).
By 2030, according to the organization for economic cooperation and development (OECD), the
prevalent cases are going to reach about 47,973,000 in Europe, 66,812,000 in the Americas and
18,234,00 in Africa, which means that the market related to diabetes and the coo-morbidities
increase to faster.
The global market size of blood glucose monitoring devices is expected to reach US$17.8 billion
by 2026, according to a new research report from Grand View, Inc., which registers 7.1% of CAGR
during the forecast period (Web-Assessed in Nov 2019).

In reference to the HbA1c, in 1996, following the recommendations of the American association
of clinical chemistry (AACC) the National glycohemoglobin standardization program (NGSP)HbA1c was implemented to standardize HbA1c results obtained in the diabetes control and
complications trial (DCCT), epidemiology of intervention and diabetes complications (EDIC) and
the United Kingdom prospective diabetes study (UKPDS), which used the high-performance
liquid chromatography (HPLC) technique as the gold standard assay, due to HbA1c's emphasis as
a control marker diabetes (Goldstein et al, 1987; Lenters-Westra, W.B. 2011; Little et al, 2011;
NGSP-Web assessed in Nov. 2019).
The college of American pathologists (CAP) conducts surveys of NGSP-certified techniques using
reference standards as part of the NGSP protocol in the reference laboratory network, the survey
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does not describe any criteria for acceptance of precision and accuracy but “recommend a mean
bias of <0.2 % and a coefficient of variance (CV) ≤ 3.5% (preferably <2%) while noting that less
acceptable assay methods are those with a mean bias of >0.3 % and CV >4%”. The NGSP requires
that the average differences between an individual network laboratory and the central primary
reference laboratory (CPRL) not exceed 0.35%, and a (CV) ± 3.5%, as the exclusive criterion for
CAP HbA1c surveys, adopted and updated in 2019, as an acceptable limit for the accuracy-based
grading will be ± 5%. The 95% of confidence interval (CI) of the differences between the certifying
method and the secondary reference laboratory (SRL) must fall within ± 0.75% HbA1c for
manufacturer certification (Goodall et al, 2007; Little et al, 2011; Withley et al, 2015; Paknikar et
al, 2016; FDA, 2016; Little et al, 2019; NGSP-Web assessed in Nov. 2019). International
federation of clinical chemistry and laboratory medicine (IFCC) methods are more time consuming
and comparatively higher in cost and are not meant for routine clinical usage.

FDA has a second regulation for HbA1c diagnostic test systems, which defines “HbA1c test system
as a device used to measure the percentage concentration of hemoglobin A1c in blood.
Measurement of hemoglobin A1c is used as an aid in the diagnosis of diabetes mellitus and as an
aid in the identification of patients at risk for developing diabetes mellitus” (FDA, 2016). “The
ADA encourages physicians to evaluate both HbA1c concentrations and self-measured blood
glucose meter results, when assessing a patient’s level of glycemic control”. The ADA
recommends that HbA1c-point of care, (POC), methods not be used to diagnose diabetes, and
suggest that the results obtained from the HbA1c-POC devise can be used to monitor diabetes in
some situations (FDA, 2016; ADA, 2018 & 2019). (See Appendix 2.3. for HgbA1c).
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The FDA imposes restrictions on HbA1C-POC test devices and has classified these devices into
class II category because they have a moderate risk associated with use. Class II devices are limited
by device-specific regulations that include performance standards, labeling requirements
associated with the device use, pre-market data requirements, post-market surveillance. The
labelling on these devices should have a list of contraindications, precautions, warnings, adverse
reactions, and other instructions for use and handling before the equipment is released on the
market (FDA, 2019).
Multiple studies have shown that HbA1c-POC testing offers substantial benefits to patients by
making testing more accessible, allows immediate feedback for the patient and for the doctor at
the time of a clinical visit, laboratory results provided avoiding repeated visits for review and
therefore providing an opportunity for more timely treatment changes, with greater satisfaction
and motivation of the patient, to achieve better control of their diabetes (Crocker et al, 2013;
Paknikar et al, 2016). Many reviews have been done, to know the different methods based on
electrochemistry biosensors to detect HbA1c through POC, see the follow excellent reviews
references (Pundir et al, 2014; Ang et al, 2015; Wang et al, 2015; Yazdanpanah et al, 2015; Lin
& Yi, 2017). (See Appendix 3 for HbA1c).
Leca et al, 2012 and Lenters-Westra & Slingerland, 2014 propose that HbA1c-POC measurements
at least once a year should be confirmed by a laboratory method and call for mandatory proficiency
testing for HbA1c-POC test users to ensure continuous quality, and for the physicians basically not
to rely on the quality control for glucose for a long term on HbA1c-POC devices (Leca et al, 2012;
Lenters-Westra & Slingerland, 2014).
Lenters-Westra & Slingerland, in 2009 evaluated 8 different glycated hemoglobin POC devices
and 6 of them did not meet the generally accepted analytical performance criteria of a CV < 3.0%
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and a NGSP manufacturer certification, and, also they evaluated in 2014, 3 of the 7 POC devices
did not meet the criteria due to a high CV and low CI (Lenters-Westra & Slingerland, 2010 and
2014).
According to Lenters-Westra et al, 2013, the main problem for the HbA1c-POC devices lies in a
poor analytical performance, due to a high analytical variation (CVa) of the HbA1c laboratory assay
bias as reference methods, and the lot numbers of dependency (Lenters-Westra & Slingerland,
2010; Lenters-Westra, E, 2011; Lenters-Westra, et al, 2013; NGSP-Web. Assessed Nov. 2019).
See Appendix 2.4. for all the prerequisites for the introduction of an HbA1c-POC.
“The global point of care (POC) hemoglobin (Hb) A1C testing market was valued at about $0.41
billion in 2018 and is expected to grow to $0.53 billion at a compound annual growth rate (CAGR)
of 6.4% through 2022” (Gale online, assessed on Dec.4, 2019).

1.4. Paper and Carbon electrodes
Paper, is a thin material produced by pressing wet fibers, typically pulp of cellulose, derived from
wood or herbs that have been dried on flexible sheets, and has microstructures in three dimensions.
Paper is a biodegradable material and due to its’ capillary effect can transport liquids, forming
hydrophobic barriers, all in one hydrophilic paper-based matrix to immobilization analyte and
reagents. Paper can be characterized by its’ weight, and the thickness of the paper is often measured
by the clamp, which is typically given in thousandths of an inch. The density of paper ranges from
250 Kg/m3 (16 lb./ft3) for tissue paper to 1,500 Kg/m3 (94 lb./ft3) for some specialty paper. Special
paper is a porous blotting paper which has a thickness of 0.07 mm to 2 mm. This special paper
includes a chromatography paper which has a thickness of 0.05 mm to 0.25 mm and the porous
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have a diameter of 5 m to 15 m. High-quality chromatography paper can be modified to allow
electrical pathways and electrical conductivity, and also provide coupling with other moieties
through its functionalization. Papers which are electrically conductive and/or magnetically
sensitive, may have conductive carbon or fibers of metal, and papers which have biodegradable
polymers may be biocompatible with PADs. One of the largest contributions to microfluidic
technology was made by the Whiteside’ group with the use of paper as a basis for bioassays, due
to its’ low cost (Martinez et al, 2010; Nie et al, 2010).

Carbon-based inks have been used extensively as conductors and found their way into devices
such as printed circuits and electrodes for sensors. A carbon-based ink is an ink containing a carbon
particulate such as graphite, amorphous carbon, or a fullerene, suspended in a binder and a solvent.
These inks are applied on a surface via several deposition techniques, including painting on with
a brush, syringe application, and screen printing. The ink is allowed to dry, and the resulting carbon
coated surface is subjected to a treatment at temperatures ranging from 50°C to several hundred
degrees Celsius. This high temperature treatment, or curing, is necessary to attain high
conductivity in the resulting composite conductors, because the carbon particles are coated with
surfactants to prevent aggregation in the ink and stabilize it. In some cases, the conductive ink
undergoes a new treatment to modify the structural properties of carbon, as in our case with the
pre-anodizing technique. Carbon electrodes based on carbon inks, show a very rich chemical
surface, making this surface suitable for building a matrix with multiple applications to sensing
and detect analytes. Because “all common carbon electrode materials retain the basic structure of
six-member aromatic ring and sp2 bonding” (Wang, J., 2006), and due to the physic structure
variability, the carbon electrodes on their surfaces differ in relative density from basal planes and
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edge planes, making this edge orientation more reactive for better adsorption and more effective
electron transfer. The proven presence of the functional groups on the surface of carbon electrodes
show increased electrochemical reactivity. The quality and quantity of functional groups depends
greatly on the material of the carbon and the pre-treatment used to make it more efficient and
suitable. Carbon has a low or no ability to react and it is stable and unreactive under specific
conditions. It has a wide potential window, as related to its’ mechanical properties, and with a very
low current in the background for these applications. One the more important aspects is the low
cost for use in sensor applications (McCreery, R.L, 1991; Wang, J., 2006).

1. 5. Proposal (Research Strategy).
We propose to make a biological sensor platform, referred to as matrix, for covalent
immobilization of GOX onto a pre-anodized paper carbon electrode (PA-PPE), by means of the
zero-length cross-linker agent EDC and NHS. We will test the following which would later enables
the use of materials as glucose sensors:
a. the activity of the GOX, which has the redox cofactor FAD/FADH2 and catalyzes the oxidation
of -D-glucose by molecular oxygen producing gluconic acid and hydrogen peroxide.
b. the effect of surface pretreatments such as treating the carbon electrode at a high potential in a
various solvents or electrolytes to generate surface functional groups, carboxyl, carboxylic, phenol,
hydroxyl, epoxy.
We also propose to use the matrix platform for immobilization of APBA and HbA1c, and study the
following effects:
a. Use pre-anodized paper printed electrode for electrochemical detection of HbA1c.
b. Employ surface pretreatments and study the effect on the electrode function.
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c. Study the interactions of surface immobilized APBA with sugars, it’s binding glucose, and
ability to capture glycated proteins, such as HbA1c.
d. Study the catalytic activity of captured HbA1c to reduce H2O2, and the relation of the
electrochemical current with respect HbA1c concentration.

1. 6. General Objectives
a. Design and build an amperometric electrochemical biological sensor and matrix platform
electrode transducer using glucose oxidase as an enzyme, to detect glucose.
b. Design and build an amperometric electrochemical biological sensor and matrix platform
electrode transducer using amino-phenyl-boronic acid to detect HbA1c.
c. The long-term objective is to build a combined kit that permits to measure both parameters using
the corresponding electrodes.

1. 7. Specific Objectives
a. Design and fabricate a printer paper electrode (PPE) using a conductive carbon and Ag/AgCl
ink, to develop a carbon-based working electrode (WE), counter electrode (CE), and silver pseudo
reference electrode (RE).
b. Create a pre-anodized (PA)-PPE applying an electrical potential to the PPE to increase the
carbon and oxygen functionalities.
c. Design and build a glucose oxidase pre-anodized printer paper electrode (PA-PPE-GOX)
transducer material for use as a glucose biosensor.
d. Design and build an amino-phenyl-boronic acid pre-anodized printer paper electrode (PA-PPEAPBA) to detect HbA1c.
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e. Analyze the surface characterization of the biosensor PA-PPE-GOX and PA-PPE-GOXGlucose.
f. Analyze the surface characterization of the biosensor PA-PPE-APBA and PA-PPE-APBAHbA1c.
g. Analyze the PA-PPE-GOX to detect glucose through different electrochemical techniques such
as cyclic voltammetry, square wave voltammetry and chronoamperometry.
h. Analyze the PA-PPE-APBA-HA1c through different electrochemical techniques as cyclic
voltammetry and chronoamperometry.
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CHAPTER 2. METHODOLOGY REVIEW

2. 1. Pre-anodization Technique.
The pre-anodization technique, without mediator, causes a surface reorientation to generate more
edge plane sites and facilitate direct electron transfer (DET). The oxidation could be taking place
at a much higher potential with a significantly negative shift peak potential, which reflects a faster
electron transfer process at the pre-anodized electrode; and this faster electron transfer occurs due
to a new generation of carbon-oxygen functional groups (-C=O, -C-OH, -COOH-) on the surface
of the electrode (Kavan, L., 1997; Ilangovan et al, 1997; Lakshmirayanan et al, 2004).
Electrochemical carbon denotes “synthetic solids consisting mainly of atoms of the element
carbon”, which can be prepared electrochemically from suitable precursors through the anodic
oxidation and /or cathodic reduction (Kavan, L., 1997). Carbon is produced in various forms,
which may exhibit different heterogeneity of its surface structure and properties. “Electrochemical
carbons’ often shows a very peculiar carbyne-like structure which is based on linear sp-bonded
carbon chains” (Kavan, L., 1997). There is a wide variety of carbon-graphite products that have
been used as working electrodes; such as black carbon, glassy carbon (GC), carbon-nanotubes
(CNTs) glassy-carbon electrodes modifies (CNT-GCE), carbon fibers, graphite powder, graphite
pyrolytic (PG), highly ordered pyrolytic graphite (HOPG), edge-plane pyrolytic graphite
electrode, multi-walled carbon nanotubes (MWCNT) modified electrode, pre-anodized screenprinted carbon electrode (designed SPCE*), each one shows different physical and chemical
properties (Banks et al, 2005, Prasad et al, 2007). The structure of graphite layers in a modified
carbon electrode surface show two types of graphite planes: the basal plane, consist of graphite
layers which runs parallel to the surface and contains all the atoms of a graphite layer, having
specific physicochemical properties which can retard the transfer of electrons; and the edge-plane,
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as defects in the surface known as steps, which runs perpendicular to the basal plane, and they
expose all the edges that are in the graphite layers and promote more charge-transfer mechanisms,
(modified electrons with a major proportion of edge-plane defects have higher electron transfer).
The basal plane and the edge-plane show, at the carbon electrode surface, different electrochemical
properties due to the nature of its chemical links in the graphite and are considered as a
heterogeneous electrode electrochemically. Redox reactions show that the kinetic of the electrodes
in the basal plane are slower than the electrode kinetic that occurs in the edge-plane, and these
differences are a result of the greater reactivity in the edge-plane compared with the basal plane
(Kneton et al, 1992; Banks et al, 2005; Banks & Compton, 2005).
Variations in Raman spectroscopy with respect to the intensity ratio of the D and E2g Raman bands
across the carbon surface, shows varying carbon microstructures and disorders in graphitic
materials (Bowling et al, 1989), and its magnitude correlates inversely with the micro-crystallite
size determined from X-ray diffraction (Ray et al, 1997). The D band at ∼1360 cm-1 arises from
the breakdown of the k-vector selection rule, concerning the reduced symmetry at graphitic edges,
and mechanical treatment generated structural defects on the surface of modified carbon which
gives rise to smaller graphitic, having more and new edge carbon atoms with high reactivity
(Nakamizo et al, 1984); and the D/E2g ratio increases with higher edge plane density (Ray et al,
1997). Prasad et al, in 2007 was able to show, significative changes in the Raman Spectroscopy
of the SPCE* (after pre-anodization), in reference to the intensity of D (disorder) band at ~1,360
cm-1 and a broadening in the ~1,582 cm-1 band, as well as the ratio between the D/E2g which was
higher; also through the X-Ray photoelectron spectroscopy confirm the presence of more carbonyl
groups (-C-OH, -C(=O)-OH, -C=O); and Bowling et al, in 1989 found that the large improvement
in the electron transfer kinetics with higher K0, had a meaningful relationship with the increase in
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~1,360 cm-1 band intensity, which is couple with edge-plane graphite, with higher edge-plane
density (Prasad et al, 2007; Bowling et al, 1989).
Studies and analyses with different classes of modified carbon electrodes were made to show how
the surface structure can affect the reactivity of the electrode. The anodic oxidation and defects in
HOPG compared to an unmodified basal plane, shows modified HOPG to be more reactive
towards the adsorption and the transfer of electrons with extreme variation in their properties due
the exposure of a large quantity of new edge-planes at the electrode surface (Bowling et al, 1989;
Rice et al, 1989). Glassy carbon (GC) that has any disturbance in the ordered baseline plane
(nearby defects) significantly increased electron transfer rates and adsorption, consequently, GC
exhibited an increase in the electrochemical activity, rapid kinetics and strong adsorption. The
disorder in defects of GC increases the density of the states and makes the carbon behave more
like a metal (McCreery et al, 1994; Dekanski et al, 2001). The contribution of the diffusion
convergent to the voltammetry, increases in such a way that achieves a faster transport of the mast
per unit of area of the electrode, resulting in larger and voltammograms current densities that
appear increasingly distorted from the well-documented macro electrode shape (Eklund et al,
1999).
The electrocatalytic activity increases due to stimulation on the carbo-oxygen functional groups
bounds at the new edge-planes sites, generated through the surface reorientation, at the surface of
the carbon electrode (Kavan, L., 1997; McCreery et al, 1994). During pre-anodization, the
modified carbon electrode (CE) tends to be more porous, due to its superficial reorientation which
generates new edge-plane sites, as well, it generates new functional carbonyl groups at the surface
of the edge-planes (Prasad et al, 2007). Zen et al, in 2000, working with pre-anodized glassy
carbon electrodes (GCE), found that the increase in the forward step at the voltammogram in redox
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reaction was due to the surface functional groups, and the associated Faradic process for the redox
system (difference between the forward and reversed intercepts), for GCE electrodes working with
Pb(II)/Pb(III) redox system solution, was under a diffusion-controlled mechanism. Prasad et al,
in 2008, working with SPCE* found that the rise in the background current in the cyclic
voltammogram is a proof of the formation of redox active groups (carbonyl groups functionalities).
The peak currents for oxidation exhibit a linear relationship with the square root of scan rate and
suggest that the electron transfer is a process controlled by diffusion (Prasad et al, 2008). The new
formed carboxy-oxygen functionalities or carbonyl functionalities post pre-anodization raises the
kinetics for electron transfer and therefore shows a remarkable electrocatalytic activity in
relationship with the analytes, promoting a means for binding the absorbing materials (Banks et
al, 2005).
There are many different pre-treatment techniques to prepare and activate carbon modified
electrodes, known as a pre-anodization process, with subsequent modification of the surface
electrode area through thermal, mechanical, chemical and electrochemical methods. Some other
relevant references include: Heat treatment procedures (Stutts et al, 1983; Hu et al, 1986);
mechanical treatment for fresh and well-defined electrodes, as abrasion and ultraclean polishing
techniques (Hu et al, 1985); irradiation with ultrasound of GC electrodes show increased density
of electroactive surface oxides (Zhang et al, 1993); activation of GC using carbon arc treatment,
with a fresh increased surface electrode area (Upadhyay, P., 1989); direct electrochemical
oxidation activation (Prasad et al, 2007; Engstrom et al, 1984; Kepley et al, 1988); intense laser
pulse treatment showing that the electron transfer activation is consistent with a high density of
edge-planes (Bowling et al, 1989); and the formation of carbon–oxygen surface groups, C=O, OC-O, O-C=O functionalities, during the oxygen plasma treatment in modified carbon black
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surfaces (Evans et al, 1979; Takada et al, 1996; Notsu et al, 1999). Activation of carbon electrodes,
using large anodic currents and polishing procedures result in cleavage and reformation of carbonoxygen bonds at the surface at the electrode, (induce the formation of edge planes as well surface
functional carbonyl groups on the graphite edge-planes) (Stutts et al, 1983; Ray et al, 1997).
The surface of the carbon is modified radically, depending on its original carbon components and
the pre-treatment selected, consequently, the structural characterization becomes more difficult to
identified. It becomes possible to prepare reproducibly active carbon surfaces, particularly from
based-carbon substrates, due to i. the surface of the electrode area expands through the surface,
which becomes rougher and increases the transport rate of the mass. ii. The new surface carbon
functional groups, (that can act as mediators with faster electron transfer), are formed in the new
edge-planes, defects or microstructure of carbon materials, which becomes new sites for a faster
transfer of electrons with low overpotentials and are determinants for the reactivity of the electrode
(Hu et al, 1985; Zhang et al, 1993; Chen et al, 1996). They function as mediators or hotspots for
the covalent binding of biological molecules to speed up the electron transfer rate, to enhance the
sensitivity and reproducibility of the electrode.
Electrochemical pre-treatment methods have proved to be effective. Pre-treatment introduces or
modifies the nature of the functional groups and these groups can serve as electron mediators
between the electrode and the electroactive species on the electrode surface: Long-duration preanodization followed by short-duration cathodization, Engstrom et al, in 1984, found that the
relationship between oxygen and carbon ratio (O/C ratio) increases, due that because the surface
of the electrode is oxygenated, compatible with the idea of new functional groups containing
oxygen are formed through the pre-anodization; application of square-wave pulses several times
between two extreme potentials as electrochemical treatment of graphite-epoxy electrode carbon
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electrode and microcylinder electrode of carbon fibers (Falat et al, 1983; Kovach et al, 1986);
electrochemical pretreatment method by cycling the potential several times over a wide potential
range between two pre-stated voltages in GC electrodes give well-defined peaks at the electrode
surface due to the immobilization of the functional groups (Kepley et al, 1988, Barbero et al,
1988); working with coke-based activated carbons modified through reduction with H2 and
oxidation with HNO3, Xie et al, in 2010 shows that the generation of carbonyl groups (groups with
oxygen in the surface of the electrode) through a Faradaic process cause modification of the
capacitance and increase the relationship between the electrode-electrolyte interface (wettability).
During the anodic polarization of GC electrodes, in an acidic media, which begins with the
oxidation of a minimum surface of the active sites. These active sites are likely to be considered
defects in the structure of the CNO graphitic, such as discontinuities in the basal plane with
different functional groups formed, such as carbonyl, carboxyl, and phenolic bonded to the carbon
shown in the recorded XPS technique analysis. If all surface-active sites are oxidized, the
penetration of electrolytes becomes more intense through the domains of graphitic structure of GC
and begins the growth of a layer of graphite-oxide, which subsequent increases in the real electrode
surface. At that point, with high positive potentials, may cause the oxidation of carbon to CO
and/or CO2, which increase the electrochemical activity (Dekanski et al, 2001).
Pre-anodization of a carbon modified electrode has a great influence on electron transfer through
greater geometric surface area. The surface area can be estimated by the Brunauer-Emmett-Teller
(BET) method, which uses isotherms. Using the BET method Lakshminarayaran et al, 2004, found
an increase on surface area due to the generation of carbon-functional groups (-C=O, -C-OH, COOH) on the electrode surface (Gregg et al, 1982; Lakshminarayaran et al, 2004).
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2. 2. Zero-Length Crosslinkers.
There are two kinds of cross-linkers: a. the zero-length cross-linkers (UV light, tetranitromethane,
carbodiimides, etc.) which induce a covalent link directly between macromolecules without
interposition of a bridge and b. the contact-site cross-linking agents, known as one-atom bridge
cross-linkers, a covalent bridge consisting of one atom (usually carbon) from the cross-linking
agent (Kunkel et al, 1981).
The zero-length crosslinkers technique, achieves chemical crosslinking or the chemical process to
join two or more molecules through a covalent bond, and forms protein conjugates, without the
introduction of extra arm atom or a spacer molecule to the product, two conjugated crosslinked
peptides. This action is also called bioconjugation, which is referred to in the use in biomolecules
especially with proteins. “The key to forming a successful bioconjugate is to select the appropriate
crosslinking reagent, which in turn contains the chemical features available in the molecules, that
link them together” (Hermanson, G. 2013). These modifications are involved in the attaching or
cleaving of chemical groups, to improve the solubility, keep the native structure of the protein,
optimize and retain the enzyme protein biological activity with low to moderate grades of
conjugation. Crosslinking reagents are molecules with more than one reactive end that are capable
of attaching to specific functional groups like carboxyl (-COOH), primary amines (-NH2),
sulfhydryl (-SH), carbonyls (-CH)), and interact with specific amino acid side chains to generate
a covalent bond (amide linkage) between a pair of proximal residues of proteins (Fasol et al, 1971;
Grabarek & Gergely, 1990; Conde et al, 2012). The crosslinking of proteins and covalent
modification rely on availability of the crosslinker reagents capable to react with existing specific
structural and functional groups inside the proteins. Zero-length cross-linking agents: abolish the
potential for cross-reactivity by mediating a direct linkage between two substances; efficient in
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forming conjugates between a carbohydrate and a protein, a peptide and a protein, and two protein
molecules. Carbodiimides are the more useful zero-length cross-linkers for the formation of amidebond between a carboxylic acid and a primary amine. For bioconjugation methods, there are small
functional groups of proteins as selectable targets. Four protein chemical targets account for most
crosslinking and chemical modification techniques:
Primary amines (–NH2): This group exists at the N-terminus of each polypeptide chain called
the alpha-amine (-amine), and in the side chain of lysine (Lys, K) residues called the epsilonamine (−amine). Because of its positive charge at physiologic conditions, primary amines are
usually outward facing (i.e., on the outer surface) at the proteins; thus, they are usually accessible
for conjugation without denaturing the protein structure.
Carboxyls (–COOH): This group exists at the C-terminus of each polypeptide chain and in the
side chains of aspartic acid (Asp, D) and glutamic acid (Glu, E). Like primary amines, carboxyl is
usually on the surface of the protein structure.
Sulfhydryls (–SH): This group exists in the side chain of cysteine (Cys, C). Often, as part of a
protein's secondary or tertiary structure, cysteines are joined together between their side chains via
disulfide bonds (–S–S–). These must be reduced to sulfhydryl’s to make them available for
crosslinking, by most types of reactive groups.
Carbonyls (–CHO): Ketone or aldehyde groups can be created in glycoproteins by oxidizing the
polysaccharide post-translational modifications (glycosylation) with sodium meta-periodate.

Zero-length cross-linkers as carbodiimides which can form three different kinds of bonds: amide
bond between a primary amine and a carboxylic acid; a phosphoramidate bond between the
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reaction of an organic phosphate group and an amine group; and a secondary and tertiary amine
bond between the reductive amination of the primary or secondary amine and aldehyde group.
The more useful carbodiimides are:
i. 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC), more common and
useful when working with water-soluble coupling conditions and the formation of a water-soluble
byproduct, urea. The ideal conjugation of biological molecules which contain amines and
carboxylates.
ii. 1-cyclohexyl-3-(2-morpholinoethyl) carbodiimide (CMC) is a water-soluble compound,
commonly used for biological conjugations, but has potential side reactions, such as allergenic
properties.
iii. Dicyclohexyl carbodiimide (DCC) insoluble in water, the applications are more common for
the organic synthesis.
iv. Diisopropyl carbodiimide (DIC) insoluble in water, also, for common use in organic reactions,
but has side reactions, such as undergo.
v. EDC plus N-hydroxysulfosuccinimide (Sulfo-NHS) reaction raises the solubility and produces
more stability, to the active intermediate, which at the end reacts with the primary amine. SulfoNHS combines quickly with the primary amines, due to the hydrophilic reactive group. According
to Barre et al, in 2017 he wrote reviews about the use for standard coupling reactions, for
conjugated biological molecules, which relied on the use of one carbodiimide reagent as EDC and
active ester formed from NHS, and Staros, in 1986 he reported that the reactions coupled with
EDC plus sulfo-NHS show more efficiently and increase the yield of conjugation, compared with
EDC alone (Staros,J. 1986; Hermanson, G., 2013; Barre et al, 2017).
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Crosslinker reactive groups are selected, based in chemical reactivities, specificity for functional
groups and water solubility. EDC is a zero-length crosslinking reagent for protein studies. EDC
activates carboxyl groups and causes a direct formation of peptide bond or amide-bond between
carboxylate (-COOH) groups from carboxylic acids, glutamate (Glu or E), aspartate (Asp or D) or
the protein C-terminal to primary amines (-NH2) of lysine or the N-terminal of the protein. EDC
couple phosphate groups to primary amines and does not become part of the crosslinked. EDC is
a water-soluble reagent, for reactions in aqueous and physiological buffers (Staros, J. 1986;
Grabarek & Gergely, 1990; Sriswasdi, S., 2013).
Sulfo-NHS esters have the same reactivity and specificity as NHS esters due to hydrophilic active
groups, they combine faster with the primary amines in the target molecules. The reaction between
the carboxylate with NHS in the presence of a carbodiimide form the NHS ester. In bioconjugation
of protein molecules “the NHS esters crosslinking reagents couple principally with the -amines
at the N-terminals and the -amines of lysine side chains” (Staros, J.1982; Hermanson, G. 2013).
NHS is a water-soluble analog of sulfo-NHS and improves the efficacy of EDC. It enables control
and modification of carbodiimide crosslinking reactions that involve the activation of carboxylates
groups, to be conjugate with the primary amines, and can create stable amino reactive
intermediates allowing an efficient conjugation to the primary amines, at physiologic pH
(Anderson et al, 1964; Staros, J. 1986; Barre et al, 2017).

The crosslinking mechanism with EDC plus NHS has an initial phase, the reaction of a carboxylic
acid group with a water-soluble carbodiimide to form O-acylisourea; the next phase can include
three different options: i. a nucleophilic substitution with an amino group, C-NH2 of lysine to form
the amide bond; ii. Hydrolysis by water which occurs if there are no primary amino groups to
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conjugate, regenerating the carboxylic acid and forming an Iso-urea form by product; (Hoare &
Koshland, 1967) and iii. adding NHS (N-hydroxysuccinimide), the uncharged analog of sulfoNHS, to an EDC coupling, (EDC couples NHS to carboxyls) this increases the stability and
improves the efficiency by capturing the transient 0-acylisourea intermediate as a stable aminoreactive sulfo-NHS ester. This process can react with the primary amine to form the amide bond,
increasing the efficacy of EDC-mediated coupling reactions as well with the two-stage process.
EDC plus sulfo-NHS reaction together is highly efficient and increases the conjugation yield
compared with that obtained only with EDC. Esters sulfo-NHS are active hydrophilic groups that
react quickly with primary amines in the target molecules. See figure 2. 2. 1 (Mansson et al, 1978;
Staros, J., 1986; Hermanson, G., 2013).

Figure 2.2.1. Sulfo-NHS plus EDC (carbodiimide) crosslinking reaction scheme. Carboxyl-to-amine crosslinking
using the carbodiimide EDC and sulfo-NHS. Addition of NHS or sulfo-NHS to EDC reactions increases efficiency
and enables molecule (1) to be activated and conjugate with another amino group from a protein. ThermoFisher
scientific Web. Assessed Dec. 2017.
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2. 3. Direct Electron Transfer (DET).
DET is a process in which one or more electrons, and equally one or more protons, are transferred
in electrochemistry reactions in a redox system. DET has a transfer energy given by the
displacement of the electron from a high energy level, to a low energy level (Shell), but can also
force the electronic transfer by adding energy to the electron. Works by Marcus, Sutin, Albery on
direct electron transfer detail with accuracy, eloquence and academic beauty, the evolution in
knowledge about DET from the physical and biochemical point of view.
The Marcus microscopic model developed for homogeneous electron transfer processes in the
outer-spheres (terminology used to describe electron-transfer reactions of coordination
compounds, “outer-sphere denotes a reaction between two species in which the original
coordination spheres which are maintained in the activated complex, an electron transfer from one
primary bond system to another”) in a single electron transfer from an electrode to species O
(oxidized form), to form the product R (reduced form) OI + RII → RI + OII. It is a heterogenous
process but “are radiation-less electronic rearrangements of reacting species, (the electron must
move from an initial state, on the electrode or in the reductant R, to a receiving state, in species O
or on the electrode, of the same energy)”. “As in any reaction, the system as a whole, proceeds
from configurations (coordinates) in the vicinity of the equilibrium ones, for the reactants to those
for the products. These coordinates involve vibrational coordinates of the reactants, when their
equilibrium values differ before and after electron transfer, as well as the orientational coordinates
of the surrounding solvent molecules: averaged equilibrium orientations of those solvent
molecules differ for reactants and products because each reactant undergoes a change of charge.
The potential energy of the reactants and surrounding medium is a function of all of these nuclear
coordinates (thousands of them) and defines a many-dimensional potential-energy surface, and the
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transfer will occur only at or near nuclear configurations (represent the totality of translational,
rotational and vibrational coordinates of all the molecules) for which the total potential energy of
the reactants and surrounding medium is equal to that of the products and surrounding medium”.
The Marcus model also establishes that “the reactants and products do not change their
configurations during the actual act of transfer”, based in the Franck-Condon principle which says,
“the nuclear momenta and positions do not change on the time scale of electronic transitions”,
which means in this particular case “the reactant and product, O and R, share a common nuclear
configuration at the moment of transfer”. According to chemical terminology, IUPAC, 1977, “The
Franck–Condon (FC) principle is the approximation that an electronic transition is most likely to
occur without changes in the positions of the nuclei in the molecular entity and its environment.
The resulting state is called a Franck–Condon state, and the transition involved, is a vertical
transition. The quantum mechanical formulation of this principle is that the intensity of a vibronic
transition is proportional to the square of the overlap integral between the vibrational
wavefunctions of the two states that are involved in the transition” (Marcus, R., 1964; UPAC,
1977; Albery, W.J., 1980; Marcus, R., 1982; Marcus and Sutin, 1985; Marcus, R., 1993; Marcus,
R., 1997; Bard & Faulkner, 2001; Compton & Banks, 2018).

The calculation of the rate constant in a classical transition-state theory, of an electron-transfer
reaction “involves calculating the probability of reaching the many-dimensional intersection
region, due to the fluctuations, multiplied by a suitably weighted frequency for crossing the
intersection region and by a transition probability for going from the R to the P surface”. Therefore,
the net result of the rate constant, k, of a bimolecular electron-transfer reaction is given by:
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Equation 6: k = KAσ2 exp(-ΔG*/RT)
K is the transition probability, K ~ 1 for an adiabatic process.
Aσ2 has dimensions of collision frequency (Aσ

2

is replaced by a related quantity which has

dimensions of a collision frequency of the ion with unit area of the electrode ~ 1 x 104 cm. s-l).
σ is the average center-to-center distance in the reacting pair during the electron transfer (the mean
separation distance in the transition state of the reaction).
ΔG* is the Gibbs-free energy of activation (Gibbs-free energy difference between the activated
complex and the precursor complex) that is related to λ, where:

Equation 7: AG* = wr + λ/4 (1 + ΔG O'/ λ) 2 and ΔGO' = ΔGO + w p - w r
ΔGO is the “standard” Gibbs-free energy change of reaction in the medium and to the work of
bringing the reactants (wr) or products (wp) to the mean separation distance σ,
ΔG O' is the free energy of the reaction when the reactants are a distance σ apart in the medium,
wr is the electrostatic work involved in bringing the reactants to the mean reactant separation
distance in the activated complex,
wp is the analogous work term for dissociation of the products,
λ represents the reorganization energy, corresponds to the energy required to distort the atomic
configurations of the reactant and its solvation shell to those of the equilibrium product state in the
absence of electron transfer, has two contributions:
i. λi changes in the intramolecular vibrations (the inner-sphere reorganization energy, and means
the free-energy change associated with changes in the bond lengths and angles of the reactants),
ii. λo Changes in solvent orientation coordinates (the outer-sphere reorganization energy, and
reflects changes in the polarization of solvent molecules); λ represents both energies as λ= λi + λo;
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Equation 8: ΔGO'= ΔGiO' + ΔGoO' = ¼ (λi + λo)
ΔGiO' the activation energy arising from distortion of the inner coordination shell in the transition
state geometry,
ΔGoO' activation energy that arises from rearrangement of the solvent dipoles between the
reactants and the transition state (Marcus, R., 1964; Albery, W.J., 1980; Marcus, R., 1982; Marcus
and Sutin, 1985). The rate of electron-exchange reactions was strongly influenced by the FranckCondon principle: the more similar the inner coordination shells of the donor and acceptor atom,
the less difficult would be the electron transfer (Libby, W.J., 1952).

The important simplifying feature of all these mechanisms is that the free energy of activation
varies as the square of the distance of the displacement along the reaction coordinate. In its
preferred equilibrium solvation, the reactants or the products nestle in a parabolic minimum. To
reach the transition state, the reactants change their solvation. This change to a less stable form of
solvation alters the energy of the electron to be transferred until the electronic energy levels in the
"reactants" and "products" are equal. The electron transfer then takes place and is followed by
relaxation of the solvent and ligands to the most stable configuration of the products. The variation
of free energy on the solvent coordinate is parabolic, whereas the electron transfer is isoenergetic
(Albery, W.J., 1980):

Equation 9: O I + R II → R I + O II
Equation 10: dΔG*I, II =2(l-) d (ΔG*I, I + ΔG*II, II) + dΔG0
Kinetic

Thermodynamic
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 kinetic coefficient,

According to Marcus, 1964 theory or model for the kinetics of chemical reactions, where electrons,
and protons can be transferred the “electron-transfer reactions constitute one type of oxidationreduction process and includes both chemical and electrochemical systems. A simple electron
transfer, in an electron-transfer reaction, between two species differing only in their oxidation
states where there is no difference in stability of products compared with reactants, (also called an
electron-exchange reaction due that the products are chemically indistinguishable from the
reactants)” (Marcus, R., 1964). No covalent bonds are formed or broken, and the reaction would
be a diffusion-controlled process. Newton et al, 1984 analyzed and described the steady-state as
“The probability of electron transfer increases with increasing electronic interaction between the
redox centers. Consequently, electron transfer is favored by small separations of the two reactants.
In addition, the equilibrium nuclear configurations of the two reactants will generally be different
before and after electron transfer: reorganization of the reactants prior to the electron transfer is
necessary so that the transfer can occur with minimal change in nuclear configuration and
momentum” (Marcus, R., 1964; Newton et al, 1984).
DET of electrons can be applied in biological studies on mechanisms and metabolic processes
involving also redox transformations of enzymes, and the use of nanostructures to facilitate
effectively the DET shortens the electron tunneling distance at the immobilized enzyme on the
surface of the nanotube electrode. Electron transfer of protein is controlled mainly by three factors
(Marcus & Sutin, 1985): i. reorganization energies; ii. potential differences and orientations of
involved redox-active sites and iii. distances between redox-active sites and mediator.
The direct electron transfer of enzymes working onto the surface of electrodes can be applied in
the study of reactions catalyzed by enzymes over biological systems, and can develop an
electrochemistry basis for the research models that are involved in a selective electron transfer of
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the redox transformations in the metabolic process (inter-biomolecular), mechanisms of this redox
transformations in the structure of the enzyme molecules (intra-biomolecular). The electrical
contacting of redox enzymes with electrodes is the basis for the development of enzymatic
electrodes for amperometric biosensors (Katz et al, 1997). Armstrong in 1987, working with
promoters (aminoglycosides as gentamycin or neomycin) to modify the surface of the electrode,
achieved a fast-interfacial electron transfer of the enzyme cytochrome c peroxidase (CCP). Katz
et al, in 1997 this showed that modifying the surface the Au-electrode with PQQ-FAD
(pyrroloquinoline quinone-flavin-adenine-dinucleotide) cofactor redox unit, this can act as an
electron relay, and the surface reconstituted enzyme apo-glucose oxidase (Apo-GOX) exhibits
direct electrical communication with the electrode and acts as bio-electrocatalyst for the oxidation
of glucose. Cai et al, 1989 immobilizing the enzyme in redox polymer matrixes, this experiment
showed that the oxidized forms of these polymers are electronically conductive, and the
conductivity increases when the fiber diameter approaches nanometers values. Guo in 1997,
worked with adsorbed enzyme horseradish peroxidase (HRP) on a glassy carbon electrode surface
can show the direct electron transfer for the catalytically active HRP.

Albery & Knowles, in 1976, proposed the efficiency function for an enzyme-catalyst process,
which describes the effectiveness of a catalyst in accelerating an enzyme-catalyzed reaction,
“involving one substrate, one product, and a single step for their interconversion”. “If an enzyme
becomes a more efficient catalyst, then a lower concentration of it can maintain the same flux in
the metabolic pathway; the enzyme will be catalytically more efficient if it can increase the net
velocity of the reaction, for the same concentrations of enzyme, substrate, and product; enzyme
will be catalytically more efficient if the same quantity of enzyme can produce the same net
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velocity from a smaller concentration of substrate; the enzyme will be catalytically more efficient
if it can maintain the same net velocity with a larger quantity of product present”. They proposed
a quantitative assessment to evaluate the efficiency of an enzyme as a catalyst basis on, efficiency
function (for a perfect catalyst which equals the unity) and for the function dependence of y, which
represent all the rate constants and the substrate concentrations (four variables of enzyme
concentration, reaction velocity, concentrations of substrate and product). Also, they proposed that
it can improve the catalytic efficiency of the enzyme according to alteration to the Gibbs-free
energy: i. “Uniform binding (the free energies of the bound states remain the same relative to each
other but are altered with respect to those of unbound states); ii. differential binding (require the
enzyme to discriminate between different bound intermediates); and iii. catalysis of elementary
steps (an enzyme must discriminate between the transition state and the ground state of the
kinetically significant step)”. One enzyme operating under reversible conditions assumes the
follow equation:
Equation 11: y = e0 (1-b / Kc. a)/v
y is the reciprocal of the turnover number of the enzyme,
Kc overall equilibrium constant for the interconversion of A and B,
e0 is the enzyme concentration,
v is the moles of A converted to B per unit volume and time,
a and b are the concentrations for the substrates A and the products B (Albery & Knowles, 1976).

Reactions characterized by strong electronic interaction or coupling between the acceptor and
donor centers are referred to as adiabatic because the probability that the activated complex will
proceed to products is, or is near, unity. The rate of electron transfer is affected for two dominant
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factors: i. the distance separating the donor and acceptor centers and ii. the thermodynamic driving
force of the reaction. Many experimental efforts have been done to improve these relationships to
quantified the nature of these relationships, modifying the distance separation between the redox
center and the acceptor centers and the electrode plates, allowing the redox centers to approach
each other sufficiently to transfer electrons (“the Free energy of activation varies as the square of
the distance of the displacement along the reaction coordinate”) assess and modifying the
biological electron-transfer enzyme proteins behavior. The standard free energy of an oxidation–
reduction reaction is defined by the difference between the reduction potentials of the two
reactants:
Equation 12: ΔGo = -nF(ΔE) = -23.06(ΔE) kcal/mol (T=298 K),
where n is the number of electrons transferred,
F is the Faraday constant and
E (the cell potential at standard state) is expressed in volts, an electron volt being the equivalent
of 23.06 kcal/mol, the energy acquired by an electron while passing through a potential of 1 V.
The equilibrium constant for the reaction can be calculated for the follow equation:
Equation 13: ΔGo = - RTLnK
k = Z exp (-ΔG*I, II / RT) → ΔG*I /RT = log(k/Z) ½
z is the frequency factor of collision between electrostatically neutral molecules in an aqueous
solution and is often estimated to be ≈1011dm3M-1. s-1
ΔG = ΔGo + RTLn[(products)x / (reactants)y] substituting ΔG= -nFE =➔ we have:
Equation 14: E = Eo - RT/nF ln[(products)x / (reactants)y] at 298oK (Nernst Equation)
E = Eo + 0.0592/n log[(reactants)y / (products)x]
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Equation 15: Eapp = Em + 2.3 RT/ nF. log [(Ox) / (Red)]
“slope of 59 mV ( = 2.3RT/F at 298oK) with n in the Nernst of 1, is indicative of a well-behaved
equilibrium; the midpoint potential Em is the solution potential at which the reduced and oxidized
forms of the protein are present in equals amounts log [(Ox) / (Red)] = 0” (Marcus, R., 1964;
Newton & Sutin, 1984; Mauk, G., 1999).

We will analyze the enzyme that interests us, its characteristics, and some aspects of vital
importance for an ideal functioning. We will review some of the work done to improve its function
regarding glucose detection without mediators and promoting a faster direct electron transfer.
GOX obtained from Aspergillus Niger is a glycoprotein, a homodimer with a molecular weight of
150 to 180 kDa, and it has two tightly bound FAD molecules. Direct electron transfer for enzymes
especially GOX, involves major difficulties due that the communication between the enzyme and
the surface of the electron, and becomes more difficult because the FAD portion of the GOX
enzyme is deeply embedded within the protein shell. “Direct electron tunneling from the FADH2
of GOX to an electrode is much too slow, because the FADH2 is buried at a depth of about 13–15
Å below the electrode-contacting periphery of its glycoprotein” (Hecth et al 1993). Kulys et al,
2006 working with GOX from Aspergillus Niger yielded an electron transfer distance of 8.1Å–
11.8 Å. “This electron transfer distance reduced by the Van Der Waals contact (1.85 Å) gave the
shortest distance from the active site to the surface of the protein. This distance varied from 6.3Å
to 10 Å”. One of the more important aspects to build a sensor is related to the distance between
the redox center of the enzyme GOX and the surface electrode plate. Both the electrode surface
plate and the redox center of the enzyme GOX function as a donor-acceptor pair. Willner et al,
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2007, proposed that the electron transfer rate-constant between these units will be given by the
Marcus equation:
Equation 16: ket ∝ exp[−β(d−do)] exp [−(ΔG◦+λ)2/ 4RTλ]
Where d and do correspond to the distance separating the donor–acceptor pair and to the Van der
Waals distance, respectively,
β is the electronic coupling constant, and
G◦ and λ correspond to the free energy change and reorganization energy accompanying the
electron transfer (Willner, et al 2007).

GOX is relatively highly specific for -D-glucose, with a reductive half reaction, the GOX-FAD
is reduced to GOX-FADH2, to produce gluconolactone and an oxidative half reaction, GOXFADH2 is oxidized to GOX-FAD, to produce hydrogen peroxide (H2O2). GOX immobilized on an
electrode surface, give an electrochemical response due to a redox reaction of FAD to FADH2,
where FAD is undergoing a reaction of two-electrons coupled with two-protons causing a redox
reaction as: GOX-FAD + 2e- + 2H+ = GOX-FADH2. Electrochemically reductive half-reaction
glucose is oxidized by FAD-GOX, about 5×103 glucose molecules are oxidized per second
(Willner et al 2007, Yang et al, 2008). The redox potential of GOX is due to its’ own prosthetic
FAD/FADH2 group resulting in the redox reaction and is -0.048 V at pH 7.2 (Kulys et al, 2006).
The potential for redox produced in the anode should be as negative (lower operational potential)
as feasible to give a maximum potential difference between the anode and the cathode, and the
potential range must be closer to the redox potential of the enzyme (FAD/FADH2 redox center) to
achieve an optimums DET in a system comprising the GOX immobilized on an electrode surface.
This results in greater system efficiency and to avoid interfering substances reactions which are
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substantially reduced [interfering substances: acetaminophen (AAP), ascorbic acid (AA), oxygen
(O2), uric acid (UA)] (Guiseppi-Eli et al, 2002; Ivnitski et al, 2006; Kurusu et al, 2006; Wang et
al, 2009).
Immobilization of GOX either using modified carbon nanotubes, modified carbon electrodes,
modified gold electrodes or graphene modified electrodes to build a matrix, have been done and
they showed important contributions to detect glucose. Cai et al, in 2004 working with GOX
immobilized onto the surface of carbon nanotubes (CNT) can obtained a direct electron transfer
happening between the active center of immobilized GOX and the surface of the CNT electrode.
Also, they showed the enzyme retained its bio-electrocatalytic activity in the glucose oxidation. A
single walled carbon nanotubes (SWCNT) modified gold electrodes, to immobilize GOX, was
made by Liu et al, 2005 to investigate the electrochemistry of GOX and the direct electron transfer.
The rate constant of electron transfer was determined and calculated using the Laviron method,
(0.3 s-1). Liu et al 2007 working with molecular wires (MW) to modified GCE and GOX can
achieved direct electron transfer to detect glucose with a redox system of E1/2 of -0.443 V and the
rate of electron transfer for immobilized GOX on GC surfaces was calculated to be 78 s-1 using
the Laviron method. Hui et al, 2013 developed a nafion-graphene-GOX modified gold disk
electrode, to immobilize GOX, reached a direct electrochemistry system with a stability,
bioactivity and electron transfer rate of Ks 1.96s-1 for GOX to detect glucose. The use of a matrix
appropriate to immobilize GOX is a more convenient way to achieve the purpose of DET and even
with greater sensitivity and better stability to act as biosensors for glucose, other studies can be
found in the next references (Chen et al, 2003; Wang et al, 2003; Liu et al, 2005; Liu et al, 2010;
Unnikrishnan et al, 2013; Dervisevic et al, 2014; Kong et al, 2014; Haghighi et al, 2017;
Baghayeri et al, 2017). CNT can promote DET due to the presence of oxygen groups (carboxylic
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acid groups) on the surface (Wang et al, 2002; Chou et al, 2005; Yang et al, 2008; Liu et al, 2018),
and can be ideal conducting nanowires due to the range of electrical conductivity (Wang et al,
2009). Modified electrodes with MWCNTs and have been shown as a faster electron transfer rate,
but Compton group, 2006 and other authors as well, have shown that SWCNTs and modified
graphite electrodes had an increased electron transfer, due to the electrochemical properties are
dominated by the oxygenated species, shown at CNT edge-plane defects at the side walls and
defect sites located at the ends (Chou et al, 2005; Ji et al, 2006: Kurusu et al, 2006; Liu et al,
2010; Liu et al, 2018).

And now I want to explain the other part of my research. HbA1c measures electrochemically
(Amperometric methods) are based in the recognition of amino-phenyl-boronic acid (APBA)
which interact with the sugars and can bind glucose and glycated proteins through boronic aciddiol bound. Boronic acid could covalently bind to 1, 2 or 1, 3-diol group and the cis-diol group of
the surface sugar from glycated proteins under weak alkaline conditions, to form reversible cyclic
boronic esters. Under bound sugar, the behavior of boronic acid-modified electrode surface, is
more negatively charged (Takahashi & Anzai, 2005; Song et al, 2009). The catalytic reduction of
H2O2 by HbA1c can be monitored as an analytical signal in a sensor HbA1c electrode, due to Hb
having four iron heme groups, that catalyze the reduction reaction of H2O2 (Zhang & Oyama, 2004;
Kim & Shim, 2013)

Reduction of hydrogen peroxide at a platinum electrode generates the number of electron transfers,
and this electron flow is proportional to the number of HbA1c molecules present in blood (Kim &
Shim, 2013). This reduction of H2O2 is specifically catalyzed by HbA1c (Bunn et al, 1978). This
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amperometric assay of HbA1c is a direct electron transfer detection, without enzymes for the intact
glycated protein recognition. APBA serves 2 functions: i. selective binding to HbA1c over the other
immobilized hemoglobin’s (using boronic acid part) and ii. Participation in the electrochemical
reaction for HbA1c measurement through its ferrocene part. DET of HbA1c, immobilized on the
surface of the electrode, can undergo DET, the bio-electrocatalysis is required to build a mediation
APBA and immobilized glycated protein (HbA1c) for continuous and efficient electron transfer
from the glycated protein to the electrode surface (Park et al, 2008; Chuang et al, 2012). The
anodic and cathodic peak potentials should be pH dependent, around pH 7.4, like a physiology
condition, the redox potential for the APBA-Hb is sufficiently negative for anode operation (Kim
& Shim, 2013).
One of the most important reasons for the DET to happen is the presence of carboxylic group,
which can be found in a range of the Fourier transform infrared (FTIR) at 1715 cm-1 and
carboxylate groups with FTIR at 1574 cm-1, (–C=O, -COOH, -OH) (Liu et al, 2010; Prasad et al,
2012). The use or application of redox mediators versus the stimulation by the pre-anodization
method to increase surface carboxylic and carbonyls groups functionalities on the edge planes
(Prasad et al 2012), shifts the redox potential of the APBA-HbA1c anode to a more positive
potential range, than the redox potential of APBA systems (Song & Yoon, 2009; Wang et al, 2015).
The new generation of HbA1c biosensor are reagent less, basically an amperometric HbA1c
biosensor with different modified methodologies and modified surface electrode technologies for
the support for HbA1c immobilization. The HbA1c enzymatic assay based on the glycated peptide
fructosyl valine (FV) oxidation with a further oxidation by fructosyl amino acid oxidase (FAO) on
a modified zinc oxide nanoparticles/polypyrrole (ZnONPs/PPy) hybrid film gold (Au) electrode
was developed by Chawla & Pundir, 2012 to detect H2O2 produced enzymatically. Stollner et al,
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2002 developed an affinity matrix composed by a membrane-immobilized haptoglobin and
immobilized anti-hemoglobin antibodies to a specific detection of the bound HbA1c by GOX
labeled anti-HbA1c antibody, this HbA1c bound reflects the ratio of HbA1c to the total Hb.
Biosensors that incorporates derivates of boronic acid as: i. An anti-HbA1c anti-body binding to
the glycated site of HbA1c and subsequent tagging of the of the carbohydrate molecule of the
antibody molecule with ferrecene-boronic acid (FcBA), the hemoglobin (Hgb) was incubated with
(FcBA) on deoxycholate (DOCA)-modified piezoelectric quartz crystal gold electrodes by
Halamek et al, 2007, showing an increase in the peak current due to the accumulative amount of
HbA1c respect of the Hb; ii. a self-assembled monolayer (SAM)-covered gold electrode to
immobilized thiophene-3- boronic acid (T3BA) reported by Park et al, 2008 and Chuang et al,
2012 showing that the impedance change reflects the amount of surface-bound HgA1c. iii. a
dendrimer-FPBA (4-formyl-phenyl-boronic-acid) modified gold electrode was used as a boronic
acid-functionalized electrode to a backfilling assay between HgA1c and GOX to detect HbA1c by
Song & Yoon, 2009. iv. Boronic acid as amino-phenyl-boronic acid (APBA) modified graphene
oxide (GO)-polished glassy carbon electrode by Krishna et al, 2011 and a modified APBA gold
nanoparticles (AuNPs) coated-screen printing paper (APBA-pTTBA) made by Kim & Shim, 2013.
v. Poly (3-amino-phenyl-boronic acid) (PAPBA) modified Nafion ® screen-printed carbon
electrode showed that binding to HbA1c decreased the redox current of PAPBA by Wang et al,
2015. vi. Phenylboronic acid-modified pyrroloquinoline quinine (PBA-PQQ) reduced graphene
oxide (ERGO) on the glassy carbon (GC) electrode by Zhou et al, 2015 showed that the oxidation
peak current decreased upon increasing the concentration of HbA1c. vii. Toluidine blue O (TBO)p-benzoic acid (TBA)-MWCNT on a screen-printed carbon electrode (SPCE) to detect both
HbA1c and Hb by Moon et al, 2017. Basically all are on DET either by measuring oxygen (O2)
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consumption and/or the amount of H2O2 produced in the reaction (Kim & shim, 2013; Fang et al
2009), by increased electrochemical signal compared (Halamek et al, 2007), between the cofactor
APBA and HbA1c and the electrode surface without mediators (Song & Yoon, 2009). Other
references can be found in an excellent review by for Sheikholeslam et al, 2011; Pundir & Chawla
in 2014; Wang et al. 2015.

2. 4. Electrochemical Techniques.
Chronoamperometry (CA) is a controlled-potential step voltammetry technique, which measure
current (i) at a fixed potential (E). Cyclic voltammetry (CV) is a reversal linear potential sweep
technique (“the potential scan equivalent to a double potential-step chronoamperometry”), which
measure current (i) as a function of a potential (E) applied over a time. Square-wave voltammetry
(SWV) is a linear potential sweep voltammetry applied to a stationary electrode, that combines a
staircase potential and square wave, which measure current (i) as a function of applied potential
(E). CA, CV and SWV use a three-electrode method: the counter electrode (CE), the reference
electrode (RE), and the working electrode (WE). The experiments consist of measuring the current
flowing through the WE during a triangular potential disturbance. The system handles a potential
that is changing when the current is flowing and affects the current/potential (energy of electrons)
at the WE, where the redox reaction occurs. The three-electrode system allows the current flow
through the WE and the CE, but can measure the current between the WE and RE. The CE becomes
more stable to the system, when the current is flowing. The CE can supply the current required by
the WE, without limiting the measured response of the cell and the closed circuit. The role of the
RE is to provide a stable and reproducible voltage to the WE, without changes in the electrical
potential, but allow explore modifications in the electrode potential, during the experiment and
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measurements. The electrical potential value should not vary over time and should be reproducible
from electrode to electrode. The working electrode’s potential is varied linearly with time (Evans
et al 1983; Kissinger et al, 1983; Eklund et al, 1999; Mirceski et al, 2013; Compton et al, 2018).
The experimental electrochemistry process make through the electrochemistry methods, means a
heterogeneous redox reaction that occurs only in the interface between the electrode and the
electrolyte. According Bard & Faulkner, 2001 factors that affect the electrochemistry process
basically, are the mass transfer, electron transfer and the chemical reactions, that happen at the
electrode surface. As well as these factors can modify the current generate at the electrode surface.
The electrochemistry process is governed by a mass-transfer controlled electrode reaction and the
concentration of gradient determines the rate of the mass transfer. If the concentration gradient is
the only mechanism that control the mas transfer the electrochemistry process is a diffusioncontrolled electrode reaction. If a redox process is in equilibrium, [the potential of the electrode
and the concentrations of Oxidation (Ox.) and Reduction (Red.) are in equilibrium on the surface
of the electrode], and there is a rapid kinetic of electron transfer the process complies with the
requirements for a Nernstian reaction, and the Nernst equation for a half-reaction can be written
as:
Equation 17: E = E0’ + RT / nF ln [(Ox.) / (Red)] x=o
where E is the potential applied,
E0’is the formal potential,
R is the gas constant (8.314JK-1mol-1),
T is the absolute temperature (oK),
n = number of electrons transferred/molecule,
F= Faraday’s constant (96,4853 C. mol-1),
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[Ox.] and [Red.] represent the surface concentrations at the electrode/solution interphase (Mabbott,
1983; Bard et al, 2001; Wang, 2006; Vedharathinam, 2011).

In CV “the potential is scanned back and forth linearly with time between two extreme values, the
switching potentials use a triangular potential waveform. When the potential of the working
electrode is more positive than that of a redox couple that is present in the solution, then the
corresponding species may be oxidized (flow of electrons going from the solution to the electrode)
and produces an anodic (oxidation) current. On the return scan, as the working electrode potential
becomes more negative than the reduction potential of a redox couple, reduction (flow of electrons
flowing away from the electrode) may occur to cause a cathodic (reduction) current” (Kissinger
et al, 1983; Bard et al, 2001; Wang, J., 2006; Vedharathinam, V., 2011).
Anodic currents are positive and cathodic currents are negative by IUPAC convention.
The potentiostat, is the electronic hardware, which controls the three-electrode cell and can run
most of the electroanalytical experiments and allows us to record the curve for the current-potential
polarization. The potentiostat does not control the potential of the working electrode, but it controls
the voltage that occur between the RE and WE, while measuring the current that flow through the
CE. The potentiostat guaranteed that the potential of the WE will not be affected by the reaction
that takes place. It can control the potential of the counter electrode only (relative to the WE). In
the order of significance, the most important electrode is the CE follow by the RE (Harnisch et al,
2012; Mott et al, 2014).
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2. 4. 1. Chronoamperometry (CA).
CA is defined as an electroanalytical technique, characterized by an excitation waveform in
variation of an applied potential. CA is a potential-step method which uses a voltage applied to the
electrodes to measure the current before, and after, the voltage has been applied. CA is an
electrochemistry technique based using a stationary electrode and a process without agitation
(unstirred process). CA has a mass transport by controlled-diffusion; with a constant controlledpotential (voltage) applied, and that can measure the current generated against the time, this current
is proportional to the concentration of the substance to be analyzed (Delahay, 1963; Bard et al,
2001).
CA assumes that the redox process happens when the oxidation (Ox.) step, plus electrons, gets to
the reduction (Red.) step, (Ox + n e- ➔ Red) and both Ox. and Red. steps are soluble. This is a
reversible reaction (electrochemically) and the potential set for the reduction to be completed on
the surface of the electrode (Wang, J., 2006). The current originated in a potential-step method
(CA), is a current-spike due to an initial electrolysis of the species on the surface of the electrode
(the current is directly proportional to the rate of electrolysis), which is followed by a timedependent decay due to the diffusion of the molecules to the level of the electrode surface. In CA,
the current is monitored as a function of time and it is recorded during the experiment as a function
of time. After the experiment, the data can also be displayed as charge as a function of the time
(the charge could by calculated by integrating the current, as is the case in the Cottrell integrated
equation:
Equation 18: Qd= 2nFAD1/2 C t1/2 π -1/2) (Anson, F., 1966; Compton et al, 2018).
The CA uses a time scale in milliseconds and seconds.
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Faradaic currents (I

Far)

are related to an oxidation or reduction reaction and the result of the

electrochemical reactions at the electrode surface. IFar decreases because oxidation used up at
electrode surface and, oxidation is only replenished by diffusion (Wang, J., 2006).
Faraday’s law defines “The amount of chemical reaction caused by the flow of current is
proportional to the amount of electricity passed”. “A Faradaic (electrochemistry) process occurs
when electrochemistry is characterized by the flow of current to/from electron donor/acceptor
species present at the electrode surface”. For a diffusion-controlled current, in a reversible redox
reaction, the current-time (i-t) curve is described by the Cottrell equation, which reflects the net
flux, (the change in the concentration gradient), and the change of the current as well, (the
measured Faradaic current is proportional to the concentration target analyte at the electrode
surface). “The Cottrell equation describe the behavior that happen during a potential-step
experiment as long as the thickness of the diffusion layer is small relative to the electrode
dimension”:
Equation 19: i = nFACD1/2π -1/2 t -1/2
where: n = number of electrons transferred/molecule,
F= Faraday’s constant (9.64853 x 104 C. mol-1),
A= electrode area (cm2); C=concentration (mol. cm -3),
D= Diffusion coefficient (cm2. s-1).
The current response is inversely proportional to the square root of the time, so the relationship
between current and time (it1/2) can be called a “Cottrell behavior” and is direct proportional to the
concentrations of the species (Delahay, P., 1963; Macdonald, D, 1977; Heineman et al, 1984;
Bard et al, 2001; Wang, 2006).
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CA can measure the concentration by measuring (i) current vs. concentration at any fixed time.
CA studies the occurrence of coupled chemical reactions analyzing the shape of the current-time
curve and measuring the coefficient of diffusion for the electroactive species (blood glucose test
stripes). The graphic between the anodic current vs. time generates a straight line and according
the equation of Cottrell means a process controlled by diffusion (De Guibert et al, 1979).
Biosensors with screen-printing technology for glucose detection through the glucose oxidase, the
meter control operation is built up over potential-step method as chronoamperometry. CA is
important because it is a fundamental method on which other techniques are based (Leroux et al,
2008; Laxmibai, 2019).
CA has proven to be an excellent technique for understanding the effects of electrode potential and
time, in mechanistic studies related to the redox process of enzymes (Fourmond, 2009). CA is
useful for monitor changes in the current that results from the enzyme switching between the
catalytical active and inactive states, under certain redox conditions (Leger et al, 2008).

2. 4. 2. Cyclic Voltammetry (CV).
CV is defined as an electroanalytical technique, characterized by the current response, based in a
stationary electrode, excited by a triangular voltage waveform in variation on applied potential.
CV is an electrochemical method to characterize the behavior of analytes that can be oxidized or
reduced electrochemically. CV can locate redox potentials and acquire the qualitative (“the halfwave potential E 1/2 is related to the standard potential for the half-reaction and is often used for
qualitative identification of species”) and quantitative (“the limiting current i, is proportional to
the analyte concentration and is used for quantitative analysis”) information from these
electrochemical reactions (Skoog et al, 2007). CV is an unstirred process (without agitation), with
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a mass transport by diffusion-controls. “CV specifies the relationship between the potential of an
electrode and the concentrations of the two species (designated Ox and Red) involved in the redox
reaction at that electrode”. This assumes that the redox process happens when the Oxidation (Ox.)
step, plus electrons, gets to the Reduction (Red.) step, (Ox + n e- ➔ Red) and both Ox and Red
steps are soluble. These are a reversible reaction (electrochemically) and the potential set for the
reduction to be completed on the surface of the electrode. CV distinguishes a reversible redox
process (controlled diffusion) through the kinetics of the potential scan-rate electrode process,
where the reagent transport is proportional to the square root of the scanning speed (Kissinger et
al, 1983).
CV is an electrochemistry technique with control of a constant potential (voltage) applied at the
electrode. The potential of the working electrode is swept at a specific scan rate (Volts/second),
and the resulting current can be measured against the time curve. The sweep potential is reversed
at a specific switching potential. The sweep potential rate is constant and the initial and switching
potentials are known, the time value can be converted to a potential and then it can be recorded as
the current against applied potential. The relationship between the potential applied to an electrode
and the concentration of redox species (oxidized and reduced form) at equilibrium, is described by
the equation of Nernst on the surface of the electrode as:

Equation 14: E = E0 + (0.0591/n) log [ Ox/Red] at T of 298 oK
where E is the potential applied,
E0 is the formal potential,
[Ox.] and [Red.] represent the surface concentrations at the electrode/solution interphase
(Nicholson et al, 1964; Mott et al, 2014; Compton et al, 2018).
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Applied potential (E) is a function of sweep rate and the potential varies linearly with the time,
rate of potential change with time E(t) = E1 -  t.
One full cycle occurs in CV scan for reversible systems, when a linearly dependent potential (in
relation to the RE) is applied, with a certain scan rate (v), to the WE. The swept from E1 (initial
potential), where no reaction undergoes to E2, (final or reverse potential) where electron transfer
is rapid, the potential is reversed when it reaches E2 and is swept back to E1. The scan rate (v) is
the change of potential as function of time v= dE/ dt”, and the current flow is also a time function,
there could be interrelates and plot the current as a function of applied electrode potential (Mabbott,
1983; Heineman et al, 1984; Harnisch et al, 2012).
Figures 2.4.1. left side and right side shows the conventional cyclic voltammogram obtained by
measure the current at the WE during the potential scans which describe: the cathodic peak
potential (Epc), anodic peak potential (Epa), cathodic peak current (ipc) and anodic peak current (ipa)
as the more important magnitudes (Nicholson et al, 1964); and also, the different steps than happen
in the redox reaction.
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Figure 2.4.2.1. left side shows: “the reduction process occurs from (a) the initial potential to (d) the switching
potential. In this region the potential is scanned negatively to cause a reduction. The resulting current is called
cathodic current (ipc). The corresponding peak potential occurs at (c) and is called the cathodic peak potential (Epc).
The Epc is reached when all of the substrate at the surface of the electrode has been reduced. After the switching
potential has been reached (d), the potential scans positively from (d) to (g). This results in anodic current (Ipa) is
because the oxidation occurs. The peak potential at (f) is called the anodic peak potential (Epa) and is reached when
all of the substrate at the surface of the electrode has been oxidized” (Nicholson et al, 1964; Kissinger et al, 1983).
Figure Right side shows: “Region A where the current remains unchanged. Region B which shows increasing current
as the potential difference is increased. This is due to the oxidation of the species in solution. Region C shows that the
current then peaks before dropping off as the rate of reaction is limited by the diffusion rate of the species in solution.
Region D shows the potential difference being decreased. As the potential difference decreases, the current decreases
because the reaction rate decreases. Region E shows the species produced in the forward scan is being reduced.
Region F shows the reaction being limited by the diffusion of the oxidised species to the electrode” (Nicholson et al,
1964; Kissinger et al, 1983; Wang, J., 2006).

The Electrode potential (E) is calculated: E=Ei + v t. where Ei is the initial potential in volts, v is
the sweep rate in volts/s, and t is the time in seconds. When the direction of the potential sweep is
switched, the equation becomes, E=Es−v t. where Es is the potential at the switching point.
Formal potentials as mid-point potential (half-wave potential of the current plateau) E1/2 from a
reversible cyclic voltammogram or in a sigmoid curve in steady-state voltammetry (qualitative
information) could be calculated by the anodic (Epa) and cathodic (Epc) peak potentials:
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Equation 20: E1/2 = Epc + Epa /2 = Eo’ + RT / nF [ Ln (Dred 1/2) / (Dox1/2)]
Where Eo’ is the redox potential,
R is the gas constant (8.1314 JK-1mol-1),
T is the absolute temperature (oK),
F= Faraday’s constant (96,4853 C. mol-1),
Dox and Dred are the diffusion coefficients for the oxidized and reduced halves of the couple
(Nicholson et al, 1964; Bard et al, 2001; Skoog et al, 2007; Compton et al, 2018).
The formal electrode potential for a redox process Eo’, can be determine through the CV, averaging
the two peak potentials due to the presence of a return potential peak: Eo’= Epc + Epa / 2. The
corresponding peak potentials Epa and Epc are independent of scan rate and concentration (Bard et
al, 2001; Aristov et al, 2015).

Ep means the separation between the two peak potentials, (Ep= Epa-Epc) is characteristic for a
redox species and can be used to determine the electrochemical reversibility for a redox process,
(number of electrons transferred) close as Ep= Epa-Epc = 59 / n mV at 25oC (2.3RT/nF), where
n is the number the electrons participating in the redox reaction. Ep allows the identification of
the mass-transfer regime for reversible redox process which is controlled by diffusive mass transfer
[according to Nernst equation, in the interface between the electrode and the electrolyte, the (Ox.)
and (Red.) reactions occur at high enough rates that the equilibrium point is broken]. The cathodic
and anodic peak potentials do not change with the scan rate, their difference, Ep is always 59/n
mV at 25.8oC in a steady state (Kissinger et al, 1983; Bard et al, 2001; Wang, J., 2006).
The heterogeneous electron transfer rate constant (Ks) for the redox reaction can be calculated
through the value of the Ep, 59/n mV for Ep. The Electron stoichiometry (n) is calculated:
Epa−Epc /2 >0.0565/ n.
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where Epa is the anodic peak potential,
Epc is the cathodic peak potential, and
n is the number of electrons participating in the redox reactions.

CV allows it to be observed that the product generated electrochemically is stable, on the time
scale of the experiment. An electronic transfer reaction usually involves the reaction of the
electrode that is influenced by the potential of the electrode. If the product is stable the peak current
observed by return potential peak scan (ipa), should be equal to the potential peak forward (ipc),
ip(red.)/ip(Ox.) =1. The forward potential scan (ipc) gives a reversible electron transfer reaction in
both directions, means the ratio for the reverse and the forward current is: Ipa/Ipc = 1 (Kissinger et
al, 1983; Aristov et al, 2015).
The peak current ip in a reversible system with a forward sweep at T of 298oK is given by the
Randles-Sevcik equation (quantitative information):

Equation 21: ip = (2.69 ×105) n 3/2 AD 1/2 ν ½ C
where ip is the peak current (in amperes),
n is the number of electrons passed per molecule of analyte oxidized or reduced,
A is the electrode area (cm2),
D is the diffusion coefficient of analyte (cm2 /sec),
ν is the potential sweep rate (volts/sec), and
C is the concentration of analyte in bulk solution (moles/cm3) (Bard et al, 2001; Wang, J., 2006;
Skoog et al, 2007). So, the peak currents are proportional to the square root of the scan rate (v1/2),
and anodic peak potential (ipa) and cathodic peak potential (ipc) increases as v1/2 increase; and it is
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directly proportional to the concentration. A graph of the Randles-Sevcik equation generates a
straight line. The slope can be used to determine the system's diffusion coefficient (D cm2/s)
(Mabbott, G., 1983; Heineman et al, 1984).

2. 4. 3. Square-Wave Voltammetry (SWV).
SWV due to its high analytical sensitivity, can determine concentrations at the picomolar level
(pM = 10 -9 mol/m3). It has the capability to reduce capacitance currents significantly, and with a
very short time of analysis. SWV allows simultaneous inspection of the redox system of both
reduction processes and oxidation processes and, therefore, gives an idea of the mechanism of the
electrode reaction. SWV is an electrochemical election method for many analytic studies
(sensitivity of pulse techniques), electrochemical measurements and mechanistic studies in
electrode operation (kinetic information for impedance techniques) and has valuable capabilities
to determine compounds simultaneously present in physiological and/or pharmaceutical samples
with similar chemical structures. According to Bard & Faulkner, 2001, combine “the best aspects
of several pulse voltammetric methods, including the back-ground suppression and the sensitivity
of differential pulse voltammetry, the diagnostic value of normal pulse voltammetry, and the
ability to interrogate products directly in much the same manner as a reverse pulse voltammetry.
It also offers access to a wider range of time scales than can be achieved by any pulse polarographic
techniques”. The voltammogram peaks obtained show their high sensitivity and exclusion of
currents from the background. SWV integrates the advantages of a CV technique and the increased
sensitivity of pulse voltammetric techniques, and invariably performed through a potentiostatsystem controlled by a computer (Barker & Jenkins, 1952; Krause & Ramaley, 1969; Lovric et al,
1991; Bard & Faulkner, 2001; Mirceski et al, 2013; Mirceski et al, 2018).
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SWV is a linear potential sweep voltammetry applied to a stationary electrode, that combines a
staircase potential and square wave in an unsteering process. The waveform of the SWV combines
a large-amplitude square wave modulation with a stair-case waveform. SWV has a stair-case
potential ramp which it is modified with a square-shaped potential pulse, and at each step of the
stair-case ramp, there are two potential pulses with equal height but with opposite direction, this
shows a single potential cycle in the SWV, and this single cycle potential is repeated at each step
in the full experiment.
The height of the single potential pulse is termed square wave amplitude (Esw), also correspond to
the magnitude of each pulse, which is one-half of the peak-to-peak amplitude on the square-wave
signal (Lovric et al, 1991; Mirceski et al, 2007).
In a surface electrode reaction, the voltammetric response consists of forward (anodic direction)
and backward (or reverse, cathodic direction) potential pulses, with their corresponding current
measurements anodic (Ifor) and cathodic (Irev) currents, taken at the end of each cycle. The first
pulse per cycle, at the end of the positive direction, corresponds to the forward current or oxidation
current (Ifor), which is in the direction of the stair-case scan, and at the end of the second pulse at
the end of the negative direction which correspond to the reverse or backward current or reduction
current (Irev), which is in the opposite direction of the scan. The two different currents generate a
peak for each of these processes. The difference between Ifor and Irev is termed the difference
current (ΔI) or net current Inet (Inet = Ifor – Irev), which is “recorded as a function of the mean
potential of each SW period”. Also, the ΔI assess the displacement of the redox equilibrium that
occurred at the electrode surface (electrode reaction) and gives the respective information of the
oxidation or reduction of the redox species through anodic and cathodic direction (also different
surface concentrations), with subsequent diffusion of mass transfer close to the electrode. In the
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voltammogram plot (difference current plotted versus the sweep potential), the plot displays a
peak-shaped which is proportional to the concentrations of the redox species at the electrode
surface (Lovric et al, 1991; Bard & Faulkner, 2001; Mirceski et al, 2018; Dias et al, 2017).
A critical time for the experiment, is represented by the duration of a single potential cycle (τ) or
by the duration of a single potential pulse tp = τ/2. The square-wave frequency (frequency of the
potential modulation and number of potential cycles in a unit of time) is the reciprocal of the staircase period f= 1τ or f = 1/2 tp, (correspond to the critical time parameter of the SW voltammetric
experiment). The potential increment (ΔE), is the height of the stair-case waveform (Mirceski et
al, 2018).
Bard & Faulkner, 2001 and Mirceski et al, 2018 define the principal parameters for the SWV as:
a. the scan increment, ΔE of the staircase ramp; the square wave is characterized by a pulse height,
Δ Ep, measured with respect to the corresponding tread of the staircase, and a pulse width tp, which
can be related to the square wave frequency and expresses the scan rate as v = ΔE/2tp if f = ½ tp
therefore v = f ΔE ( ΔE correspond to the step of the staircase ramp).
b. Square wave amplitude (Esw) and
c. The duration of the potential pulse tp.
Osteryoung in 1993, described “the theoretical response by means of a dimensionless current
function, ψ for the surface reaction, which is related to the current, i by a factor containing
parameters of the experiments and the system:

Equation 22: i = (nFAD1/2Cb/ √πtp) ψ (ΔEs, Esw)
n is the number of electrons transferred,
F Faraday constant,
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A is the area of the electrode,
D is the reactant diffusion constant (typical value is 10-6 cm2.s-1),
Cb is the bulk concentration of the reactant,
tp is the pulse width (half of the staircase period),
ψ is the dimensionless current function, which depends on the amplitude (Esw) and the scan
increment (ΔE),
ΔEs is the step height (the potential increment from one cycle to the next),
Esw is the square wave amplitude (Osteryoung, J., 1993).

In a reversible reaction, the current response, described in terms of a normalized current function,
which occurs in a voltammetry pulse technique, depends only on the sequence of potential applied
to the electrode regardless of time. According to Miscerki et al, 2018 the “real current I, that
includes the net peak current ΔIp, is a linear function of the square-root of the frequency and
corresponds at the first diagnostic criteria of a reversible electrode reaction of a dissolved redox
couple”. The voltammogram graphic obtained by plotting the normalized current function versus
the normalized potential n(E-E½) “is independent of pulse width, concentration or identity of
reactant” (Osteryoung & Osteryoung, 1985; Osteryoun, J. 1993; Mirceski et al, 2018).
“The peak potential separation (ΔEp) is a function of normalized amplitude (nEsw, n is the number
of electrons exchanged in the electrode reaction)” (Mirceski et al, 2013).
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CHAPTER 3. EXPERIMENTAL AND DISCUSSION FOR GLUCOSE & GOX

3. 1. Materials and Method

3. 1.1. Materials and apparatus
Glucose Oxidase (GOX), EC 1.1.3.4 from Aspergillus Niger, -D-glucose: oxygen 1oxidoreductase, (CAS 9001-37-0) lyophilized power containing 100,000 – 250,000 units/g solid;
Glucose

(D-(+)-glucose

>99.5%

power

(CAS

50-99-7)

bioreagent;

1-ethyl-3(3-

dimethylaminopropyl) carbodiimide hydrochloride (EDC) (CAS 25952-53-8) reagent; Nhydroxysuccinimide (NHS) (CAS 106627-54-7) reagent; Ru (NH3) Cl2 (hexamine-ruthenium III
chloride) 98% (CAS 14282-91-8) reagent; phosphate buffered saline (PBS) 10X concentrate (CAS
7558-79-4) with a pH 7.2-7.6 at 25oC; ascorbic acid (AA) 99% power (CAS 50-81-7) reagent;
salicylic acid (SA) power (CAS 69-72-7) and lactic acid (LA) 85% viscous liquid (CAS 50-21-5)
were all purchased from Sigma Aldrich Co and used as received.
Highly concentrated graphene oxide (HC-GO) composition ≥79% carbon and ≤20% oxygen,
viscosity at 25oC 1,000-2,000 mPa.s, sheet resistance 50 Ω/sq. at 25 m thickness; Ag/AgCl ink,
surface resistivity <75mΩ/square/mil and viscosity 5,570-14,600 CPS; Carbon ink 79% C-220
carbon resistive ink make by Conductive Compounds, with a surface resistivity 10.68 /Sq. and
viscosity at 25o C. 43,050 CPS and oxygen 20% was purchased from Graphene Laboratories
(Calverton, NY.).
Deionized water (>18MΩcm) was obtained from a Millipore purification system (Biomedical
solutions Inc. Bedford, MA.), to prepare all aqueous solution.
Potassium ferricyanide [K3Fe (CN)6] (CAS 13746-66-2) power reagent was purchased from
Fisher.
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SU-8 50 negative tone photoresist formulation 50, with a thickness of 50 mms as purchased from
Micro-Chem, Newton. MA.
Chromatographic paper Whatman 1 chr. 1030-025, grade 3MM, from Tish scientific, cellulose,
with a thickness of 0.34mm and diameter 25 mm.

3. 1. 2. Preparation of solutions.
The phosphate buffer solution (PBS) 0.01 M phosphate buffer, 0.0027 M potassium chloride and
0.137 M sodium chloride with a pH 7.4 was used in all studies, it is made for dissolved 1 tablet of
PBS compound from Sigma Aldrich Co., in 200 ml of deionized water at 25oC.
The EDC/NHS (0.35M/0.1M) solution was prepared as follow: 0.0033 g of EDC plus 0.0012 g of
NHS dissolved in 50 L of deionized water and kept at 4oC.
The 5 mM potassium ferricyanide solution was prepared by passing 0.074 g of KCl dissolved in
10 ml of deionized water through a 0.0164 g of K3Fe (CN)6 in 10 mL of deionized water. The
solutions were stored at room temperature (25oC).
The 5 mM hexamine-ruthenium chloride solution Ru (NH3)6 Cl2, which was prepared by
dissolving 0.0154g of Ru (NH3)6 Cl2 in a 0.1 M of KCl (0.074 g KCl in 10 mL of deionized water).
The solution was sored under N2 and keep at 4oC.
20 mM GOX solution was prepared by dissolving 0.0020 g of GOX (lyophilized power) in 1 mL
of PBS. The solution was stored at 4oC.
Solutions of varying glucose concentrations solution were prepared by dissolving different known
amounts of glucose (D-(+)-glucose) power, in 1 mL of PBS at room temperature (25oC).
Ascorbic acid, salicylic acid and lactic acid solutions were prepared to achieve a glucose equivalent
concentration of 0.1 M.
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3. 1. 3. Specific surface area
The specific surface area the sample was calculated using the Brunauer, Emmett and Teller (BET)
surface adsorption method and theory, through the accelerated surface area and porosimetry
system (ASAP) 2020 Sorptometer made by Micromeritics, by measuring N2 adsorption on the
surface of the sample. The sample was degassed at 150ºC for 70 min at 10 mm Hg, in order to
remove any remaining solvent and ensure complete dryness and emptiness of the pores. After this
result of the amount of adsorbed N2 at a bath temperature of 76 K were obtained.

3. 1. 4 Electrochemical measurements.
Voltammetry measurements CV, CA, and SWV were carried out with a CH Instrument (CHI 730E,
Electrochemical Analyzer, Austin TX.) electrochemical workstation in a three-electrode cell
assembly, at room temperature (25oC), with electrodes which consists of the printed paper-carbon
electrode (PPE) microfluidic device. The modified electrodes such as graphene oxide-PPE (PAPPE-GO) and pre-anodized-PPE (PA-PPE) were analyzed with the different electrochemical
techniques, and, the modified PA-PPE-GO-GOX and PA-PPE-GOX electrodes were analyzed and
compared with the identical electrochemical techniques. All the PA-PPEs have a working
electrode area of 0.03141 cm2.
CV measurements were carried out at a different scan rates range 30 mV/s to 500 mV/s. We used
different probes as 5 mM potassium ferricyanide, 5 mM hexamine ruthenium III chloride and 0.01
M PBS in PA-PPE-GOX- biosensor, through direct electron transfer, to evaluate the
electrochemical oxidation in order to demonstrate the presence of immobilized GOX and therefore
the analysis of glucose. All the experiments were carried out at room temperature 25oC, with
different scan rates to find the best scan rate for the experiment.
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CA experiments were carried out with glucose concentrations range 30 M to 50 mM.
The SWV experiments were carried out with different concentrations of glucose range from 0.2
mM to 0.84 mM and analyzed with tht PA-PPE-GO-GOX and PA-PPE-GOX biosensors.

3. 1. 5. Spectrometers studies.
The FT-IR spectrum was recorded by using Spectrum 100 FT-IR Spectrometer, Perkin Elmer.
Spectrum is Perkin Elmer’s premier software package for collecting, viewing and processing FTIR spectra., all the studies were testing at room temperature (25oC). The optical module contains
a Class II/2 Helium Neon (HeNe) laser, with an achievable precision of ca 0.008 cm-1, which emits
visible, continuous wave radiation at a wavelength of 633 nm and has a maximum output power
of 1 mW, reduces signal artifacts and improves response linearity, high-quality, low-angle, offaxis optics minimize aberrations and provide the highest optical efficiency. The PPE, PA-PPE and
PA-PPE-GOX biosensors 5 of each, were prepared according to details showed in next two
sections, to carry out the experiments and compare and analyze the results obtained.

3. 1. 6. X-ray photoelectron spectroscopy studies.
XPS is a powerful technique that provides us with information about a sample surface, which is
located on the surface of a platform or electrode, about its molecular composition and its chemical
bonding. The XPS analysis were carried out with a PHI 5600 spectrometer with a hemispherical
energy analyzer, using an aluminum (Kα) source of 1487 eV at 100 Watts. The sample was
maintained at high vacuum. The pressure in the analysis chamber during XPS analysis was in the
low range of 10-9 Torr. All spectra were recorded at 54o take-off angle, the analyzed area being
currently about 1 mm2. All spectra were recorded with 1.0 eV step, 10 cycles, 20 sweeps and
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corrected using carbon signal (C1s) at 284.5 eV. XPS spectra were analyzed using Casa-XPS
software version 2.3.18. The Shirley method was used for extracting the background necessary for
curve fitting.

3. 1. 7. Fabrication of paper electrodes.
The PPEs were designed through the adobe illustrator graphic design software and were
subsequently manufactured using the template printing technique. A template print mask with the
electrode pattern was created by means of low-adhesion laser-cut films with an internal Zing 16
laser cutter (Epilog, Golden, CO). The prepared electrode patterns were placed on the SU-8 2010
photographic resistance treated chromatographic paper, which was previously prepared using the
photolithography technique. SU-8 epoxy-based is a negative photoresist, and negative refers to a
photoresist whereby the parts exposed to UV rays crosslink and needs to bake again after UV
exposure to complete the polymerization. The photolithography technique consists in: applied SU8 photoresist over the chromatography paper; baked in a hot plate for 20 min at 135oC; a selectively
polymerization with UV (350-400 nm) exposure at 100% for 20 sec. using a mask 0.7 cm diameter
that show the design area, in black ink printed, to generate a hydrophobic and hydrophilic areas;
transfer the chromatography paper to the hot plate por 5 min at 135oC and later developed with
acetone and isopropyl alcohol at 70%. Them left to dry at room temperature x 20 min. See figure
3.1.
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Figure 3.1. Design showing the process of making the disposable paper electrode (pictures not drawn to scale).

The conductive carbon ink paste was careful impregnated into the electrode patterns to make 2 of
the 3-electrode system consisting of a: carbon-based counter electrode (CE), a carbon-based
working electrode (WE) with a surface area of 0.03141 cm2 and a conductive Ag/AgCl ink-based
pseudo-reference electrode (RE) as a 3er electrode system, see fig. 3.1. and fig. 3.2. After each step,
following the application of carbon ink to the two electrodes WE and CE, and next the Ag/AgCl
ink over RE, the PPE were backed at 95oC for 25 min in an oven (Dungchai et al, 2009; Martinez
et al, 2010; Nie et al, 2010; Lan et al, 2013; Liu et al,2014).

Figure 3.2. (A) Digital photo image of the PPE. (B) the electric circuitry for the electrode. The circuitry consisted of
working electrode (WE), counter electrode (CE), and reference electrode (RE).
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3. 1. 8. Fabrication of Modified Electrode.
After the PPE has been prepared, then the pre-anodization process is done by applying a potential
at 2.0 V, through the i-t electrochemical technique method, over working electrode vs Ag/AgCl
counter electrode, for 300 s., placing the PPP in a beaker which contained a pH 7.4 PBS. With a
pre-anodized time of 300 s. the ratio between O1s and C1s (O1s/C1s ratio) has more changes and as
well as create more carbonyl-groups functionalities (Evans et al, 1979; Notsu et al, 1999). The
pre-anodization method create more edge plane sites and can make the modified carbon electrode
(CE) more electroactive, but also provides low susceptibility to electrode fouling (Prasad et al,
2007; Yang et al, 2008; Prasad et al, 2008; Thiyagarajan et al, 2014). The next step was add the
EDC/NHS (0.35M/0.1M) solution, which was prepared with 0.0033g of EDC and 0.0012g of NHS
and dissolved in 50 mL of deionized water, and drop coated 5 mL over the WE at the PA-PPE and
left for 30 min at room temperature (25oC), after that, the excess was removed and washed with
0.01 M PBS 1 L. Then GOX was coupled through EDC and NHS cross-linkers. The GOX
solution was prepared by dissolving 20 mg GOX in 1 mL 0.01M PBS and drop coated 5 L on to
EDC/NHS activated PA-PPE. The electrodes (PA-PPE-GOX) were then dried at room temperature
for 2h, and subsequently washed with 0.01M PBS 1 L to remove unbounded GOX. The prepared
electrodes including, also modifies electrodes prepared with GO (PA-PPE-GO-GOX) was further
used for the voltammetry measurements and evaluated the electrochemical oxidation of glucose
through direct electron transfer without utilizing any mediators. The figures 3.3 & 3.4 show the
schematic diagram and the representation for the full process done to prepare and tested the
modified electrode.
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Figure 3.3. Schematic diagram and representation of modified electrode: PA-PPE-EDC/NHS-GOX-Glucose.

Figure 3.4. Schematic diagram and representation of modified electrode: PA-PPE-EDC/NHS-GOX-Glucose, showing
the two enable ways to immobilize the GOX and final products of the process.
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3. 2 Results and discussion
3. 2. 1. Specific surface area
The BET surface area report shows a 5.07 m2 of area per gram of the material. The geometric
surface area for the working electrode is 0.03141 cm2. The Braunauer-Emmett-Teller (BET)
surface area is 12.675 cm2 with a pore size of 92.607 Å and pore volume of 0.016736 cm3/g.
(Brunauer et al. 1938).

3. 2. 2. Pre-anodization technique
The pre-anodization as a cleaning technique and performed as a pretreatment, the carbon electrode
is cleaned and exposed to the application of a potential, and the functional groups are formed on
the surface as a multiple edge plane formation. The fig. 3.5 shows the electrochemical oxidation
process that happens when a positive potential (2V) is applied versus time (300 s). The current or
the flow of electrons going from the solution to the electrode and produces an anodic (oxidation)
current.

Figure 3.5. Pre-anodization (PA) graphic.
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3. 2. 3. Surface Characterization of PA-PPE-GOX.
a. Fourier transform infra-red (FT-IR).
The FT-IR spectrum of GOX exhibits basically two peaks with additional bands:
i. The Amide I band (is an overlapping spectrum of -helices, -sheets, turns and random coils,
which form the basic structure of the protein) peak at 1650 cm-1 and 1715 cm-1 caused by C=O
stretching vibrations of peptide linkages in the backbone of the protein GOX, (Zhao et al, 2010).
Identified C=O stretching vibrations of peptide linkages in the GOX backbone, at 1600cm-1 to
1700 cm-1 (Liang et al, 2003) and 1650 cm-1 to 1750 cm-1 (Hui et al, 2013).
ii. Amide band II peak at 1462 cm-1 caused for combinations of N-H in a plane bending and C-N
stretching linkages for the peptide groups, (1490 cm-1 identified as the combination of N-H inplane bending and C-N stretching of the peptide groups) (Liang et al, 2003; Hui et al, 2013;
Malasevic et al, 2008).
iii. Amide band III on 1239 cm-1, predominantly -sheet (Mainly C=O) correlated with Delfino
datas (Delfino et al, 2013; Boyaci, et al, 2015).
Additionally, we founded two wide bands in the region 3400 to 2900 cm-1 representing the amide
A and the bond linkages to -CH3 stretching at 3400 cm-1 and 2958 cm-1, respectively, correlated
with Prasad study (Prasad et al, 2015). According to a consensus of research’s, the presence of
the amide I region between 1600 cm-1 to 1700 cm-1, with their different C=O stretching vibrations,
and amide II region at 1550 cm-1 to 1462 cm-1 with the C-N stretch coupled to N-H bending, that
correspond to the peptide groups, they provide information on the type of secondary structure,
these types of vibrations are the -helix, -strands, and different kinds of turn structures as -turns
and -antiparallel. The -helix structure can be assigned in the range of 1655 cm-1 and 1545 cm-1,
and the -strands has been assigned in 1630 cm-1 and 1530 cm-1 bands. (Goormaghtigh et al, 2006;
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Alhazmi, H. 2019). Amide I and amide II bands in the FT-IR spectrum of the free enzyme is
generally accepted as indicative of the enzymatic activity and could be used to monitor the GOX
characteristics after immobilization.

Figure 3.6. FT-IR Spectrum for PA-PPE-GOX.

b. X-ray photoelectron spectroscopy (XPS).
XPS studies conducted on the PA-PPE-GOX sensor to demonstrate the immobilization of GOX
show us that the data with C is fitted by a mix of pure C(1s), with C-C and C-O-C bonds in the
proportions shown in the figure 3.7. B & C. Pure C would peak at 284 eV. The peak of C(1s)
moves from 284 eV and focuses around 285.8 eV corresponding the (overlap C-C, C-H, C=C
bonds) (Libertino et al, 2007; Ni et al, 2008). C(1s) centered peak around 288 eV with two binding
energy, 288.3 (N-C-O bond) and 286.3 (C-O bond), which be assigned to overlap groups such as
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[R-CH2-NH-(C*O)-] and [(R-CH2*-NH-(CO)-] respectively (Libertino et al, 2008) and overlap
286.3 eV (CN), 287.7 eV (C-N) and 288.2 eV (C-O) bonds) (Ni et al, 2008).

Figure 3.7. XPS for GOX (A) found C(1s) (B & C), N(1s) (D) and O(1s) (E) graphics.

The following works in XPS on the C(1s) core-level spectra set out the principles for compound
configurations associated with proteins. Boyd et al, 1995 use the peak of C(1s) identified in 284.6
eV, as an adventitious carbon to evaluate the reference of the spectra, the peaks obtained at 285.9
eV and 287.7 eV were assigned to the carbon and (nitrogen sp2 and sp3) bonds and the peak
obtained at 288.2 eV is assigned to the (C-O) bond. Five peaks at C(1s) core-level spectra were
identified by Bhattacharyya et al, 1998, which were assigned the binding energy to the respective
bond, 284.7 eV (pure carbon C1), 285.3 eV [C=N (C2) bond], 286.7 eV [CN (N3)], 287.7 eV [CN bond (C4) bond] and 289.6 eV [C-O bond (C5)]. Dementjev et al, 2000 found a peak with a
union energy at 287.9 eV, which identifies it as C(1s) and a good indicator of the interaction
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between C and N (C-4N), characteristic of carbon atoms (four bonds) that has a single or double
bond with nitrogen atoms.

To validate our findings, we will review some work that focuses on demonstrate the presence of
GOX, based on the different configurations of C(1s) spectra. Li et al, 1998 found that the
successful immobilization of GOX on the surface of a film, shows two significant changes in
relation to the peaks obtained by the binding energy (BE), the first corresponds to the reduction in
intensity of the carboxyl group by 288.7 eV and the second to increase in intensity at the peak of
the peptide union at 287.8 eV. Libertino et al, 2007 and 2008 assigned 288.3 eV (N-C-O) to [RCH2-NH-(C*O)-], and 286.3 eV (C-O) to (R-CH2*-NH-(CO)-), as chemical groups of the
proteins, characteristic of the GOX immobilization. We can see the C(1s) binding energy shift for
the functional groups and the main compounds in the figure 3.8.

Figure 3.8. Binding energy (BE) for the functional groups, and compound type of the carbon chemical state C(1s).
Moulder et al, 1992, and Web-EAG laboratories. Assessed in March 2020

For the binding energy of N(1s) spectrum, figure 3.7. D, we found a centered peak at 400 eV,
which is the correct one corresponding to pure N(1s) peak at 399 eV (Libertino et al, 2007 shows
that the intensity of the N(1s) peak was centered at 400 eV). Also, the N(1s) spectra core-level
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found the following binding energies at different peaks and was attributed to their respective union.
398.3 eV (overlap N1 sp3 as N-C and C-NH2 bonds) (Boyd et al, 1995; Dementjev et al, 2000; Ni
et al, 2008). 399.1 eV (overlap NC and C=N-C bonds) (Dementjev et al, 2000). 399.9 eV (N=C
bond) (Ni et al, 2008). 400.6 eV (N-C sp2 bonding) (Boyd et al, 1995) and 400.8 eV [NO (N4)]
(Bhattacharyya et al, 1998).
The next works confirms the presence of organic molecules, due to the configurations of N(1s)
and C(1s) spectrum, in the surface of the biosensor and support the immobilization of GOX. The
centered peaks overlapping binding energy for the 398.5 eV (C-NH2 bond) assigned by Dementjev
et al, 2000. 398.8 eV (N-C sp3 bonding) assigned by Boyd et al, 1995, and 399.1 eV (C=N-C
bond) assigned by Dementjev et al, 2000. 400.7 eV (overlapping N-C sp2 bonding and NH2
groups) according to Ni et al, 2008. All of them, contributed to identify different bounds between
the N(1s) and C(1s) as part of the configurations of carbon nitride compounds. Also, Libertino et
al, 2007 detect a centered signal at 400 eV, in the spectra of N(1s) for the GOX immobilized.

Our oxygen data, figure 3.7.E, is fitted by a mix of pure O(1s) at 532 eV and some carbonates such
as C-O (almost at the same energy as C, see figure below) in the proportions shown in the figure
3.7. E. Pure O would peak at the vertical line (almost at the same energy as C-O). See figure 3.9
for more details of the binding energy of O(1s) and compounds type.
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Figure 3.9. Binding energy for oxygen. Moulder et al, 1992. Internet archive, open library. Assessed March 2020.

According to our data obtained especially the changes in the spectrum of C(1s) peak, related to the
chemical group’s characteristic of the proteins, and the spectrum of N(1s), we can suggest that the
GOX is successfully immobilized in our PA-PPE-GOX biosensor. These changes are in
accordance with the revised literature by Boyd et al, 1995; Bhattacharyya et al, 1998; Li et al,
1998; Libertino et al, 2007; Libertino et al, 2008; Ni et al, 2008.

3. 2. 4. Electrochemical characterization of PA-PPE-GOX.
After immobilizing GOX onto PA-PPE, the electrochemical studies were carried out in 0.01M
PBS under N2.
a. The cyclic voltammetry (CV) profile for PA-PPE-GOX exhibited a pair of well-defined and
nearly symmetric redox peaks with a formal potential of -0.44 V (Fig. 3.10. A), which is like the
previous reports (Yang et al, 2008), and close to the standard electrode potential of GOX (Kang et
al, 2009).
We compare the CV for PPE-PA-GOX tested with 5mM K-Ferricyanide which get an anionic
probe-left side with increased current, and we tested with 5mM Ruthenium-Hexamine Chloride
5mM which get a cationic probe-right side graphics (Fig. 3.10. B), at 0.050 V/s scan rate. Two
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different probes towards the same electrode, explain the electron transfer involved and interaction
between electrodes (negative charge) and electrostatic interaction between electrode and probe
molecules (specific potential for oxidation and reduction).
The difference in potential between the peaks of the reduction (Epc) and oxidation (Epa) curves is
ΔEp = (Epa - Epc) = 0.0599 V (a value that is close to the theoretical value of 0.059 V for the
ferrocene redox pair) for all scan rates between 50 and 500 mV s-1, the peak current ratio (ipa/ipc)
is equal to 1.01, and the and the formal electrode potential for a redox process Eo’ = 0.43145.
In addition, the CV clearly indicate that the redox peaks are derived from the immobilized GOX,
when compared to the unmodified electrodes without GOX. The electrochemical response of GOX
immobilized onto the PA-PPE is attributed to the direct electron transfer of GOX for the
conversion of FAD/FADH2 (Wang et al, 2002: Cai & Chen 2004; Yang et al, 2008), (Nernstianelectrochemical reaction in which the rate of reactions is governed by the diffusion of the
electroactive species to the surface of a planar electrode, as a reversible and surface-confined
process). The direct electron transfer reaction of GOX/FAD redox reaction involved two-electron
coupled with two-proton transfer: GOX/FAD + 2e- + 2H+ = GOX/FADH2.

Figure 3.10. (A) CV response of PPE-PA-GOX immobilized with 0.01 M PBS at a scan rate of 50 mV/s. (B) CV for
PPE-PA-GOX with 5mM K-ferricyanide (anionic probe-left side, red color) and 5mM ruthenium-hexamine chloride
5mM (cationic probe-right side, blue color) comparative.
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CV studies allow us to show the behavior of the electrode with respect to the scan rate, if there is
any change in the current and allows us to determine what type of reaction take place in the
electrode. The scan rate effect on PA-PPE-GOX electrodes is shown in Fig. 3.11, the CV’s at
different scan rates (v) ranged from 50 to 200 mV/s (Fig. 3.11.A). The anodic and cathodic peak
currents changed appreciable and increased with respect to the change in scan rate and exhibited a
good linear relationship for both the anodic and cathodic current and scan rates (Fig. 3.11.B). The
relationship between the log peak current versus log scan rate, in the plot was linear with a slope
of 0.561714 ( = transfer coefficient) which indicates a surface-diffusion controlled redox
electrode process.

Figure 3.11. (A). CV response of PA-PPE immobilized with GOX in 0.01 M PBS at a scan rate of 50-200 mV/s, and
(B), plots of anodic (ipa) and cathodic (ipc) peak current versus scan rate.

The heterogeneous electron transfer rate constant, ks on the PA-PPE-GOX electrode was calculated
with Laviron equation (Laviron, 1979).
Equation 23: Log ks = α log (1-α) + (1-α) logα-log (RT/nF ν)-α (1-α) nFΔEp /2.3RT
R is the universal gas constant (8.314 J mol-1K-1),
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T room temperature at Kelvin degree (298oK),
F is the Faraday constant (9.64853 x 104C),
n number of electron transfers and
v is the scan rate.
The calculated charge transfer coefficient ( ) was 0.5617 and with two electron transfers (n=2).
The heterogeneous electron transfer rate constant ks was calculated to be 3.363 s-1, which is higher
than the ks reported for the carbon nanostructured materials: (Ks of 1.69 s-1 for Janegitz et al 2011);
(Ks of 2.83 s-1 for Kang et al, 2009); (Ks of 3.273 s-1 for Hua et al, 2012); (Ks of 1.713 s-1 and 1.12
s-1 for Razmi et al, 2013); and gold nanoparticle incorporated matrices: (Ks of 1.713 s-1 for Wu et
al, 2007); and (Ks of 2.2 s-1 for Zhang et al, 2011). From this it is evident that the carbonyl
functionalities and edge plane-like sites formed during the pre-anodization process at PPE, play
an important role in improving the electron transfer communication between the redox centers of
GOX and electrode.
The surface average concentration of electroactive GOX (Γ) value was calculated from the
equation 24: Γ= Q/nFA. (Q) charge involved in the reaction, (n) number of electrons transfer,
(F) Faraday constant, (A) area of WE.
Γ= 8.30013 e-9 mol/cm2, which is bigger than Liand & Zhuobin, 2003 (Γ= 5.1 x 10e-11 mol/cm2);
Kang et al, 2009 (Γ= 1.12e-9 mol/cm2); Zhang, et al. 2011 (Γ= 2.56 e-10 mol/cm2); Razmi et al,
2013 (Γ= 1.8e-9 mol/cm2) and Baghayeri, M. 2015 (Γ= 4.65± 0.76 e-10 mol/cm2), means that the
higher heterogeneous direct electron transfer rate constant is directly influenced by the multilayer
coverage of GOX.
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Different experiments of calibration conducted through CV on the PA-PPE-GOX-Glucose
biosensor show good performance to identify glucose at different concentrations with a sensitivity
of 60.8723 AmM-1cm-2 (SE 1.544, CV% 1.336) which, was calculated as the current density
(current/area) and plotted against the concentration of glucose. The calculated sensitivity is higher
than Zhang et al, 2011 (16.6 AmM-1cm-2); Unnikrishnan et al, 2013 (1.85 AmM-1cm-2); Razmi
& Mohammad-Rezaei, 2013 (0.085 AM-1cm-2).

b. Square wave voltammetry (SWV) analysis. The electrocatalytically activity of the PA-PPEGOX towards glucose is studied by conducting square wave voltammetry experiments with
different concentrations of glucose ranging from 0.2 mM to 0.84 mM and 0.01 M PBS under N2.
Successive additions of glucose resulted in a gradual decrease in reduction current (Fig. 3.12. A),
and it is linearly proportional to the increased concentration for glucose (fig.3.12. B). This trend
could be explained by the fact that with the addition of glucose triggers, the enzyme-catalyzed
reaction of GOX and glucose by formation of FADH2 from FAD, at the level of the biosensor
surface with subsequent decreases of the cathodic peak current (Janegitz et al, 2011; Liu et al,
2014). This reaction causes a decrease in the amount of oxidized GOX on the PA-PPE electrode
and reduces the electrode reduction current.

86

Figure 3.12. (A) Square wave voltammogram for different concentration of glucose at GOX immobilized in PA-PPE,
(B) the plot peak current A versus glucose concentration in mM showing the linear progression decrease at the
surface of the electrode.

In order to establish the increased sensitivity of the newly developed electrode, PA-PPE-GOX
towards glucose detection, we compared the current response developed for GOX immobilized on
graphene oxide through EDC/NHS cross coupling method, GO-PA-PPE-GOX with PA-PPEGOX. As can be seen from the calibration plots of PA-PPE-GOX and GO-PA-PPE-GOX (Fig.
3.13. B), the pre-anodized electrode exhibited, quantitatively, 2.612 times higher current response
than GO modified electrodes. The improved electro-catalytical activity at PA-PPE-GOX again
points towards the better electron transfer communication between GOX at the surface of the
electrodes electrochemically activated or pre-anodized electrodes than with GO modified
electrodes.
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Figure 3.13. Square wave voltammogram (SWV) for different concentration of glucose at PA-PPE-GOX (A) and
corresponding calibration curve for PA-PPE-GOX and GO-PPE-GOX (B).

c. Chronoamperometry analysis (CA). CA is one of the more sensitivity methods and can reach
lower detection limits. The electro-catalytical activity of PA-PPE-GOX was further characterized
by conducting CA experiments for the reduction of glucose, with a constant controlled potential
of -0.55 V, comparing the response with 0.01 M PBS (pH 7.4) and different concentrations of
glucose that ranging from 30 M to 50 mM. Different experiments were carried out, measuring
current against time, at high and low glucose concentrations, until a minimum and maximum
glucose level was optimized. Since the current is proportional to the glucose concentration, the
current graph against time shows changes in glucose concentration on the electrode surface, also
obtaining a linearity in the graphic response.
Figure 3.14.A and Figure 3.14.B depicts the chronoamperometric responses of glucose reduction
at 0.01 M PBS and a different concentration of glucose with a fixed potential of −0.55 V. Because
of the negative operating potential, for the detection of glucose, that eliminates the interference
from other electroactive species such as, ascorbic acid, uric acid, and dopamine present in the real
blood samples.
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Figure 3.14. Chronoamperometric response for PA-PPE-GOX towards different concentrations of glucose (30 M to
50 mM).

As the concentration of glucose increases, there is a shift from the linearity between concentration
and current (Fig. 3.14. A and fig. 3.14. B), exhibiting a typical Michaelis-Menten kinetics, see
figure 3. 15. A, (Marcos et al, 1993; Shirale et al, 2006). The line-weaver-Burk plot (Liu et al,
2014) a double reciprocal plot, show a linear curve graphic, based in the following equation:
Equation 25: 1/v = (1 / vmax) + (Km / vmax.) (1 / [S]),
Where v is the initial reaction rate at a given substrate concentration,
v max is a constant reaction rate,
Km is the Michaelis-Menten constant,
[S] is the substrate concentration.
(Vmax = 0.021714, m= 1.38343, b= -46.05323), which corresponds with the linear equation
y = b + mx, with a direct correlation between current 1/v (1/mA) and glucose concentration 1/[S]
(1/mM) (Shirale et al, 2006).
The Km calculated was found to be 0.03 mM (3.0 x10-2mM), values of Km of GOX which is lower
than GOX immobilized on graphene quantum dot (Km of 0.76 mM for Razmi et al, 2013), GOX
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immobilized reduced graphene oxide (Km of 0.215 mM for Sehat et al, 2014), poly (pphenylenediamine)-based nanocomposite (Km of 0.42 mM for Baghayeri, M., 2015), and with the
GOX adsorbed pre-anodized screen printed-carbon electrodes (Km of 1.07 mM for Yang et al,
2008).
A lower Km means a higher enzymatic activity of immobilized GOX at PA-PPE; thus, the results
suggests that the present PA-PPE-GOX have a high affinity towards glucose, with a limit of
detection as low as 1.8 x 103 ug/5L. The Figure 3.15. B shows a linearity relationship range for
glucose 1mM through 50mM (target range of 18 mg/dL – 900 mg/dL), (SD: 0.879, SE: 0.0265,
R2: 0.9890), which include the normal range of blood glucose in humans as well the abnormal
range values of hypoglycemia or hyperglycemia.

Figure 3.15. characteristic response of Michaelis-Menten kinetics (A), corresponding linearity range of 1mM through
50 mM (B).

Glucose serum is linear from 5 mg/dL to 900 mg/dL (0.28 mmol/L to 44.40 mmol/L).

3. 2. 5. Interfering species.
The total blood level of glucose is around 100 mg/dL and may reach values above 400 mg/dL in
uncontrolled diabetic patients. There are substances in the blood considered interference species,
and their blood levels are minimal, comparable to glucose. These types of substances can interfere
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with glucose readings in biosensors. We conducted multiple studies in amperometric i-t technique,
to validate the specificity of the biosensor, PA-PPE-GOX, on glucose (Glc), ascorbic acid (AA),
salicylic acid (SA) and lactic acid (LA), as interfering species. Concentrations of interfering
species were adjusted to a glucose equivalent of 0.1 M. Different experiments were carried out to
achieve an adequate amount of volume samples, which was 5 L. All the studies were conducted
in i-t mode with a potential of 0.5 V, time of 1000 sec, and non-stirring process, as well as, the 0.1
M glucose samples and AA (0.1M), SA (0.1M) and LA(0.1 M) samples, were applied at different
times, allowing the system to stabilize between samples.
The graph shows two large initial peaks, 200 sec and 300 sec, corresponding to glucose 0.1 M, the
following peaks around 360 sec, 420 sec and 485 sec correspond to SA, LA and AA respectively.
Amperometric readings are shown in the graph and the currents of the interfering species are very
small, and there was a need to adjust the graph to assess their values. We calculate the current ratio
between glucose and interfering species, which was for SA (1.65%), LA (5,354%) and AA (4.99%)
respectively. See figure 3.16.

3. 16. Amperometric studies (i-t) for interfering species in glucose sensing experiments.

91

The current ratio between the glucose and the interfering species allow us to infer that our sensor
shows great affinity for glucose. The current value of the interfering species represents a higher
concentration (0.1M) than the concentrations that these species can obtain in total blood.
Therefore, we observe a minimum current response of the interfering species with respect to
glucose, suggesting that there is a selectivity and specificity of the biosensor towards glucose.

3. 2. 6. Discussion and inferences.
The modified prepared electrodes PPE-PA-GOX and PA-PA-GOX-glucose have:
i. A well-defined redox peak, due to improved electrochemical conductivity through the preanodization and covalent immobilization techniques with cross-linking agents. The redox peak has
a formal potential of -0.44 V, close to the standard electrode potential of GOX (Yang et al, 2008;
Kang et al, 2009), and this electrochemical response is due to the direct electron transfer for the
reaction of the FAD/FADH2 happening in the immobilized GOX (Yang et al, 2008; Cai & Chen,
2004; Wang et al, 2002).
ii. Through FT-IR we were able to demonstrate GOX immobilization, due to the presence of the
Amide I and amide II bands which is accepted as indicative of enzymatic activity and has been
used to monitor the GOX characteristics after immobilization.
iii. The spectrum of C(1s) and N(1s) found in studies conducted through XPS, allows us to
demonstrate the presence of glucose oxidase enzyme, immobilized in our electrode PA-PPE-GOX,
which goes according to what is described in the literature (Boyd et al, 1995; Li et al, 1998;
Bhattacharyya et al, 1998; Libertino et al, 2007; Libertino et al, 2008; Ni et al, 2008).
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iv. The direct electron transfer, Ks 3.363 s-1 is much higher than previous studies from carbon
nanostructured materials (Janegitz et al, 2011; Kang et al, 2009; Hua & Wang, 2012; Razmi &
Mohammad-Rezaei, 2013), gold nanoparticle incorporate matrices (Wu & Hu, 2007; Zhang et al,
2011), and comparable with SPCE-Nafion® film (Yang et al, 2008), with a rapid detection time
less than 10 sec.
v. The surface average concentration of electroactive GOX (Γ) value was calculated Γ = 8.30013
e-9 mol/cm2, means that the higher heterogeneous direct electron transfer rate constant is directly
influenced by the multilayer coverage of GOX.
vi. The PA-PPE-GOX exhibits higher current response, 2.612 times, comparable with Graphene
Oxide (GO) modified electrodes.
vii. PA-PPE-GOX has a higher affinity for glucose, Km 0.03 mM, with a wide range to detect
glucose from 5 mg/dL to 900 mg/dL as well as low detection limit of 1.8 ug/5L, which involved
the glucose human range of measurements of diabetes variability in both hypoglycemic and
hyperglycemic states. A lower value of the Km suggests that immobilized GOX maintains
enzymatic activity and displays an outstanding attraction to glucose. The linearity of the Glucose
concentrations range for precision evaluations in the human glucose range is between 30 mg/dL
through 400 mg/dL. Our PA-PPE-GOX-glucose biosensor meet both recommendations addressed
by the FDA and to be used for SMBG, to minimize hypoglycemia state and maximize the
euglycemia. “Blood glucose monitoring systems (BGMSs) intended for prescription-use in the
hospital setting should be able to measure blood glucose accurately down to 10 mg/dL and up to
500 mg/dL, or a clinical justification should be provided for alternate measuring ranges and
BGMSs intended for use outside of a hospital setting, and which will not reasonably be used to
test neonatal samples, should be able to measure blood glucose accurately down to 20 mg/dL”
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(FDA, 2016), and “To meet the clinical needs of the user population, Self-Monitoring Blood
Glucose, should minimally be able to measure blood glucose accurately between 50 mg/dL and
400 mg/dL, or a clinical justification should be provided for alternate measuring ranges” (FDA,
2018).
viii. Calibration experiments of the PA-PPE-GOX-Glu. biosensor showed good performance to
identified glucose at different concentrations with a sensitivity of 60.8723 mM-1cm-2 (SE 1.544,
CV% 1.336) calculated as the current density (current/area) and plotted against the concentration,
higher than Zhang et al, 2011 (16.6 AmM-1cm-2); Unnikrishnan et al, 2013 (1.85 AmM-1cm-2);
Razmi & Mohammad-Rezaei, 2013 (0.085 AM-1cm-2).
ix. In order to review the reproducibility, 4 electrodes were tested for a period of 3 months, two
times for the first and second month, and once on the third month. The PA-PPE-GOX-Glucose
showed an error percent of 3.76%, which means they have good reproducibility after 90 days, and
showing that the electrodes have good shelf life, reproducibility and stability.
x. The validation for the electrode, PA-PPE-GOX towards glucose, was carried out through the
analytical recovery experiments, which were performed with different samples of whole blood and
the percentage of recovery was calculated from the data (calculated value of glucose, original
concentration or spiked concentration) x 100. The values are (94%, 90% and 101%) e-Average of
95%. GOX have specificity for glucose, but due to complex systems of substances found in the
blood, GOX is not completely specific for glucose, that means we need to work with this kind of
variable to improve the sensitivity and chemical stability of the biosensor.
xi. By analyzing the interfering species, which represent a higher concentration (0.1M) than the
concentrations in total blood and the calculated current ratio found between the glucose and the
interfering species, allows us to infer that the biosensor shows a great affinity for glucose.
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Therefore, the minimum current response obtained for the interfering species, suggests that the
biosensor has a higher selectivity and specificity towards glucose.

3. 3. Conclusions.
Our electrode (PPE-PA-GOX-Glucose), showed good stability and selectivity in a physiology
range of pH and temperature, and by the negative operating potential eliminates the interference
from ascorbic acid, salicylic acid, lactic acid, uric acid, and dopamine.
We characterize the biosensor (PA-PPE-GOX-Glucose) through the FT-IR and XPS studies to
demonstrate the immobilization of the enzyme GOX.
Excellent electrochemical reversibility, high stability, reproducibility, technically simple and
possibility of preparation at short period of time are of great advantages of this glucose biosensor.
The amperometric biosensor has feasibility, portability and low costs and offers new possibilities
for the development of portable and customized equipment for better glucose control.
The biosensor meets addressed recommendations for the FDA to use in both, blood glucose
monitoring systems (BGMSs) and self-monitoring blood glucose (SMBG), due to its wide range
of values (5 mg/dL to 900 mg/dL).
The biosensor has the ability to distinguish between glucose and interfering species, high
selectivity and specificity.
Our next step as future work, is conducting a clinical field research, and analyze each of these
previous aspects, to obtain a stronger biosensor electrode to handle diabetic patients, and to have
a better SMBG and BMGSs. The glucose variability, (hypoglycemic and hyperglycemic states),
has a poor glycemic control and has an increased risk for complications, such as diabetic
retinopathy prolonged hospital admission and mortality (Mendez et al, 2013; Nathan D., 2014).
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CHAPTER 4. EXPERIMENTAL AND DISCUSSION FOR GLYCATED HEMOGLOBIN
(HbA1c.) ELECTRODE

4. 1 Materials and methods.
4. 1.1. Materials.
A Human blood hemolysate as lyophilized glycated hemoglobin (HbA1c) reference, RM 405
(lyophilized form to about 0.5 ml of a solution of hemolysate of human erythrocytes with a
substance

concentration

of

total

hemoglobin

of

0.23

mmol/L(15g/L.);

1-ethyl-3(3-

dimethylaminopropyl) carbodiimide hydrochloride (EDC) (CAS 25952-53-8) reagent; Nhydroxysuccinimide (NHS) (CAS 106627-54-7) reagent; Ru (NH3) Cl2 (hexaamineruthenium III
chloride) 98% (CAS 14282-91-8) reagent and phosphate buffered saline (PBS) 10X concentrate
(CAS 7558-79-4) with a pH 7.2-7.6 at 25oC, were all purchased from Sigma Aldrich Co and used
as received.
Amino-phenyl-boronic acid (APBA) 98% (CAS 30418-59-8) power reagent was purchased from
VWR International Alfa Aesar.
Fresh human whole blood purchased from Interstate blood Zen Bio. Inc.
Ag/AgCl ink, surface resistivity <75mΩ/square/mil and viscosity 5,570-14,600 CPS; Carbon ink
79% C-220 carbon resistive ink make by Conductive Compounds, with a surface resistivity 10.68
W/Sq. and viscosity at 25o C. 43,050 CPS and oxygen 20% was purchased from Graphene
Laboratories (Calverton, NY.).
Deionized water (>18MΩcm) was obtained from a Millipore purification system (Biomedical
Solutions Inc. Bedford, MA.), to prepare all aqueous solution.
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Hydrogen peroxidase (H2O2) 30 wt.% solution (CAS 772-84-1) oxidizing agent and potassium
ferricyanide [K3Fe (CN)6] power reagent (CAS 13746-66-2) was purchased from Lab Chem
Fisher.
SU-8 50 negative tone photoresist formulation 50, with a thickness of 50 mms as purchased from
Micro-Chem, Newton. MA.
Chromatographic paper Whatman 1 chr. 1030-025, grade 3MM, from Tish scientific, cellulose,
with a thickness of 0.34mm and diameter 25 mm.

4. 1. 2. Solutions preparation.
The phosphate buffer solution (PBS) 0.01 M with a pH 7.4 was used in all studies, it is made for
dissolved 1 tablet of PBS compound from Sigma Aldrich Co., in 200 ml of deionized water at
25oC.
The EDC/NHS (0.35M/0.1M) solution was prepared as follow: 0.0033 g of EDC plus 0.0012 g of
NHS dissolved in 50 mL of deionized water and keep the solution at 4oC.
The 5mM potassium ferricyanide solution was prepared passing chloride through a solution of
potassium ferrocyanide as dissolving K3Fe (CN)6 0.0164 g in 10 mL of deionized water and
0.074g of KCl in 10 mL of deionized water, keep at room temperature (25oC).
The 5 mM hexaamineruthenium chloride solution Ru (NH3)6 Cl2, which was prepared as: 0.0154g
of Ru (NH3)6 Cl2 dissolved in a 0.1 M of KCl (0.074 g KCl in 10 mL of deionized water, and later
the solution was put in N2 x 30 min. and keep at 4oC.
The 10 mM APBA solution was prepared as follow: 0.0136 g of APBA 98% power dissolved in
10 mL of 0.01 M PBS keep at 4oC.
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The glycated hemoglobin was reconstituted lyophilized HbA1c and with hemolyzing reagents. A
volume of 1 mL of deionized water was added to the lyophilized HbA1c to reconstitute, allow
standing for 15 minutes at room temperature, mixed gently and then stored at 4oC. The
reconstituted RM 405 was diluted with (26mM NaH2PO4/ 10 mL, + 7.4 mM Na2HPO4/ 10 mL)
0.5 mL + 0.5 ml of 13.5 mM KCN) hemolyzing reagent, the final concentration of HbA1c was
obtained to be a 6.25% in a 0.23 mM hemoglobin solution.
The 5mM H2O2 solution was prepared as follow: 0.0025 ml of H2O2 30% dissolved in 5 ml of
0.01M PBS and keep at 4oC.

4. 1. 3. Specific surface area
The specific surface area the sample was calculated using the Brunauer, Emmett and Teller (BET)
surface adsorption method and theory, through the accelerated surface area and porosimetry
system (ASAP) 2020 Sorptometer made by Micromeritics, by measuring N2 adsorption on the
surface of the sample. The sample was degassed at 150ºC for 70 min at 10 mm Hg, in order to
remove any remaining solvent and ensure complete dryness and emptiness of the pores. After this
result of the amount of adsorbed N2 at a bath temperature of 76 K were obtained.

4. 1. 4 Electrochemical measurements.
Voltammetry measurements CV, CA were carried out with a CH Instrument (CHI 730E,
Electrochemical Analyzer, Austin TX.) electrochemical workstation in a three-electrode cell
assembly, at room temperature (25oC), with electrodes which consists of the printed paper-carbon
electrode (PPE) microfluidic device. All the PA-PPEs have a working electrode area of 0.03141
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cm2. We analyze and compare the results obtained with the different modified electrodes made,
through CV and CA electrochemical techniques.
CV measurements were carried out at a different scan rates range 30 mV/s to 500 mV/s. We used
different probes as 5 mM potassium ferricyanide, 5 mM hexamine ruthenium III chloride and 0.01
M PBS in PA-PPE-APBA and PA-PPE-APBA-HbA1c biosensors, through direct electron transfer,
to evaluated the electrochemical oxidation in order to demonstrate the presence of immobilized
APBA and therefore the immobilization of APBA-HbA1c. We also carried out experiments with
modified electros such as PA-PPE-APBA-HbT y PA-PPE-APBA-HbA1c with 0.01 M PBS and
different concentrations of H2O2 to determine the best response obtained through H2O2. All the
experiments were carried out at room temperature 25oC, with different scan rate to find the best
scan rate to the experiment.
CA experiments were carried out the PA-PPE-APBA-HbA1c electrodes with different % of
concentrations of HbA1c, range 0.0015% to 6.25%, different scan rate, we select 0.100 V/s as the
best option scan rate and 0.55 V of potential, and at room temperature 25oC.

4. 1. 5. Spectrometers measurements.
The FT-IR spectrum was recorded by using Spectrum 100 FT-IR Spectrometer, Perkin Elmer.
Spectrum is Perkin Elmer’s premier software package for collecting, viewing and processing FTIR spectra., all the studies were testing at room temperature (25oC). The optical module contains
a Class II/2 Helium Neon (HeNe) laser, with an achievable precision of ca 0.008 cm-1, which emits
visible, continuous wave radiation at a wavelength of 633 nm and has a maximum output power
of 1 mW, reduces signal artifacts and improves response linearity, high-quality, low-angle, offaxis optics minimize aberrations and provide the highest optical efficiency. Different electrodes 5
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each, were prepared to carry out the experiments to compare and analyze the results through the
PA-PPE-APBA, PA-PPE-APBA-HbT and PA-PPE-APBA-HbA1c biosensors. The electrodes used
was prepared according to details showed in the next two sections.

4. 1. 6. X-ray photoelectron spectroscopy studies.
The XPS analysis were carried out with a PHI 5600 spectrometer with a hemispherical energy
analyzer, using an aluminum (Kα) source of 1487 eV at 100 Watts. The sample was maintained at
high vacuum. The pressure in the analysis chamber during XPS analysis was in the low range of
10-9 Torr. All spectra were recorded at 54o take-off angle, the analyzed area being currently about
1 mm2. All spectra were recorded with 1.0 eV step, 10 cycles, 20 sweeps and corrected using
carbon signal (C1s) at 284.5 eV. XPS spectra were analyzed using casa-XPS software version
2.3.18. The Shirley method was used for extracting the background necessary for curve fitting.

4. 1. 7. Fabrication of paper electrodes.
The PPEs were designed through the adobe illustrator graphic design software and were
subsequently manufactured using the template printing technique. A template print mask with the
electrode pattern was created by means of low-adhesion laser-cut films with an internal Zing 16
laser cutter (Epilog, Golden, CO). The prepared electrode patterns were placed on the SU-8 2010
photographic resistance treated chromatographic paper, which was previously prepared using the
photolithography technique. SU-8 epoxy-based is a negative photoresist, and negative refers to a
photoresist whereby the parts exposed to UV rays crosslink and needs to bake again after UV
exposure to complete the polymerization. The photolithography technique consists in: applied SU8 photoresist over the chromatography paper; baked in a hot plate for 20 min at 135oC; a selectively
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polymerization with UV (350-400 nm) exposure at 100% for 20 sec. using a mask 0.7 cm diameter
that show the design area, in black ink printed, to generate a hydrophobic and hydrophilic areas;
transfer the chromatography paper to the hot plate por 5 min at 135oC and later developed with
acetone and isopropyl alcohol at 70%. Them left to dry at room temperature x 20 min. See figure
4.1.

Figure 4.1. Design showing the process of making the disposable paper electrode (pictures not drawn to scale).

The conductive carbon ink paste was careful impregnated into the electrode patterns to make 2 of
the 3-electrode system consisting of a: carbon-based counter electrode (CE), a carbon-based
working electrode (WE) with a surface area of 0.03141 cm2 and a conductive Ag/AgCl ink-based
pseudo-reference electrode (RE) as a 3er electrode system, see fig. 4.1. and fig. 4.2. After each step,
following the application of carbon ink to the two electrodes WE and CE, and next the Ag/AgCl
ink over RE, the PPE were backed at 95oC for 25 min in an oven (Dungchai et al, 2009; Martinez
et al, 2010; Nie et al, 2010; Lan et al, 2013; Liu et al,2014).
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Figure 4.2. (A) Digital photo image of the PPE. (B) the electric circuitry for the electrode, (picture not drawn to
scale). The circuitry consisted of working electrode (WE), counter electrode (CE), and reference electrode (RE).

4. 1. 8. Fabrication of modified electrode.
After the PPE has been prepared, then the pre-anodization process is done by applying a potential
at 2.0 V, through the i-t electrochemical technique method, over working electrode vs Ag/AgCl
counter electrode, for 300 s., placing the PPP in a beaker which contained a pH 7.4 PBS. With a
pre-anodized time of 300 s. the ratio between O1s and C1s (O1s/C1s ratio) has more changes and as
well as create more carbonyl-groups functionalities (Evans et al, 1979; Notsu et al, 1999). The
pre-anodization method create more edge plane sites and can make the modified carbon electrode
(CE) more electroactive, but also provides low susceptibility to electrode fouling (Prasad et al,
2007; Yang et al, 2008; Prasad et al, 2008; Thiyagarajan et al, 2014). The next step was add the
EDC/NHS (0.35M/0.1M) solution, which was prepared with 0.0033g of EDC and 0.0012g of NHS
and dissolved in 50 mL of deionized water, and drop coated 5 mL over the WE at the PA-PPE and
left for 30 min at room temperature (25oC), after that, the excess was removed and washed with
0.01 M PBS 1 L. Then APBA was coupled through EDC and NHS cross-linkers and immobilized
in the PPE. The 10 mM APBA solution was prepared by dissolving 0.0136 g of APBA 95% power
in 10 mL 0.01M PBS and drop coated 5 L on to EDC/NHS activated PA-PPE. The electrodes
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(PA-PPE-APBA) were then dried at room temperature (25oC) for 2h, and subsequently washed
with 0.01M PBS 1 L to remove unbounded APBA. The HgbA1c solution was reconstituted
lyophilized HbA1c and with hemolyzing reagents. 5 L of HbA1c was added to the working
electrode and left dry four 1 hour at 4oC. Then washed with 1 ml of 0.01 M PBS to removed
unbounded HbA1c and evaluated with electrochemical experiments. The PA-PPE-APBA-HbT
biosensors was prepared adding an aliquoted the sample of Hb with 100 L of deionized water
and drop 5 L over the modified electrode, left at 4oC x 1 hour. Then washed with 1 L of 0.01M
PBS. The figures 4. 3 show the schematic diagram and the representation for the full process done
to prepare and tested the modified electrode.

Figure 4.3. Design of the PA-PPE-APBA-HgbA1c electrode showing the different steps to immobilization of HgbA1c
and the catalytic reaction with H2O2.

4. 2 Results and discussion
4. 2. 1. Specific surface area
The BET surface area report shows a 5.07 m2 of are per gram of the material. The geometric
surface area for the working electrode is 0.03141 cm2. The Braunauer-Emmett-Teller (BET)
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surface area is 12.675 cm2/g with a pore size of 92.607 Å and pore volume of 0.016736 cm3/g.
(Brunauer et al. 1938).

4. 2. 2. Pre-anodization technique
The pre-anodization as a cleaning technique and performed as a pretreatment, the carbon electrode
is cleaned and exposed to the application of a potential, and the functional groups are formed on
the surface as a multiple edge plane formation. The fig. 4.4 shows the electrochemical oxidation
process that happens when a positive potential (2V) is applied versus time (300 s). The current or
the flow of electrons going from the solution to the electrode and produces an anodic (oxidation)
current.

Figure 4.4. Pre-anodization (PA) graphic.

104

4. 2. 3. Surface characterization of PA-PPE-APBA and PA-PPE-APBA-HbA1c.
a. Fourier transform infra-red (FT-IR).
To characterize the electrodes, we compared the Fourier transform infra-red (FT-IR) spectrum
between APBA and the APBA-HbA1c, through the PA-PPE-APBA and PA-PPE-APBA-HbA1c
electrodes, to show the differences that occur when the HbA1c bound APBA and is immobilized.
Also, we compared the FTIR for PA-PPE-APBA-HbT and PA-PPE-APBA-HbA1c.
I. The FT-IR spectrum of APBA (Fig. 4.5. A) found exhibits basically two peaks with additionally
peaks as characterization associated:
i. amide I band 1732 cm-1 peak (1659 - 1841 cm-1) caused by ester bonds, C=O stretching
vibrations in carboxylic acid and carbonyl moieties, 1740 cm-1 for C=O from carboxylic acids &
carbony moieties (Wang et al, 2013); 1452 cm-1 for C-N stretching (Prasad et al, 2015); ester
bonds at 1,730 cm-1 (Xu et al, 2014) and the wide band 1600 cm-1 to 1700 cm-1 identified C=O
stretching vibrations of peptide linkages in the backbone.
ii. Amide band II 1456 cm-1 peak caused for combinations of N-H in a plane bending and C-N
band stretching linkages, at 1457 cm-1 for the peptide groups (1490 cm-1 identified as the
combination of N-H in-plane bending and C-N stretching of the peptide groups at 1442 cm-1)
(Malesevic et al, 2008; Liang & Zhuobin, 2003).
iii. Third peak, Amide band III on 1239 cm-1, correlated with Delfino data’s (Delfino et al, 2013).
iv. Fourth peak, B-O stretching vibrations at 1379 cm-1 (near 1,370 cm-1 broad asymmetric B-O
stretching band (Faniran & Shurvell,1968; Diao et al, 2012; Zhou et al,2014).
Additionally, we founded:
v. Two wide bands in the region 3400 to 3300 cm-1 representing the amide A and B bond linkages
to B-OH and NH stretching overlapped with O-H stretching vibration, and -CH3 stretching at 3430
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cm-1, correlated with Wang, Xu and Prasad studies (Wang et al, 2013; Xu et al, 2014; Prasad et
al, 2015).
vi. Sixth peak, characteristic (B–O) stretches at 1380 cm−1 and 1350 cm-1 and aromatic (B-OH)
bending can be also observed at 1029 and 860 cm-1 after reaction, suggesting the successful
amidation reaction of the anchored carboxyl groups with the amine groups of APBA, (a strong
band at 1350 cm-1, and weak absorption band at 850 cm-1 (Faniran & Shurvell, 1968; Diao et al,
2012; Zhou et al, 2014; Wang et al, 2015).
vii. Seventh peak, (C-O) stretching vibrations at 1239 cm-1 and 1158 cm-1 (assigned as vCO
asymmetric at 1238 cm-1 and vCO symmetric at 1,149 cm-1 (Faniran & Shurvell, 1968).
vii. Eighth peak (C-H) stretching vibrations of phenyl ring at 2,958 cm-1 incorporated in the band
corresponding to C-H stretching 2,950 cm-1 (Xu et al, 2014; Gu et al, 2012), for carboxylic acid
groups at 2,800 to 3,050 cm-1 (Diao et al, 2012).
II. The FT-IR spectrum for glycated hemoglobin (HbA1c) Fig. 4.5. B, we found:
i. Amide I broad band 1588 to 1687 cm-1 which correspond to (C=O) stretching of protein amide
groups, N-O stretch band for heme group bound NO 1700 to 1620 cm-1, N-O stretch band for
heme-bound near 1,617 cm-1 with two discrete N-O stretch bands near 1617 cm-1 for CI band and
1632 cm-1 for CII band; also will be found absorbance of the amide I band of a protein with 
helix near 1656 +/- 2 cm-1 (~1654 cm-1) and a protein with  sheet structure near between 1645
and 1632 cm-1 (~1633 cm-1) (Dong & Caughey, 1994; Barth, A. 2007).
ii. A second broad band Amide II band 1,588 cm-1 to 1415 cm-1 for N-H bending vibration strongly
coupled to CN stretching vibration of peptide groups of proteins (correlated due to an out-phase
combination of N-H in plane bending and C-N stretching vibrations of peptide groups (Dong &
Caughey, 1994; Krimm & Bandekar, 1986).
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iii. A third peak 1156 cm-1 involved in a wide band O2 bound to Fe+2 for C-O-H and C-O-C bonds
ring vibrational mode of C-O-H and C-O-C bonds at 1170 cm-1 (Dong & Caughey, 1994;
Gunasekaran et al, 2010).
iv. Four wide band with particular variations and absorbance between 1978 cm-1 to 1825 cm-1 for
C-O stretch band in the carbonyl spectrum at the heme bound C-O and cysteine band, also C-O
stretch band for heme-bound CO at 1951 cm-1 and bisignate cysteine band at 1857 cm-1 (Chen &
Spiro, 2002).
v. A fifth wide band between 3400 to 3050 cm-1 for Amide B band and Amide A band due to N-H
stretching vibrations, -OH stretching documented by Gunasekaran et al, 2010 and Prasad et al,
2015. (3303cm-1 Amide-A band due to N-H stretching vibration and 3068 cm-1 Amide-B band due
to overtone of Amide I band) (Chen and Spiro, 2002).

Figure 4.5. Fourier transfer infra-red (FT-IR) for PA-PPE-APBA (A) and FT-IR for PA-PPE-APBA-HbA1c (B).

The fig. 4.6. show the difference observed between the FTIR for PA-PPE-APBA-HbT and PAPPE-APBA-HbA1c. The amide I band between 1600 cm-1 to 1700 cm-1, with their different C=O
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stretching vibrations, and amide II band at 1565 cm-1 to 1462 cm-1 with the C-N stretch coupled to
N-H bending, that correspond to the peptide groups, they provide information on the type of
secondary structure, these types of vibrations are the -helix, -strands, and different kinds of turn
structures as -turns and -antiparallel. The -helix structure can be assigned in the rage of 1655
cm-1 and 1545 cm-1 with a strong feature close at 1550 cm-1 in amide II band, and the −strands
has been assigned in 1630 cm-1 and 1530 cm-1 bands. (Goormaghtigh et al, 2006; Murphy et al,
2014; Alhazmi, H. 2019). Human hemoglobin exhibits several exogenous ligands that include O2,
CO and NO bound to Fe2+ and CN-, N3, OCN-, SCN- and NO bound to Fe3+. Positives and keys
for identification Hb are N-O stretch band for heme-bound NO close to 1617 cm-1, C=O stretching
of protein amide groups close at 1700 cm-1 to 1620 cm-1, C-N stretch ligand to HbA Fe3+, four CO stretch bands near 1969 cm-1 reflecting the interaction between the heme pocket with CO and
the nature expression of the Fe-C bond (Dong & Caughey, 1994).

Figure 4.6. FT-IR for PA-PPE-APBA-HbT (A) and FT-IR for PA-PPE-APBA-HbA1c (B).
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b. X-ray photoelectron spectroscopy (XPS).
XPS studies were conducted to demonstrate the immobilization of APBA and of course APBAHbA1c in the biosensor. All our findings are in accordance with the revision of the literature, with
greater emphasis on those works that support the objective of the study, the presence of APBA and
APBA-HbA1c in the biosensor. We will do a more in depth-analysis of the observations that match
ours XPS findings of the different elements.

Boron
We compare sample No. 1 corresponding to the PA-PPE electrode, modified with EDC/NHS and
sample 3 corresponding to modified PA-PPE-APBA biosensor. In both cases B(1s) shows several
peaks centered between 186.7 eV to 192.5 eV (Wang et al, 2015). Sample 3 shows B(1s) core
levels peaks at 188.1 eV (pure). 189.9 eV (B-C bond) (Paul et al, 2012). 190.5 eV (overlapping
C-N and B-C bonds), these peaks correspond to phenylboronic acid binding (Kim et al, 2007 and
Mohapatra et al 2009). B-(OH)2 (Wang et al in 2015). 191.2 eV (overlapping C-B and B-O bonds),
(Ong & Huang, 2004; Kim & Shim, 2013; Fabre et al, 2017). 192.5 eV (B-O bond), (Kim et al,
2007), see figure 4.7. F.
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Figure 4.7. PA-PPE-APBA XPS studies showing the complete graphic for the elements funded (A), carbon, C(1s)
core-level spectra (B) and (C), oxygen (D), nitrogen N(1s) core-level spectra (E) and boron (E).

Hendrickson et al,1970, found shifts of B(1s) the binding energy in 25 different compounds, with
a range between 186.7 eV to 195.1 eV (Δ eV~8.4 eV). The binding energy for chlorobenzeneboronic acid was at 191.9 eV and that of -mercaptophenylboronic acid was at
191.5 eV with a calculated CNDO of +0.498. Carey et al, 1994, working with acid mercaptoalkylboronic found that the binding energy for B(1s) electrons was 192 eV. According to
Ong & Huang in 2004, boron is usually oxidized as B2O3, with the B(1s) energy shifted to 190.5
eV as Eb, VBM and 193.6 eV as Eb, FL, the peak located at 187.3 eV is assigned to the elemental
boron and the peak at 191.2 eV corresponds to the (C-B) bond. These references allow us to assig
the binding energy at 192.5 eV (C-B) relate to the presence of boronic acid.
Also, XPS studies conducted by Kim et al in 2007 show three bands correlated with their binding
energies for the B(1s) atom and their respective bonds, located in 189.6 eV as (B-C), 190.7 eV as
B-N and 192.5 eV as (B-O) bond. They also analyze different B bonds with other atoms (C&N)
110

and identify, 283.5 eV (C-B bond) and 397.6 eV (N-B bond). Barriet et al, 2007 in its analysis of
the spectrum of B(1s) obtained a peak at 190.7 eV which can be assigned to different species of
boronic phenyl acid in its trigonal sp2 hybridization and Mohapatra et al in 2009, based on its
analyses considers it possible that the union (OH--boronic acid) to form a tetra-coordinated boron
corresponds to the peak 190.04 eV as phenyboronic acid. Our changes obtained in the spectrum of
B(1s) at 189.9 eV and 190.5 eV validate the presence of boronic acid configurations.
Other studies recently confirmed the existence of boronic acid in different binding energy bonds,
which, confirm our findings in the biosensor. Paul et al, 2012, assigns the B(1s) spectra with three
centered components and their respective bond, 193.0 eV as boron oxide (B-O), 191.6 eV as boron
nitride (B-N), and 189.9 eV as boron carbide (B-C). Kim & Shim, 2013, found a peak in 191.2 eV
in the B(1s) spectrum and identified it as a (C-B) bond. Wang et al, 2015, obtained a spectrum of
B(1s) between 188.0 to 192 eV. Fabre et al, 2017, considers that the peak in the spectrum of union
energy in 191.9 eV can be assigned to a (B-O) bond, attributable to boronic acid moieties.
Carbon
XPS studies for PA-PPE-APBA show basically a grand band for binding energy of C(1s) through
280 eV to 291.5 eV which different peaks. Carbon run 1, the data is fitted by a mix of pure C(1s),
(C-C bond) and (C-O-C bond) in the proportions shown (figure 4.7.B & C). Pure C(1s) would
peak at the vertical line at 284 eV overlapping the (C-B) bonds. Carbon, run 2, the data is fitted by
a mix of pure C(1s), (C-C) and (C-O-C) bonds in the proportions shown see figure 4.7. B & C.
The centered peak at 284.9 eV could be assigned to overlap (C-C) bond (Kim et al, 2007), pure
carbon C1 bond (Boyd et al, 1992) and (C-N/C=N) bonds (Wang et al, 2015). The centered peak
at 286.5 eV could be assigned to (C-O-C) bonds and [CN (N3)] bond (Bhattacharyya et al, 1998),
and centered peak at 284.6 eV could be assigned to (C-O), overlapping (C-C/C-H) bonds (Golczak
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et al, 2008, Mohapatra et al, 2009) and pure carbon C1 bonds (Bhattacharyya et al, 1998). See
figure 4.7. B & C.
XPS studies for PA-PPE-APBA-HbA1c show a grand band with different binding energy of C(1s),
279.5 eV to 291.5 eV. Carbon run 1, the data is fitted by a mix of pure C(1s), (C-C) and (C-O-C)
in the proportions shown, see figure 4.8.B. Pure C(1s) would peak at 284 eV, show for the vertical
line, and overlapping a (C-B bonds). Carbon run 2, the data is fitted by a mix of pure C(1s), (C-O)
and (C-O-C) in the proportions shown, see figure 4.8.C. The centered peak at 284.6 eV could be
assigned to (C-C) bond (Kim et al, 2007; Mohapatra et al, 2009). The centered peak at 284.4 eV
could be assigned to (C-O) bonds and overlapping (C-C/C-H) bonds (Golczak et al, 2008; Wang
et al, 2015). A centered peak at 286.9 eV could be assigned to overlapping (C-O-C), (C=O) and
(CN) bonds (Kim et al, 2007), (CN) (N3) bond (Bhattacharyya et al, 1998) and (C=O/C-O)
(Golczak et al, 2008;Wang et al, 2015). A peak at 287.7 eV overlapping C1 as sp3 (Boyd et al,
1995), (C-N) bond (Bhattacharyya et al, 1998) and the (C=O) bond, due to protein chains of the
hemoglobin (Wang et al, 2018). Overlapped peak at 288.5 eV could be assigned to (C-O) bond
(Boyd et al, 1995), (O-C=O bonds) as presence of (-COOH) groups (Wu et al, 2001), (-NH-CObond) (Liu et al, 2009) and (C-N and C-O bonds) (Mohapatra et al, 2009). See figure 4. 8. B &
C and figure 4.9.
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Figure 4.8. PA-PPE-APBA-HbA1c XPS studies showing the complete graphic for the elements funded (A), carbon,
C(1s) core-level spectra (B) and (C), nitrogen N(1s) core-level spectra (D), oxygen (E) and boron (F).

The spectrum of C(1s) and N(1s) represent a complex group of atoms that have multiple
configurations due to their different bounds and overlap the binding energies. We analyze in more
detail the works focused on validating our findings.
The following studies in XPS establish the carbon and nitrogen ratios at their spectral base and
electronic properties in surface matrices, simple bonds of each atom and conjugated forms. Boyd
et al, 1995, basically allocates the existence of four peaks by deconvolution of the spectrum of
C(1s) and situate them according to their bonds, 288.3 eV (C-O bond), 287.7 eV (C1) sp3 bonding,
285.9 eV (C2) sp2 bonding and 284.6 eV (AC bond). The two middle binding energy they assigned
as (C-N) bonding. We mentioned early five peaks at C(1s) core-level spectra were identified by
Bhattacharyya et al, 1998, which were assigned to a respective binding energies (BE) located,
284.7 eV (pure carbon C1), 285.3 eV [C=N (C2) bond], 286.7 eV [CN (N3) bond], 287.7 eV [CN (C4) bond] and 289.6 eV [C-O (C5) bond].
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The following section analyzes the integration of C(1s), N(1s) and B(1s) into matrix structures
with nanoparticles and confirm the presence of (C-B), (C-N), (C-C), (B-N), as part of the boronic
acid and functional groups. XPS studies conducted by Wu et al, 2001, deconvolution the spectrum
of C(1s) in four components and relate each binding energy to their respective bonds, 283.92 eV
(C-C or C-H), 285.02 eV (C-N or C=N), 285.80 eV (C-N+ or C=N+) and 286.59 (C=O). Also, they
found an extra higher binding energy level which was related with (O-C=O) bonds at 288.14 eV
to 288.81 eV and they assigned to the presence of (-COOH) groups. Kim et al in 2007, found a
broad band deconvoluted in three bands centered, 283.5 eV (C-B bond), 284.6 eV (C-C bond) and
286.3 eV (C-N bond) which, will incorporate other binding energies for (C=O and CN bonds).
Golczak et al, 2008, found the same four components with some differences, 284.4 eV (C-C/CH), 285.0 eV (C-N/C=N), 285.8 eV (C-N+/C=N+/C-Cl), and 286.72 eV (C=O/C-O) which it to be
assigned to functional groups. Liu, et al, 2009, found a peak overlapping other peaks at 288.41 eV
and identifies it as amide bond (-NH-CO-).
Studies conducted in XPS, in the next section, analyze and confirm the findings in the biosensor
about the presence of boronic acid, C-O functional groups, and hemoglobin protein components.
According a Mohapatra et al, 2009, the peak found at 284.6 eV represents the carbon and aromatic
carbons that characterize the benzene ring of the imine. Also, they assigned the peak at 283.2 eV
with the (C-B) bond, another two peaks, 285.86 eV (C=N bond) and 288.5 eV (C-O bond). They
suggest that all these changes found are important evidence for the presence of boronic acid imine
on the electrode surface. Wang et al, 2015, has found the same four components of the C(1s)
spectrum and relates them to their respective bonds, 283.8 eV (C-B), 284.4 eV (C-C/C-H), 285.0
eV (C-N/C=N), 286.1 eV (C=O/C-O) and suggest that the C-O/C=O bonds correspond to the
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functional groups. Wang et al, 2018 suggest that one peak located at 287.6 eV assigned to the
(C=O) bond could be attributed due to of the protein chains of Hb.

Figure 4.9. XPS studies for carbon. Sample 1 (PA-PPE), sample 2 (PA-PPE-GOX), sample 3 (PA-PPE-APBA),
sample 4 (PA-PPE-APBA-HbA1c).

Nitrogen
XPS studies for PA-PPE-APBA for the N(1s) core-level showed a grand band centered at 399.3
eV and another small band overlapping the first centered at 401.7 eV. Nitrogen it peaks at the right
energy showing it is pure at 399.5 eV (Baranton & Belanger, 2005), the rest correspond to
mixtures of N (pure) and NO at 399.8 eV, see figure 4.7. D and figure 4. 10, sample 3. Other
binding energies found, 399.3 eV could be assigned to (C-N) bonds and overlapped (C=N) bond
(Chan et al, 1992) and 401.8 eV will be attributed to overlapping (C=N) bonds or (C-N) bonds
and a pyrolic N bond (Chakraborty et al, 2018).

XPS studies for PA-PPE-APBA-HbA1c, N(1s) peaks about 0.8 eV to the left, with a grand band
starting at 393.4 eV and finish over 405.0 eV. Sample may contain different peaks located at
different binding energy which can maybe overlap bounds. 398.3 eV which will be assign to the
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overlapped N1 bounds as (C-N) bond (Boyd et al, 1995; Bhattacharyya et al, 1998) or (C-NH2)
bond (Dementjev et al, 2000). 399.0 eV (overlapping C-NH2 and C=N-C bonds) (Dementjev et al,
2000; Kim et al, 2007). 399.5 eV [pure N(1s)] (Kim & Shim et al, 2013), (C=N bond) (Chan et al,
1992), amine nitrogens (-NH-) (Wang et al, 2015). 400.1 eV overlapping (C-N bond) (Chan et al,
1992), (C=N bond) and N2 in the N-C sp2 binding energy (Boyd et al, 1995). 400.4 eV which it
would assign to conversion of the amine group (NH2) into an amine group (NH-CH) (Song et al,
2009). 402.4 eV (C-N+ or N-O bond) and could be assigned to higher energies for the N-radicals
(Boyd et al 1995). The peak at 400.1 eV as considered as (C-N) which could be assigned to the
bonds from hemoglobin (Chakraborty et al, 2018), overlapping (C-N=N-C) bonds (Baranton &
Belanger, 2005). See figure 4.8. D. and figure 4. 10. sample 4.

We will review the complexity of interactions between C(1s) and N(1s) and analyze the basic
structure of the nitrogen and its potential electronic interrelationship properties, through the
following works done in XPS. Chan et al in 1992, determined four peaks for the N(1s) nucleus,
for polymers, based on the increase in the positive charge for the nitrogen atom which causes an
increase in the binding energy, and interpreted according to their bond, 399.4 eV (C=N bond),
400.2 eV (C-N bond), 401.2 eV (C=N+ bond) and 402.5 eV (C-N+ bond). XPS studies conducted
by Boyd et al in 1995, they found that the binding energies are deconvoluted in three basic peaks
which interpret as: N2 assigned to the N-C(sp2) bonding with an binding energy of 400.0 eV, N1
attributed to the sp3 bonding with an energy of 398.3 eV, and the N-O bond with an energy of
402.5 eV, which can be attributed to high-energy components for N-radicals.
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The following section allows us to analyze the presence of organic molecules and combined
structures of C(1s), N(1s) and B(1s) as an addendum to the previous carbon revisions. N(1s)
spectrum studies conducted by Bhattacharyya et al in 1998, show that this compound of different
binding energies, which were assigned to their respective bonds, 398.3 eV [C-N (N1)], 398.8 eV
[CN (N2)] and 400.8 eV [NO (N4)], closing these binding energies for C(1s) and N(1s) for
organic molecules. Dementjev et al 2000, assigned the binding energies for the peaks with the
bonds, 398.5 eV (C-NH2), 399.1 eV (C=N-C) and 400.7 eV (-NH2 bond). Baranton & Belanger,
2005, found a peak at 399.5 eV and they considered these was por presence of the N-(C2H5)2
substituent, another peak at 400.0 eV which assigned to a (C-N=N-C) linkage, in a DEA modified
electrode. Kim et al, 2007, finds a band centered at 399 eV and performed a deconvolution, finding
three centered peak at 397.6 eV (PN0) assigned to (N-B) bond, 398.6 eV (PN1) assigned to (N-C)
structures (graphite-like N-C) and 400.7 eV (PN2) assigned to N atoms bonding to C atoms
(pyridine-like N-C) structures.
The presence of boronic acid and the immobilization of APBA in our biosensor is validated by the
following studies in XPS. Song et al, 2009, working on Dend-FPBA, found a peak at 400.2 eV
which was assigned to the binding energy of the (NH2) group, and they attributed this response
due to the modification at electrode by the boronic acid, and the spectra changes in C(1s) and N(1s)
due to the conversion of the amino group (NH2) into a imine group (NHCH). Kim & Shim in 2013,
showed through the N(1s) spectrum a different peak located at 399.4 eV after the APBA
immobilization. Wang et al in 2015, through to the modified electrode to detect HbA1c, found
basically three peaks located, 398.8 eV assigned to the protonation of the imine nitrogens (=N-) as
emeraldine state, 399.6 eV assigned to amine nitrogens (-NH-) as leucoemeraldine state and 401.1
eV assigned to the N+ as to positively charged nitrogens:oxidized amine.
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The following study allows us to validate the presence of hemoglobin in our biosensor. Ummam
et al, 2017, working with a gold-nanoparticles modified boron-doped diamond (AuNPs-BDD) to
detect hemoglobin found a peak at 400 eV which was attributed to (C-N bonds) from the
hemoglobin. Chakraborty et al, 2018 found a spectrum of the N(1s) which showed different peaks
and related them to their respective bonds, 397.8 eV (pyridinic N), 398.8 eV (pyrolic N), 399.6 eV
(N-Fe), 400.8 eV (quaternary N) and 401.8 eV (pyrolic N), signaling another peak at 400. eV as
part of the hemoglobin spectrum.

Figure 4. 10. XPS studies for nitrogen. Sample 1 (PA-PPE), sample 2 (PA-PPE-GOX), sample 3 (PA-PPE-APBA),
sample 4 (PA-PPE-APBA-HbA1c).

Oxygen
XPS studies for PA-PPE-APBA, sample 3, for the spectrum of O(1s) showed a grand band range
527.0 eV to 536.0 eV, with a centered peak 532.1 eV and 532.4 eV which could correspond to
overlap (C=O and C-O bonds) which could be considered representative of the groups of boronic
acid (Barriet et al, 2007). Another band centered at 530.4 eV which will assigned to overlap (FeO bond) (Mohapatra et al, 2009) and FeO2 bonds. The sample at the correct energy for pure O(1s)
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at 532.0 eV at the vertical line. The peak at 533.0 eV may have some (C-O-H) bonds and (B-O)
bond (Chan et al, 1992; Wu et al, 2001)), see figure 4.7. D and figure 4.11.
XPS studies for PA-PPE-APBA-HbA1c, sample 4, had a band range starting in 526.0 eV and
finishing at 538.5 eV for the O(1s) spectrum with a centered peak at 532.0 eV for a correct energy
for pure O(1s) overlap (C=O and C-O bonds) (Chan et al, 1992: Barriet et al, 2007). Another
centered peak at 529.0 eV overlapping (Fe-O) bonds (Woo et al, 2001; Mohapatra et al, 2009), a
centered peak at 533.0 eV may it for some (C-O-H), (B-O) and (Fe-O-C) bonds (Wu et al, 2001;
Mohapatra et al, 2009; Song et al, 2009; Liu et al, 2011). Notice that it may also contain (C-O
bond) as they both peak at almost the same energy (532.3 eV) (Chan et al, 1992) and bonds for
modification surface as Fe2O3 particles. Also, a centered peak at 531.0 eV (C=O bond) and the
centered peak at 532.0 eV (C-O bond), due to C(1s) spectrum on the protein chains of Hb (Wang
et al, 2018), see figure 4.7. E and 4.11

Figure 11. XPS studies for oxygen. Sample 1 (PA-PPE), sample 2 (PA-PPE-GOX), sample 3 (PA-PPE-APBA), sample
4 (PA-PPE-APBA-HbA1c).
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The O(1s) spectrum is a multifunctional complex which can have water and waste as part of its
configurations, it is interesting to find the specific points and document the relationships with our
biosensor. The spectra of O(1s) range in binding energy at 530.9 eV to 533.8 eV, in organic
compounds according to Beansom & Griggs, 1992. In the range between 532.0 eV to 533.7 eV
they found the more common organic species with oxygen as alcohols, esters, ketones, ethers and
organic acids.
To understand the usefulness of the O(1s) in our reading we will review some works that analyze
the structure and configurations of the oxygen as functionals groups. XPS studies conducted by
Chan et al in 1992, in copolymers and PANA-HCl found that the O(1s) spectrum has three
components, to different binding energy, which it was able to assign to their respective bond, 531.0
eV (C=O bond), 532.5 eV (C-O bond), 533.4 eV (H2O) and they suggest that this results indicate
a concurrent self-doping by the (-COOH) groups. Woo et al 2001, working with silane (Si) as a
coupling agent between an interfacial interaction between a magnetic particle and a binder, found
that the binding energy at 530.2 eV can be assigned to the (Fe-O) bond, as well as, found another
peak for the O(1s) at 531.9 eV which it considers can be attributed to the (Si-O-Fe) bond. Wu et al
in 2001, found similarity between O(1s) spectrum with small differences in the binding energies,
which they compared with the studies of Chan et al, 1992. The O(1s) spectrum for copolymer and
poly-diphenylamine (PDPA) films, was assigned to 531.68 eV (C=O bond), 532.63 eV (S-O bond)
and 533.2 eV (O-H bond). They also, assigned another peak in the range at 532-49 eV to 533.75
eV, in copolymers, as (C-O) bond.
The following detailed studies support the presence of boronic acid, in our samples, through the
O(1s) links with other atoms such as C(1s), B(1s), Fe(sp2) and therefore the presence of glycated
hemoglobin. Barriet et al in 2007, working with 4-mercaptophenylboronic acid (MPBA) and other
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compounds containing boronic acid in its structure, found that the localized peak approximately at
532. eV shows that the samples have water, in addition they observe other peaks with binding
energy at 531.2 eV and at 532.7 eV and could correspond to the (C=O) and (C-O bonds). They
also argue that the peak at 532.2 eV is considered representative of the groups of the boronic acid.
Mohapatra et al, 2009, found two peaks in the binding energy of the O(1s) spectra and was able
to deconvolution in three peaks assigning to each peak with its respective bond: 530.5 eV (Fe-O
bond), 531.5 eV (B-O bond) and 532.08 eV (Fe-O-C bond) which it to be attributed boronic acid
functionalized iron oxide nanoparticles. Song et al 2009, found a peak on the spectrum of O(1s) at
533.31 eV, in a modified dendrimer layer 4-formyl-phenylboronic acid (Dend-FPBA) electrode to
detect HbA1c, which was assigned to the (B-O) bond by a modified-boronic acid. Liu et al 2011,
working with 4-formyl-phenylboronic acid (FPBA) modified-electrode for determination of
glycated hemoglobin found in the O(1s) spectrum a new peak at 533.31 eV which was assigned to
the (B-O bond). Wang et al in 2018, working with Hb and Hb-polydopamine (Hb-PDA)
nanoparticles, found two peaks in the O(1s) spectrum located at 531.0 eV and 532.0 eV, which
was assigned to the (C=O) and (C-O) bonds, which indicated the presence of Hb-PDA at the
surface.

Iron
XPS studies for iron (Fe) spectrum in PA-PPE-APBA-HbA1c, modified electrode, see figure 4. 8.
F, showed a most likely pure and mixed with Fe bound to something else (peak is shifted by about
1.2 eV to lower energies). A band range 705.0 eV to 729.5 eV was found at the spectrum of Fe(1s).
A centered peak at 710.0 eV which will be assigned to the Fe(2p) orbitals (Fe3O4) (Mohapatra et
al, 2009; Chakraborty et al 2018). A peak at 710.4 eV which could correspond to (Fe-OOH)
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bounds (Grosvenor et al, 2004). Overlapping between 710.0 eV and 710.3 eV one peak at 710.2
eV assigned to (Fe3O43+) which will be attribute to satellite structure for Fe (III) present and it will
be like Fe (II) (Fe2p1/2) (McIntyre et al, 1977; Lin et al, 1997). Peak at 709.8 eV [Fe(p2)] as (FeO) bond (McIntyre et al, 1977; Grosvenor et al, 2004). The centered peak at 721.5 eV could be
assigned to satellite peaks to the Fe(2p) as the Fe (II) (2p3/2) and Fe (III) (2p3/2) states binding
energies. An overlap centered peak at 726.5 eV for satellite Fe (III) (2p1/2) y Fe (II) (2p1/2) (Lin et
al, 1997).

The following two sections review the multiple configurations of the Fe(sp2) spectrum, with their
different ferric, Fe (II) and ferrous, Fe (III) states. McIntyre & Zetaruk in 1977, analyzed the
spectrum of Fe(2p) and they found similarities between, 711.0 eV ± 0.15 [-Fe2O3 (Fe2p3/2)] with
a satellite band at 719.0 eV [-F2O3 (Fe2p)], predicted component of the Fe(2p1/2) line. 711.0 eV
± 0.2 [-Fe2O3 (Fe2p3/2)] with the same intensity distribution but, it is reduced by 0.2 eV compared
to (-Fe2O3). Another peak at 709.5 ± 0.2 (Fe-O, Fe2p bond). Lin et al in 1997, found that the
spectrum of Fe(2p) can have a range as wide as from 700 eV to 730 eV containing different peaks
which will be correspond to the pure iron (Fe0) state, doublets for both 709.3 eV [Fe (II)] and 711.6
eV [Fe (III)] states, a double line for the Fe (II) shake-up satellite, and a simple line for the Fe (III)
state shake-up satellite. They found two shake-up satellite peaks, 714.5 eV [Fe2+(2p3/2)], 719.0 eV
[Fe3+(2p3/2)] and two satellite peaks for, 723.3 eV [Fe2+(2p1/2)], 724.7 eV [Fe3+(2p1/2)].
Grosvenor et al in 2004, analyzed the spectra of Fe3+(2p3/2) and they found different oxide species
and relating each with different peaks that vary in its binding energy around 3.2 eV as maximum
to 2.5 as a minimum, 709.8 eV (ΔV=2.5 eV) (-Fe2O3), 709.8 eV (ΔV=3.2 eV) (-Fe2O3), 710.2
eV (ΔV=3 eV) [-FeO(OH)] and 710.3 eV (ΔV=3 eV) [-FeO(OH)]. Biesinger et al in 2011,
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analyzes the Fe (II) and Fe (III) spectra finding similarities between the two spectrums compared
to the different components for Fe (III) analyzed by Grosvenor et al in 2004. All Fe (II) exhibit a
high spin with multiple peaks and low spin ones do not exhibit these peaks. Also, they found
different components like Fe (III), which vary in their binding energy, with 6 peaks for each
component, 709.8 eV-719.3 eV (-Fe2O3),  eV− eV (-Fe2O3),  eV-719.8eV FeO(OH)], 710.3 eV–719.5 eV (-Fe2O3) and another two, a single 706.6 eV [Fe(0)] and a multiple
(5 peaks) binding energy, 708.4 eV-715.4 eV (FeO).
This last section reviews the works focus in validate the presence of boronic acid and glycated
hemoglobin in the sample. Mohapatra et al 2009, working with the spectra the Fe(2p), found two
binding energy at 710.0 eV and 725.0 eV which will be correspond to Fe3O4. Chakraborty et al in
2018, found a peak at 710 eV in the spectrum of Fe(2p), and they considered it to be the iron
present in the blood dots (BD), in a divalent Fe (II) state, which confirm the precursor an ironcontaining metalloprotein hemoglobin. The hemoglobin can be considered as biological Fenton
catalyst, which degraded heme group. And they show that the spectrum of the hemoglobin had
different peaks with correspond to binding energy, 285.0 eV assigned to the C(1s) core-level
spectra, 400.0 eV assigned to the spectrum of N(1s), 532.0 eV assigned to the spectrum of O(1s)
and 710.0 eV assigned to the spectrum of Fe (II).

The XPS detailed analyses the atoms of B(1s), C(1s), N(1s), O(1s) and Fe(2p) confirming the
immobilization of APBA in our biosensor. This indicates the immobilization of HbA1c, since this
is done through the cis-diol bounds of the boronic acid to the glycosylated hemoglobin. We were
also able to demonstrate the presence of hemoglobin, through the Fe(2p) atoms, which is an ironcontaining oxygen-transport metalloprotein. The hemoglobin molecule contains 4 subunits of
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globular protein attached to a heme group. The heme group contains an ion of Fe (II) inside a
porphyrin ring, and this state facilitates the union of oxygen for transport. Wang et al, 2018, also,
identified two peaks with the binding energy an theirs correspond bound, 283.0 eV (C-C bond)
and 534.0 eV (C-O bond), and a third peak at 400 eV attributed to the C-N bonds that form
hemoglobin.

4. 2. 4. Electrochemical characterization of PA-PPE-APBA-HbA1c.
Modified electrodes were used to demonstrate the immobilization of APBA, with different probes
such as 5 mM potassium ferricyanide chloride, 5 mM hexamine ruthenium III chloride and 0.01
PBS through the CV tests. Studies were performed through CV with H2O2 y 0.01M PBS, and
modified electrodes (PA-PPE-EDC/NHS-APBA and PA-PPE-EDC/NHS-APBA-HbA1c) to
demonstrate the immobilization of HbA1c through APBA.

a. Cyclic voltammetry (CV) analysis. A pair of well-defined and nearly symmetric redox peaks
can only be observed with a formal potential of -0.34 V to -0.65 V at the PA-PPE-APBA-HbA1c,
which result for redox process of the heme groups of HbA1c captured on APBA, similar to reports
Kim & Shim, 2013.
We compare the CV graphic for PA-PPE-APBA, which show an anionic probe-left side with
increased current with 5 mM potassium ferricyanide chloride, and a cationic probe-right side with
5 mM hexamine-ruthenium III chloride which prove the APBA immobilization. Two different
probes towards the same electrode, explain the electron transfer involved and interaction between
electrodes (negative charge) and electrostatic interaction between electrode and probe molecules
(specific potential for oxidation and reduction). The fig. 4.12.A show the CV for 5 mM potassium
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ferricyanide chloride and fig. 4.12.B. show the CV for 5 mM hexamine ruthenium chloride over
PA-PPE-APBA with different scan rate range 30 mV/s to 200 mV/s, probing the immobilization
the APBA in the modified electrode.

Figure 4.12. A. CV for PA-PPE-APBA with 5mM K-ferricyanide (anionic probe-left side) and B. 5mM rutheniumhexamine chloride 5mM (cationic probe-right side) comparative.

The HbA1c was immobilized by PA-PPE-APBA through cis-diol interactions between the diol
group of glucose of HbA1c and the boronic acid group. Overall, the oxygen functionalities and
edge plane-like sites formed at the PA-PPE play an important role in facilitating the electron
transfer between the APBA-HbA1c and electrode. The catalytic reduction peak of H2O2 by the
immobilized HbA1c, appeared around -0.31 V on the PA-PPE-APBA-HbA1c, show in Fig. 4.13.A
& 4.13.B, probe with 0.01 M PBS and H2O2 5 mM, at 0.100 V/s of scan rate, means that the
catalytic process occurs and the reduction current of H2O2 increases when the concentration of
H2O2 increases. The best results with different concentrations of HbA1c was obtained in H2O2 of 5
mM. (SD: 0.0845, SE: 0.0378, R2 of 0.997321).
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Figure 4.13. CV response of PA-PPE-HbA1c immobilized by APBA with different concentrations of H2O2.

We compare the catalytic reduction of Total Hemoglobin (HbT) and HbA1c through (PA-PPEAPBA-HbT) and (PA-PPE-APBA-HbA1c) electrodes, probes with 0.01 M of PBS and 5 mM H2O2
which was selected by showed the best activity. The peak in HbT is decreased compared to the
HbA1c peak, with the two probes, because HbT do not have too much bounding groups and
therefore show less reduction, see Fig. 4.14.A & 4.14.B.

Figure 4.14. (A & B) CV response of PA-PPE-APBA-HbA1c and PA-PPE-APBA-HbT with 5mM H2O2 at a scan rate
of 50 mV/s.
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CV was analyzed for PA-PPE-APBA-HbA1c at different scan rates ranged from 50 to 300 mV/s.
We found a well-defined graphic for a redox process with an electroactive reduction and
electroactive oxidation curves with two well-defined peaks, fig.4.15. A. The currents for the anodic
and cathodic peaks have a good linearly relationship with the scan rate, see fig. 4.15.B. and the
plot of logarithm between the log of peak current (ip) versus log of scan rate (v), the relationship
show a linear (log ip (A) = 0.7967 + 0.4629 log v) proportionality suggested that the reaction,
indicates a surface-diffusion controlled process, with a curve slopes of m= 0.4629 as a transfer
coefficient (a) (fig. 4.15.C) (SD: 0.1154, SE: 0.0483, R2: 0.98854), it is thus expected that the PAPPE-APBA-HbA1c molecule does not extend gradually to an unfolded structure, and its behavior
is very similar to voltammetric sensor developed by Zhou et al, 2015, based on phenylboronic
acid-modified pyrroloquinolone (APBA-PPQ) and reduced graphene oxide.

Figure 4.15. (A). CV response of PA-PPE immobilized with APBA-HbA1c 3.125% in 0.01 M PBS at a scan rate
of 50-300 mV/s, and (B), plots of anodic and cathodic peak current with scan rate, (C) show the plot of the log
of scan rate (V/s) and log of peak current (A), with linear relationship and slope of 0.4629.
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The electron transfer constant, (Ks) for the PA-PPE-APBA-HbA1c biosensor was calculated with
the Laviron equation (nΔEp < 200) (Laviron, 1979):
Equation 26: Ks = (1-) nFv / RT
Where a represent charge transfer coefficient ( = 0.4629),
n is the transferred electrons number; F: Faraday constant 96,485.3321 C.mol-1,
R is the Universal gas Constant, 8.1314 J mol-1 K-1,
T: Room temperature (298o K), and
The Ks = 4.277 s-1.
The surface average concentration (Γ) of electroactive APBA value, was calculated from the
equation Γ = Q/nFA, and Γ = 9.6416 e-9 mol/cm2, which it is bigger than Kim & Shim, 2013 (Γ =
1.03 e-10 mol/cm2), means that the higher heterogeneous direct electron transfer rate constant is
directly influenced by the multilayer coverage of APBA. The (Γ) is bigger than Cobalt ferrite
nanoparticles and chitosan film on the surface of glass carbon electrode biosensor to detect H2O2
based on direct electrochemistry of Hb (Yang et al. 2011, Γ= 2.10e-11mol/cm2).
Different experiments of calibration conducted through CV on the PA-PPE-APBA-HbA1c
biosensor show good performance to identify glycated hemoglobin at different concentrations with
a sensitivity of 208.9461 AmM-1cm-2 (SE 0.2578) which, was calculated as the current density
(current/area) and plotted against the concentration of HbA1c.

b. Chronoamperometry (CA) analysis. We analyzed the CA response for the PA-PPE-APBAHbA1c because it is more sensitive and can reach lower and higher detection limits. The
amperograms for the reduction of HbA1c were recorded using the sensor probe in 0.01 M PBS (pH
7.4) and H2O2 5 mM containing different concentration of HbA1c. Figure 4.16. shows the CA
responses of HbA1c reduction at different concentrations of HbA1c at -0.55 V. As there is a
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progressive increase in the concentration of HbA1c immobilized, the current catalyst of HbA1c
concentration increases, therefore is an increase in the catalytic current of H2O2. HbA1c specifically
catalyzes the reduction of H2O2 (Kim & Shim, 2013). The figure 4.16.A and figure 4.16.B show
the CA responses at different concentrations of HbA1c, lower as 0.0015% through 6.25% higher
and the fig. 4.16.C show the plot for log of peak current (1e-4A) and log of HbA1c% concentrations.
The analysis of plot fig. 4.8.C show (SD:0.2790; SE: 0.0659; and R2: 0.9943) show that the
biosensor-electrode PA-PPE-APBA-HbA1c have high sensitivity, with a low detection limit as
4.54ng/5mL. The linearity of the glucose concentrations range for precision evaluations in the
human range is between 30 mg/dL through 400 mg/dL and for HbA1c 2.6 through 16.9% (FDA,
2016).

Figure 4.16. (A & B) Chronoamperometric (CA) response for PA-PPE-APBA-HbA1c towards different concentrations
of HgbA1c. (C) Plot: Y= log of the peak current A and X= log of the HbA1c % concentration.
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4. 2. 5. Discussion.
i. A well-defined redox peak, due to improved electrochemical conductivity through the preanodization and covalent immobilization techniques with cross-linking agents. The PA-PPEAPBA-HbA1c. has a redox peak of -0.34 V to -0.65 V, which result for the redox process of the
heme groups of HgbA1c captured on APBA (Kim & Shim, 2013).
ii. The immobilization of APBA and APBA-HbA1c was demonstrated with different probes, in our
modified electrodes.
iii. Through FT-IR we can demonstrate first the immobilization of APBA cofactor and
subsequently the immobilization of APBA-HbA1c, with their respective modifications and
differences in their characterization. Likewise, we established the differences observed in the
immobilization of total hemoglobin and glycated hemoglobin.
iv. The spectrum of B(1s), C(1s), N(1s) and O(1s) found in studies conducted through XPS, allows
us to demonstrate first the presence of the APBA immobilized in our electrode PA-PPE-APBA
and second the immobilization of glycosylated hemoglobin (HbA1c), because it is attached to the
APBA through the cis-diol bonds of the boronic acid. Also, we can demonstrate the presence of
hemoglobin, due to the spectrum of the Fe(2p), which appears only when there is an ironmetalloprotein precursor the hemoglobin (McIntyre & Zetaruk in 1977; Lin et al in 1997;
Grosvenor et al in 2004; Biesinger et al in 2011; Mohapatraa et al 2009; Chakraborty et al in
2018; Wang et al in 2018).
v. The PA-PPE-APBA-HbA1c as the progressive increase in the concentration of immobilized
HgbA1c, the current catalyst of HbA1c concentration increases, therefore is an increase in the
catalytic current of H2O2. HbA1c specifically catalyzed the reduction of H2O2 (Kim & Shim, 2013).
Plot the log HbA1c concentration % versus log current show a linear range between 0.0015%
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through 6.25% with high sensitivity and detection limit range of 4.54 ng/5 mL. This relationship
shows a linear proportionality suggested that the reaction, indicates a surface-diffusion controlled
process, with a curve slopes of m= 0.4629 as a transfer coefficient (a).
vi. The electron transfer rate constant, (Ks) for the PA-PPE-APBA-HbA1c electrode was calculated
with the Laviron equation (nΔEp < 200) and Ks = 4.277 s-1.
vii. The surface average concentration of electroactive APBA (Γ) value was calculated = 9.6416
e-9 mol/cm2).
viii. Calibration experiments of the PA-PPE-APBA-HbA1c biosensor showed good performance
to identified glycated hemoglobin at different concentrations with a sensitivity of 208.9461
mM-1cm-2 (SE 0.2578) calculated as the current density (current/area) and plotted against the
concentration.
ix. The biosensor shows high selectivity and specificity, toward glycated hemoglobin, when we
compared the glycated hemoglobin (HbA1c) and total hemoglobin (HbT), adjusted on different
concentrations.
x. In order to review the reproducibility, different electrodes (PA-PPE-APBA-HbA1c) were testing
in 3 days and 90 days show an EP of 3.96% and 4.47% respectively, means the electrodes have
good shelf life, reproducibility and stability.
xi. The validation for the electrodes (PA-PPE-APBA-HbA1c) was do through the analytical
recovery experiments, which was performed with different samples of whole blood and the
percentage of recovery was calculated from the data (calculated value of HbA1c /original
concentration or spiked concentration) x 100. The values are 90%, 105%, 102%, 97%) with
eAverage 98.5% for HgbA1c (see Fig. 4.17).
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Figure 4. 17. Shows the plot graphic for percentage of recovery for the PA-PPE-APBA-HbA1c for whole blood
HgbA1c biosensor.

4. 3. Conclusions.
We can prove the electro catalytic proprieties of HbA1c, through CV and CA electro chemistries
studies, show the interaction between HbA1c, HPBA and the specific reaction of H202 with HbA1c.
We can characterize the electrodes (PA-PPE-APBA and PA-PPE-APBA-HbA1c) through the FTIR spectroscopy and XPS, showing the changes which occur when the APBA and the HbA1c are
immobilized in the electrode.
The biosensor shows high selectivity and specificity when we compared the glycated hemoglobin
and total hemoglobin.
The novel pre-anodized paper printed electrode transducer to detects HbA1c (PA-PPE-APBAHbA1c) shows high sensitivity (208.9461 A mM-1 cm-2) and low detection limit (4.54 ng/5mL),
selectivity, stability, feasibility, portability and low costs.
Our biosensor offers new possibilities for the development of portable and customized equipment
for better glucose control. Also, as a basis for the development of new applications in the medicalbiological area.
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OVERALL CONCLUSIONS

Our project allowed us to develop two biosensors, which can serve as the basis for building a
diagnostic system for self-monitoring blood glucose (SMBG), blood glucose meter systems
(BGMSs) and hemoglobin A1c- point-of-care (HbA1c POC), which meets the FDA requirements
and recommendations.
Used individually, the biosensor for measuring glucose (PA-PPE-GOX-Glucose), provides the
physician with accurate and quantitative measure of clinical glucose values in states of
hypoglycemia and hyperglycemia. It also, serves as a system to monitor in the management of
patients in these critical clinical states.
Glycolate hemoglobin measurement biosensor (PA-PPE-APBA-HbA1c) will help physicians gain
immediate knowledge of glucose behavior in diabetic and pre-diabetic patients, reducing
subsequent medical visits to evaluate laboratory outcomes and provide timely and preventive
management.
These biosensors have the potential for clinical acceptance due to their high sensitivity, high
specificity, feasibility, low cost, and portability, as well as individualizing for management and
monitoring in diabetic and prediabetic patients.
Can serve as a basis for building systems for people with disabilities.
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ABBREVIATIONS

A1cDAG

A1c-derived average glucose

AA

ascorbic acid

AACC

American association clinical chemistry

AAP

acetaminophen

ADA

American diabetes association

APBA

amino phenyl boronic acid

BET

Bernauer-Emmett-Teller

BGMS

blood glucose monitoring system

CA

chronoamperometry

CAGR

compound annual growth rate

CAP

college of American pathologists

CCP

cytochrome c-peroxidase

CDC

Center for disease control and prevention

CE

counter electrode

CMC

1-cyclohexyl-3-(2-morpholinoethyl) carboiimide

CNDO

complete neglected of differential overlap

CNTs

carbon nanotubes

CPRL

central primary reference laboratory

CV

cyclic voltammetry

CVD

cardiovascular disease

DCC

dicyclohexyl cardodiimide

DCCT

diabetes control and complications trial

DET

direct electron transfer

Dend-FPBA

dendrimer layer 4-formil-phenyl-boronic acid

DIC

diisopropyl carbodiimide

DOCA

deoxycholate

DPA

diphenylamine

EDC

1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride

EDIC

epidemiology of intervention and diabetes complications
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FAD

flavin adenine dinucleotide, oxidized form

FADH2

flavin adenine dinucleotide, reduced form

FAO

fructosyl amino acid oxidase

FBPA

4-formyl-phenyl-boronic acid

FcBA

ferrecene-boronic acid

FDA

The food and drug administration

FPG

fasting blood glucose

FTIR

Fourier transform infrared

FV

fructosyl valine

GC

glassy carbon

GCE

glassy carbon electrode

GDH

glucose dehydrogenase

GDH-PQQ

glucose-1-dehydrogenase-pyrroloquinoline quinone

GM

blood glucometer

GOX

glucose oxidase

HbA

hemoglobin A

HbF

fetal hemoglobin

HCGO

highly concentrated graphene oxide

HCT

hematocrit

HOPG

highly ordered pyrolytic carbon electrode

HPLC

high performance liquid chromatography

HRP

horseradish peroxidase

IFCC

international federation of clinical chemistry and laboratory medicine

IUPAC

international union of pure and applied chemistry

LA

lactic acid

MBA

4-mercaptobenzoic acid

MBG

mean blood glucose

MPBA

-mercapto-phenylboronic acid

MWCNTs

multi-walled carbon nanotubes

NGSP

National glycohemoglobin standardization program

NHS

N-hydrosuccinimide or 1-hydroxy-2-5-pyrrolidinedione
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OECD

Organization of economic cooperation and development

OGTT

oral glucose tolerance test

PAPBA

poly (3-amino-phenil boronic acid)

PA-PPE

pre-anodized printer paper electrode

PBA-PQQ

phenyboronic acid-modified pyrroquinoline quinine

PDPA

poly(diphenylamine)

PG

plasma glucose

POC

point-of-care

PPE

printer paper electrode

PPQ-FAD

pyrroquinoline quinone-flavin adenine dinucleotide

RE

pseudo-reference electrode

RGO

reduced graphene oxide

SA

salicylic acid

SAM

self-assembled monolayer

SMBG

self-monitoring blood glucose

SPCE*

pre-anodized screen-printed carbon electrode

SRL

secondary reference laboratory

SWCNTs

single-walled carbon nanotubes

SWV

square-wave voltammetry

T3BA

thiophene-3-boronic acid

TBA

p-benzoic acid

TBO

toluidine blue O

UA

uric acid

UKPDS

United Kingdom prospective diabetes study

WE

working electrode

WHO

World health organization

XPS

X-ray photoelectron spectroscopy

ZnONPs/PPy

zinc oxide nanoparticles/polypyrrole
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APPENDICES

Appendix 1.
1.1. Criteria for the diagnosis of diabetes (ADA, 2019)
Fasting plasma glucose (FPG) ≥126 mg/dL (7.0 mmol/L). Fasting is deﬁned as no caloric intake
for at least 8 h.*
OR
2-h Plasma glucose (PG) ≥200 mg/dL (11.1 mmol/L) during oral glucose tolerance test (OGTT).
The test should be performed as described by the WHO, using a glucose load containing the
equivalent of 75-g anhydrous glucose dissolved in water. *
OR
A1C ≥6.5% (48 mmol/mol).
The test should be performed in a laboratory using a method that is NGSP certiﬁed and
standardized to the DCCT assay. *
OR
In a patient with classic symptoms of hyperglycemia or hyperglycemic crisis, a random plasma
glucose ≥200 mg/dL (11.1 mmol/L).
*In the absence of unequivocal hyperglycemia, diagnosis requires two abnormal test results from
the same sample or in two separate test samples
1. 2. Criteria deﬁning prediabetes. * (ADA, 2019)
Fasting plasma glucose (FPG) 100 mg/dL (5.6 mmol/L) to 125 mg/dL (6.9 mmol/L) (IFG)
OR
2-h plasma glucose (PG) during 75-g oral glucose tolerance test (OGTT) 140 mg/dL (7.8 mmol/L)
to 199 mg/dL (11.0 mmol/L) (IGT)
OR
A1C 5.7–6.4% (39–47 mmol/mol)
*For all three tests, risk is continuous, extending below the lower limit of the range and becoming
disproportionately greater at the higher end of the range.

1. 3. Criteria for testing for diabetes or prediabetes in asymptomatic adults
1. Testing should be considered in overweight or obese (BMI ≥25 kg/m2 or ≥23 kg/m2 in Asian
Americans) adults who have one or more of the following risk factors:
▪ First-degree relative with diabetes
▪ High-risk race/ethnicity (e.g., African American, Latino, Native American, Asian
American, Paciﬁc Islander)
▪ History of CVD
▪ Hypertension (≥140/90 mmHg or on therapy for hypertension)
▪ HDL cholesterol level <35 mg/dL (0.90 mmol/L) and/or a triglyceride level >250 mg/dL
(2.82 mmol/L)
▪ Women with polycystic ovary syndrome
161

▪
▪

Physical inactivity
Other clinical conditions associated with insulin resistance (e.g., severe obesity,
acanthosis nigricans)

2. Patients with prediabetes (A1C ≥5.7% [39 mmol/mol], IGT, or IFG) should be tested yearly.
3. Women who were diagnosed with GDM should have lifelong testing at least every 3 years.
4. For all other patients, testing should begin at age 45 years.
5. If results are normal, testing should be repeated at a minimum of 3-year intervals, with
consideration of more frequent testing depending on initial results and risk status.
Table. 1. 4. Glucose meters accuracy standards. (ADA, 2019, FDA, 2018)
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Appendix 2. HbA1c.
2. 1. Discovery of HgA1c and its sequential utility in the medical clinic.
➢ 1958: Allen et al, demonstrated the heterogeneity of the human hemoglobin (Hb).
➢ 1958: Huisman, T.H.J. and Meyering, C.A. Isolate three different hemoglobin fractions,
including the isolation of Hemoglobin A1c.
➢ 1966: Holmquist, W.R. and Schroeder, W.A. identify five subtypes of hemoglobin A,
including HbA1c.
➢ 1968: Bookchin, R.M. and Gallop, P.M. Identify the structure of HbA1c as a glycoprotein,
➢ 1968: Rahbar, S. discovers that HbA1c percentage for this fraction is elevated in patients
with diabetes.
➢ 1976: Bunn, H.F. characterizes the biosynthesis in formation of HbA1c
➢ 1976: Koenig, R.J and Cerami, A. propose HbA1c as an indicator for blood glucose levels
in diabetes
➢ 1977: measured of Total HbA1 introduced in routine clinical laboratories as a tool for
monitoring diabetes.
➢ 1995: Diabetes control and complications trial research group (DCCT), establishes
significance of HbA1c as a clinical marker in type-1 diabetes.
➢ 1998: United Kingdom prospective diabetes study (UKPDS), sets the relationship between
HbA1c y frequency of microvascular complications in patients with type 2 diabetes.
➢ 2007: NGSP recommendations for the standardization criteria of HbA1c assays indicate
average blood glucose.
➢ 2010: WHO, ADA, validate HbA1c as diagnostic test for diabetes and prediabetes
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2. 2. The relationship between HbA1c results from the NGSP network (%HbA1c) and the
IFCC network (mmol/mol) and calculations:
Type of Patient
Non-diabetic (normal)
Diabetic
High risk developing diabetes

NGSP Value
<5.7 %
6.5% or higher
5.7% – 6.4%

IFCC Value
<39 mmol/mol
48 mmol/mol or higher
39-46 mmol/mol

NGSP – National glycohemoglobin standardization program
IFCC – International federation of clinical chemistry
HgbA1c (IFCC) SI units mmol/mol = {[HgbA1c (NGSP) unit in % x 10.93] – 23.50}
(IFCC)A1c (mmol/mol) = [(NGSP)A1c (%) – 2.15] x 10.929
NSGP (%) = 0.09148 x IFCC (mmol HbA1c / mmol Hb) = 2.512
The equation to calculate eAG (in mg/dL) from hemoglobin A1c (in %) is as follows:
eAG (mg/dL) = [28.7 x (NGSP)A1c (%)] – 46.7 or eAG (mg/dL) = (28.7 x HbA1c%) – 46.7
Table A1.2 Relationships between NGSP, IFCC and eAG.

Diabetes UK. Assessed May 2020.
Hanas, Ragnar MD. And John, Garry. 2010 consensus statement on the worldwide standardization
of the hemoglobin A1C measurement. Diabetes Care. 2010. Vol. 33 (8): 1903-1904.
Hanas, R. MD and John, W.G. MD. 2013 Update on the worldwide standardization of the
hemoglobin A1c measurement. Pediatric diabetes. 2013. doi: 10.1111/pedi.12047
NGSP. International federation of clinical chemistry (IFCC) standardization of HbA1c. (Assessed
November 2019).
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J. Translating the A1Cassay into estimated average glucose values. Diabetes Care. 2008. 31:1473–
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2. 3. Recommendations for HbA1c testing (ADA, 2018 & 2019).
• Perform the A1C test at least two times a year in patients who are meeting treatment goals
(and who have stable glycemic control). E
•

Perform the A1C test quarterly in patients whose therapy has changed or who are not
meeting glycemic goals. E

•

Point-of-care testing for A1C provides the opportunity for more timely treatment changes.
E

American Diabetes Association. Glycemic targets: Standards of medical care in diabetes-2018.
Diabetes Care. 2018. 42 (suppl. 1): S61-S70. https://doi.org/10.2337/dc18-S006.
American Diabetes Association. Glycemic targets: Standards of medical care in diabetes-2019.
Diabetes Care. 2019. 42(suppl. 1): S61-S70. https://doi.org/10.2337/dc19-S006.

2. 4. The following prerequisites for the introduction of an HbA1c-POC instrument should be
met to ensure optimal POC testing: (Lenters-Westra et al, 2012)
(1) HbA1c-POC instruments should fall under responsibility of the central laboratory and (2)
acceptable analytical performance (ideally: no bias, coefficient of variation < 3.0% (based on IFCC
numbers), < 2.0% (based on DCCT numbers)). Validation of the POC instrument by central
laboratory.
(2) connectivity to the central Laboratory for data management.
(3) education and training for users should be done by experienced POC coordinators (e-learning).
(4) only accredited users should be allowed to use the instrument.
(5) internal and external quality control should be coordinated by a POC coordinator.
(6) ordering and control of reagent/cartridges should also be done by a POC coordinator (check of
new lot number).
(7) once a year the patients HbA1c should be analyzed with the central laboratory method.
Lenters-Westra, Erna; Schindhelm, Roger K; Bilo, Henk J. and Slingerland, Robbert J.
Haemoglobin A1c: Historical overview and current concepts. Diabetes research and clinical
Practice. 2013. 99: 75-84.

166

Appendix 3. HbA1c.

Pundir, Chandra S and Chawla, Sheetal. Determination of glycated hemoglobin with special
emphasis on biosensing methods. Analytical Biochemistry. 2014. 444:47-56. Permission received
to publish tables.
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Table S1. A partial list of the electrochemical HbA1c sensors.
Electrode

Method

Sensing
Target

Ref.

N/A

Limit of
detection
(LOD)
1 ng/ml

AuNPs/GCE

impedance
(Rct change)
impedance
(Rct change)
impedance
(capacitance
change)
potentiometric

N/A

N/A

no redox mediator or
enzyme

10–100 ng/μl N/A

N/A

Park
2008
Chua
2012

HbA1c

Ppy, HbA1c antibody

4–18 μg/ml

N/A

N/A

Qu et

potentiometric

HbA1c

alizarin red s (ARS)

5.0–50 μg/ml

N/A

N/A

FAO/ZnONPs/
Ppy/Au

amperometric
(CV)

Fructosyl
valine

Fe(CN)63-/Fe(CN)64, FAO

0.1–3.0 mM

38.42 μAmM-1

0.1 mM

Liu a
Croo
Chaw
Pund

PVIFAO3/CPE4

amperometric

Fructosyl
valine

m-PMS5, FAO

20 μM–0.7
mM

500 nA  mM-1
(at 0.1 V)

20 μM

Sode
2001

PVA-FAO/Pt

amperometric
(FIA)

Fructosyl
valine

FAO

0.2–10 mM

4.6 nA cm-2
mM-1
(at 0.6 V)

0.2 mM

Ogaw
2002

FAO/FeNPs/Au amperometric
(CV)

Fructosyl
valine

Fe(CN)63-/Fe(CN)64, FAO

0.1–2.0 mM

Chaw
Pund

GCE

amperometric

Fructosyl
valine

FcBA6

0.1–4.0 mM

50 μM
(151.5 μM for
LOQ)
0.5 mM

platinum

amperometric

HbA1c

glucose oxidase
horseradish peroxidase
Anti-Hb antibody

5–20%

N/A

Stolln
2002

ZrO 2/DDAB7/P
GE8

amperometric

HbA1c

FcBA

6.8–14.0%

Si/Au-CysFPBA29

amperometric

HbA1c

ferrocenemethanol,
glucose oxidase

4.5–15.0%

APBA/pTTBA
10/
AuNPs/SPCE
PAPBA/SPCE

amperometric

HbA1c

H2O2

amperometric

HbA1c

PAPBA on the eletrode

T3BA 1/Au
T3BA/Au
PPy2–
AuNPs/Au
GCE

Linear
range

Sensitivity

HbA1c

Key species
(redox mediator,
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